EOS Med Chem Impurity Stock 20201029-45

   

EOS Med Chem is serving more than 100 Pharma companies, we have the original Drug Discovery Compounds, Like Impurity, small molecule and inhibitor.

Impurity we keep stock more than 80000, most in stock, we are World Sole Original Supplier, Each impurity we could supply: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA.

EOS Med Chem Quotation include: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, COA, MSDS.

Welcome to visit: our youtube:  https://youtu.be/r5cJdXKNXHk 

Contact:

EOS Med Chem, Medicinal Chemical is Big

執大象，天下往，往而無害，安平泰

Ms Nina

Youtube: https://youtu.be/r5cJdXKNXHk 

E: info@eosmedchem.com 

W: www.eosmedchem.com 

Tel: 0086-531-69905422

SALE OFFICE: 16F, China Overseas Plaza, Jinan City, China

9,10-Dihydro-2,6(7)-dimethylanthracene, CAS: 1215596-01-2, stock: 5.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈.

9,10-Dihydro-9,10-ethanoanthracene-9-carboxylic Acid, CAS: 20202-05-5, stock: 7.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄O₂.

9,10-Dihydroanthracene, CAS: 613-31-0, stock: 6.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂.

9,10-Dihydrobenz[a]anthracen-11(8H)-one, CAS: 60968-15-2, stock: 1.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄O.

9,10-Dihydrobenz[a]anthracen-11(8H)-one-d10, CAS: /, stock: 9.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₄D₁₀O.

9,10-Dihydroxy-2,3-dihydroanthracene-1,4-dione, CAS: 17648-03-2, stock: 7.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀O₄.

9,10-Dimethoxy-2-anthracenesulfonic Acid Sodium Salt, CAS: 67580-39-6, stock: 7.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃NaO₅S.

9,10-Dimethylanthracene, CAS: 781-43-1, stock: 6.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄.

9,10-Dioxo-9,10-dihydroanthracene-2-carboxylic Acid, CAS: 117-78-2, stock: 4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₈O₄.

9,10-Diphenylanthracene, CAS: 1499-10-1, stock: 7.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₁₈.

9,10-Ethanoanthracene-9(10H)-propanamide, CAS: /, stock: 3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉NO.

9,9’-Bianthracene, CAS: 1055-23-8, stock: 5.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₁₈.

9,9’-Bifluorenyl, CAS: 1530-12-7, stock: 9.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₁₈.

9-(1-Naphthyl)-10-(2-Naphthyl) Anthracene, CAS: 855828-36-3, stock: 3.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₂₂.

9-(2-Naphthyl)anthracene, CAS: 7424-72-8, stock: 9.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₆.

9-(3-Bromophenyl)-10-phenylanthracene, CAS: 1023674-80-7, stock: 8.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₁₇Br.

9-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)anthracene, CAS: 709022-63-9, stock: 6.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁BO₂.

9-(4-Bromophenyl)-10-(1-naphthyl)anthracene, CAS: 1160506-32-0, stock: 6.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₁₉Br.

9-(4-Bromophenyl)-10-(2-naphthyl)anthracene, CAS: 936854-62-5, stock: 7.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₁₉Br.

9-(4-Bromophenyl)-10-phenylanthracene, CAS: 625854-02-6, stock: 7.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₁₇Br.

9-(N-Methylaminomethyl)anthracene, CAS: 73356-19-1, stock: 6.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅N.

9-([1,1’-Biphenyl]-4-yl)-10-bromoanthracene, CAS: 400607-05-8, stock: 4.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₁₇Br.

9-Acetylanthracene, CAS: 784-04-3, stock: 3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂O.

9-Anthraceneacetic Acid 2,5-Dioxo-1-pyrrolidinyl Ester, CAS: 1253107-42-4, stock: 8.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₅NO₄.

9-Anthraceneboronic Acid, CAS: 100622-34-2, stock: 9.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁BO₂.

9-Anthracenecarboxylic Acid, CAS: 723-62-6, stock: 1.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀O₂.

9-Anthracenemethanol, CAS: 1468-95-7, stock: 1.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂O.

9-Anthracenepropan-1’-one 1’-(4’-Methylbenzene), CAS: /, stock: 5.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₀O.

9-Anthracenepropanoic Acid, CAS: 41034-83-7, stock: 4.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄O₂.

9-Anthracenepropanoic Acid Ethyl Ester, CAS: 109690-74-6, stock: 4.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈O₂.

9-Anthracenylmethyl Chloride, CAS: 24463-19-2, stock: 9.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁Cl.

9-Anthracenylmethyl Methanesulfonothioate, CAS: /, stock: 4.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄O₂S₂.

9-Anthraldehyde, CAS: 642-31-9, stock: 2.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀O.

9-Anthryl Methacrylate, CAS: 32468-70-5, stock: 3.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄O₂.

9-Anthryldiazomethane, CAS: 10401-59-9, stock: 9.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀N₂.

9-​Anthraceneacetic Acid, CAS: 6624-23-3, stock: 5.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂O₂.

9-​Anthraceneacetonitri​le, CAS: 2961-76-4, stock: 5.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁N.

9-Bromo-10-(1,1’:3’,1’’-terphenyl-5’-yl)anthracene, CAS: 474688-74-9, stock: 1.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₂₁Br.

9-Bromo-10-(10-naphthalen-2-ylanthracen-9-yl)anthracene, CAS: 1172087-81-8, stock: 6.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₂₃Br.

9-Bromo-10-(2-naphthyl)anthracene, CAS: 474688-73-8, stock: 8.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₅Br.

9-Bromo-10-(2-phenylphenyl)anthracene, CAS: 400607-16-1, stock: 4.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₁₇Br.

9-Bromo-10-(naphthalen-1-yl)anthracene, CAS: 400607-04-7, stock: 2.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₅Br.

9-Bromo-10-phenanthren-9-ylanthracene, CAS: 845457-53-6, stock: 4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₁₇Br.

9-Bromo-10-phenylanthracene, CAS: 23674-20-6, stock: 6.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₃Br.

9-Bromo-10-[4-(1-naphthyl)phenyl]anthracene, CAS: 1092390-01-6, stock: 2.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₁₉Br.

9-Bromo-9,10-dihydro-9,10-ethenoanthracene, CAS: 126690-96-8, stock: 9.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁Br.

9-Bromo-9,10-dihydro-9,10-[1,2]benzenoanthracene, CAS: 15364-55-3, stock: 3.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₃Br.

9-Bromoanthracene, CAS: 1564-64-3, stock: 7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉Br.

9-Carboxyanthracene MTSEA Amide, CAS: 1159977-19-1, stock: 5.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇NO₃S₂.

9-Carboxyanthracene MTSEA Amide-d4, CAS: 1330045-80-1, stock: 2.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₃D₄NO₃S₂.

9-Chloroanthracene, CAS: 716-53-0, stock: 7.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉Cl.

9-Chlorophenanthrene, CAS: 947-72-8, stock: 8.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉Cl.

9-Chlorophenanthrene-13C6(mixture of 2 isomers, Contain 4.2% unlabeled), CAS: /, stock: 9.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₆H₉Cl.

9-Hydroxybenz[a]anthracene, CAS: 34570-62-2, stock: 2.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₂O.

9-Isopropyl-2-methylbenz[a]anthracene, CAS: /, stock: 9.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀.

9-Methylanthracene, CAS: 779-02-2, stock: 1.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂.

9-Methylbenz[a]anthracene, CAS: 2381-16-0, stock: 8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄.

9-Methylbenz[a]anthracene-d14, CAS: 1794766-60-1, stock: 5.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉D₁₄.

9-Nitroanthracene, CAS: 602-60-8, stock: 2.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉NO₂.

9-Nitrofluorene, CAS: 14544-96-8, stock: 1.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉NO₂.

9-Phenylanthracene, CAS: 602-55-1, stock: 2.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₄.

9-Trifluoroacetylanthracene, CAS: 53531-31-0, stock: 1.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₉OF₃.

9-Vinylanthracene, CAS: 2444-68-0, stock: 2.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂.

Acenaphth[1,2-a]anthracene, CAS: 205-83-4, stock: 5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₄.

2,​4,​6-​Trifluoro-s-triazine, CAS: 675-14-9, stock: 8.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃F₃N₃.

Acenaphth[1,2-a]anthracene-d14, CAS: /, stock: 8.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄D₁₄.

Acenaphth[1,2-b]anthracene, CAS: 207-18-1, stock: 9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₄.

2-Amino-4,6-dichloro-s-triazine, CAS: 933-20-0, stock: 8.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₂Cl₂N₄.

2-Amino-4,6-dichloro-s-triazine-13C3, CAS: /, stock: 6.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₃H₂Cl₂N₄.

Acenaphth[1,2-b]anthracene-d14, CAS: /, stock: 3.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄D₁₄.

Acid Alizarin Blue BB, CAS: 10114-40-6, stock: 8.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₆Na₂O₁₄S₂.

2-Amino-4-hydroxy-6-chloro-s-triazine, CAS: 38862-29-2, stock: 8.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₃ClN₄O.

Ammelide, CAS: 645-93-2, stock: 7.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₄N₄O₂.

Acid Alizarin Red B, CAS: 1836-22-2, stock: 7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₉N₂Na₃O₉S₂.

Acid Anthracene Brown PG, CAS: 6369-32-0, stock: 1.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₅N₃Na₂O₆S.

Ammelide -13C3, CAS: 1173021-81-2, stock: 9.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₃H₄N₄O₂.

Acid Blue 129, CAS: 6397-02-0, stock: 1.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₉N₂NaO₅S.

Acid Blue 25, CAS: 6408-78-2, stock: 2.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₃N₂NaO₅S.

Acid Blue 260, CAS: 67827-60-5, stock: 2.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₂₆N₃O₆SNa.

Acid Green 25, CAS: 4403-90-1, stock: 6.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₀N₂Na₂O₈S₂.

Acid Green 27, CAS: 6408-57-7, stock: 5.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₂N₂Na₂O₈S₂.

1-(4-(4-Hydroxyphenyl)butan-2-yl)-1H-indole-5,6-diol, CAS: /, stock: 1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉NO₃.

Acid Red 97, CAS: 10169-02-5, stock: 8.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₂₀N₄Na₂O₈S₂.

N-Isopropylnoradrenochrome, CAS: 3736-31-0, stock: 9.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₃.

N-Isopropylnoradrenochrome-d7, CAS: /, stock: 5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₆D₇NO₃.

Alizarin, CAS: 72-48-0, stock: 5.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₈O₄.

Alizarin Red S (Technical Grade), CAS: /, stock: 6.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₈O₇S  • xNa.

Aloe Emodin 8-Glucoside, CAS: 33037-46-6, stock: 1.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀O₁₀.

Aloe-emodin, CAS: 481-72-1, stock: 1.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀O₅.

Aloe-emodin-d5, CAS: 1286579-72-3, stock: 1.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₅D₅O₅.

Altersolanol A, CAS: 22268-16-2, stock: 3.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆O₈.

Anthracene, CAS: 120-12-7, stock: 3.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀.

Anthracene 9,10-dipropionate Disodium Salt, CAS: 82767-90-6, stock: 6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈Na₂O₄.

Anthracene-1,4-dione, CAS: 635-12-1, stock: 8.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₈O₂.

Anthracene-13C6, CAS: 189811-60-7, stock: 5.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₆H₁₀.

Anthracene-2,6-dicarboxylic acid, CAS: 138308-89-1, stock: 4.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₀O₄.

Anthracene-9,10-diboronic acid bis(pinacol) ester, CAS: 863992-56-7, stock: 2.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₂B₂O₄.

Anthracene-d10, CAS: 1719-06-8, stock: 1.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄D₁₀.

Anthragallol, CAS: 602-64-2, stock: 4.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₈O₅.

Anthraquinone, CAS: 84-65-1, stock: 8.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₈O₂.

Anthraquinone-2,7-disulfonic Acid Disodium Salt, CAS: 853-67-8, stock: 8.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₆Na₂O₈S₂.

Anthraquinone-2-sulfonic Acid Sodium Salt Monohydrate, CAS: 153277-35-1, stock: 4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₇NaO₅S• H ₂O.

Anthraquinone-D8, CAS: 10439-39-1, stock: 8.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄D₈O₂.

Anthrarobin, CAS: 577-33-3, stock: 1.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀O₃.

Anthrone, CAS: 90-44-8, stock: 7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀O.

Atramycin B, CAS: 137109-49-0, stock: 3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₄O₈.

Aurantioobtusin, CAS: 67979-25-3, stock: 9.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄O₇.

Averantin, CAS: 5803-62-3, stock: 7.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀O₇.

B-(6-Methyl-3-pyridazinyl)boronic Acid, CAS: 1258867-68-3, stock: 6.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇BN₂O₂.

Banoxantrone Dihydrochloride, CAS: 252979-56-9, stock: 6.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈N₄O₆ • 2(HCl).

Benzanthrone, CAS: 82-05-3, stock: 3.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₀O.

Benzoctamine Hydrochloride, CAS: 10085-81-1, stock: 1.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀ClN.

Benzoctamine-d3 Hydrochloride, CAS: 1329833-52-4, stock: 7.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇D₃ClN.

Benzylmaleimide, CAS: 1631-26-1, stock: 3.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉NO₂.

Benz[a]anthracen-3-ol, CAS: 4834-35-9, stock: 3.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₂O.

Benz[a]anthracen-3-ol-13C6, CAS: /, stock: 6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂¹³C₆H₁₂O.

Benz[a]anthracen-3-ol-d11 (Major), CAS: /, stock: 5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉D₁₁HO.

Benz[a]anthracene, CAS: 56-55-3, stock: 4.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₂.

Benz[a]anthracene-13C6, CAS: /, stock: 6.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂¹³C₆H₁₂.

Benz[a]anthracene-7,12-dione, CAS: 2498-66-0, stock: 5.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₀O₂.

Benz[a]anthracene-7,12-dione-D4, CAS: /, stock: 7.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₆D₄O₂.

Benz[a]anthracene-7-acetic Acid, CAS: 20316-12-5, stock: 4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₄O₂.

Benz[a]anthracene-7-acetic Acid Methyl Ester, CAS: 63018-40-6, stock: 5.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₆O₂.

(2S)-2-Aminomethyl-1-ethylpyrrolidine, CAS: 22795-99-9, stock: 3.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆N₂.

(2S)-2-Aminomethyl-1-ethylpyrrolidine-d5, CAS: /, stock: 5.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁D₅N₂.

Benz[a]anthracene-7-acetic Acid-13C2, CAS: 1794781-73-9, stock: 9.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³C₂H₁₄O₂.

Benz[a]anthracene-7-acetonitrile, CAS: 63018-69-9, stock: 8.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₃N.

1-​Ethyl-​5-​(hydroxymethyl)​-2-​pyrrolidinone, CAS: 1823506-95-1, stock: 7.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃NO₂.

1-​Ethyl-​5-​(hydroxymethyl)​-2-​pyrrolidinone Tosylate, CAS: /, stock: 1.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₄S.

Benz[a]anthracene-7-acetonitrile-13C2, CAS: 1794751-97-5, stock: 1.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³C₂H₁₃N.

Benz[a]anthracene-7-chloromethane-13C, CAS: 1391054-60-6, stock: 2.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³CH₁₃Cl.

1-​Ethyl-​5-​oxo-​proline Butyl Ester, CAS: /, stock: 8.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉NO₃.

1-Ethyl-2-[(methylamino)methyl]pyrrolidine, CAS: 60923-27-5, stock: 2.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₈N₂.

Benz[a]anthracene-7-methanol, CAS: 16110-13-7, stock: 3.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄O.

Benz[a]anthracene-7-methanol 7-Acetate, CAS: 17526-24-8, stock: 4.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₆O₂.

1-Ethyl-2-[(methylamino)methyl]pyrrolidine Hydrochloride, CAS: 1391053-31-8, stock: 5.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₉ClN₂.

1-Ethyl-2-[(methylamino)methyl]pyrrolidine-d3 Hydrochloride, CAS: 1794827-45-4, stock: 8.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆D₃ClN₂.

Benz[a]anthracene-7-methanol-13C, CAS: 1391054-65-1, stock: 6.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³CH₁₄O.

Benz[a]anthracene-7-methanol-13C 7-Acetate, CAS: 1391053-07-8, stock: 8.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀¹³CH₁₆O₂.

2-(Aminomethyl)-1-ethylpyrrolidine, CAS: 26116-12-1, stock: 7.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆N₂.

Benz[a]anthracene-d12, CAS: 1718-53-2, stock: 8.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈D₁₂.

Benz[j]aceanthrylene and Benz[e]aceanthrylene(70:30 Mixture), CAS: /, stock: 9.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₂.

2-Methoxy-4-amino-5-ethylsulfonylbenzoic Acid, CAS: 71675-87-1, stock: 9.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₅S.

2-Methoxy-4-amino-5-mercaptobenzoic Acid, CAS: 59168-57-9, stock: 5.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₃S.

Benz[j]aceanthrylene-13C2,d2 and Benz[e]aceanthrylene-13C2,d2, CAS: /, stock: 2.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³C₂H₁₀D₂.

Bis(4-chlorobutyl) Ether, CAS: 6334-96-9, stock: 9.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆Cl₂O.

4-Amino-​2-​methoxy-​5-​(methylthio)​benzoic Acid, CAS: 71675-98-4, stock: 9.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₃S.

Blue FPG-A, CAS: 78617-94-4, stock: 2.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₁₇ClN₇Na₃O₁₁S₃.

BML-266, CAS: 96969-83-4, stock: 1.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₆N₂O₄.

4-​Amino-​2-​methoxy-​5-​(methylsulfonyl)​benzoic Acid, CAS: 71675-99-5, stock: 5.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₅S.

Bromaminic Acid, CAS: 116-81-4, stock: 8.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₈NO₅SBr.

Bromaminic Acid Sodium Salt, CAS: 06/06/6258, stock: 7.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₇BrNNaO₅S.

5-​(Aminomethyl)​-​1-​ethyl-2-​pyrrolidinone, CAS: 67433-52-7, stock: 4.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄N₂O.

Carminic Acid, >70%, CAS: 1260-17-9, stock: 5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀O₁₃.

Chrysophanic Acid, CAS: 481-74-3, stock: 8.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀O₄.

5-​Oxo-​proline Butyl Ester, CAS: 61450-21-3, stock: 5.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅NO₃.

Chrysophanol 8-O-glucoside, CAS: 13241-28-6, stock: 1.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀O₉.

Damnacanthal, CAS: 477-84-9, stock: 1.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₀O₅.

Damnacanthal-d3, CAS: /, stock: 4.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₇D₃O₅.

Dechlorane 603, CAS: 13560-92-4, stock: 2.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₈Cl₁₂.

Desmethylmaprotiline Hydrochloride, CAS: 92202-51-2, stock: 7.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂ClN.

Des[2-[(2-Hydroxyethyl)amino]ethyl] Mitoxantrone(Mitoxantrone Impurity A), CAS: 89991-52-6, stock: 7.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉N₃O₅.

Diacerein, CAS: 13739-02-1, stock: 8.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₂O₈.

Diacerein-13C6, CAS: 1391052-74-6, stock: 9.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃¹³C₆H₁₂O₈.

Dibenzo[a,c]anthracene, CAS: 215-58-7, stock: 9.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₄.

Methyl 4-Amino-2-methoxy-5-thiocyanobenzoate, CAS: 59168-56-8, stock: 8.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₃S.

Dibenzo[a,c]anthracene-13C6, CAS: 215-58-7, stock: 4.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆¹³C₆H₁₄.

N-[[(2S)-1-Ethyl-2-pyrrolidinyl]methyl]carbamic Acid 1,1-Dimethylethyl Ester, CAS: 883555-07-5, stock: 7.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄N₂O₂.

R-(+)-2-Aminomethyl-N-ethylpyrrolidine, CAS: 22795-97-7, stock: 6.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆N₂.

Dibenz[a,h]anthracene, CAS: 53-70-3, stock: 1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₄.

Dibenz[a,h]anthracene-d14, CAS: 13250-98-1, stock: 8.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂D₁₄.

Dimethyl 1,8-Anthracenedicarboxylate, CAS: 93655-34-6, stock: 9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄O₄.

Disodium Anthraquinone-2,6-disulfonate, CAS: 853-68-9, stock: 3.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₆Na₂O₈S₂.

Disperse Blue 1, CAS: 2475-45-8, stock: 4.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂N₄O₂.

Disperse Orange 11, CAS: 82-28-0, stock: 6.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁NO₂.

Disperse Polyester Dark Blue, 90%, CAS: 56524-76-6, stock: 5.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄N₂O₄.

Emodin, CAS: 518-82-1, stock: 2.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀O₅.

Emodin 1-β-D-Glucoside, CAS: 38840-23-2, stock: 7.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀O₁₀.

Emodin 8-β-D-Glucoside, CAS: 23313-21-5, stock: 3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀O₁₀.

Emodin 8-O-β-D-(6’-O-Malonylglucoside), CAS: 928262-58-2, stock: 9.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₂O₁₃.

Emodin Triacetate, CAS: 6030-60-0, stock: 4.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₆O₈.

Emodin-d4, CAS: 132796-52-2, stock: 6.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₆D₄O₅.

Ethyl-9,10-ethanoanthracene-9(10H)-propanoate, CAS: /, stock: 6.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂O₂.

Ethynyltrimethylsilane, CAS: 1066-54-2, stock: 8.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀Si.

Frangulin A, CAS: 521-62-0, stock: 10g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀O₉.

Gallocyanine, CAS: 1562-85-2, stock: 3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃N₂O₅ •  Cl.

Hemipyocyanine, CAS: 528-71-2, stock: 1.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈N₂O.

INCA 6, CAS: 3519-82-2, stock: 6.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₂O₂.

α-(6-Methoxy-2-naphthyl)-o-toluic Acid, CAS: 94305-64-3, stock: 1.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆O₃.

β-(1-Anthroyl)propionic Acid, CAS: 72648-39-6, stock: 8.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄O₃.

γ-Oxo-3-phenanthrenebutanoic Acid, CAS: 13728-55-7, stock: 1.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄O₃.

Kermesic Acid, CAS: 18499-92-8, stock: 3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₀O₈.

Macrosporin, CAS: 22225-67-8, stock: 1.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂O₅.

Maprotiline Hydrochloride, CAS: 10347-81-6, stock: 1.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄ClN.

(+)-Quisqualic Acid, CAS: 52809-07-1, stock: 4.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇N₃O₅.

Maprotiline-d5 Hydrochloride, CAS: 1794942-12-3, stock: 8.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉D₅ClN.

Melitracen Hydrochloride, CAS: 10563-70-9, stock: 5.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆ClN.

(+)​-​B-​Methoxydiisopinocamp​heylborane, CAS: 99438-28-5, stock: 5.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₇BO.

(-)-α-Kainic Acid, CAS: 487-79-6, stock: 6.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅NO₄.

Melitracen-d6 Hydrochloride, CAS: 1189648-08-5, stock: 2.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀D₆ClN.

(-)-α-Kainic Acid Lithium Salt, CAS: /, stock: 5.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄LiNO₄.

(-)-α-Kainic Acid Monohydrate, CAS: 58002-62-3, stock: 4.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₅.

Mitoxantrone, CAS: 65271-80-9, stock: 2.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈N₄O₆.

Mitoxantrone Dihydrochloride, CAS: 70476-82-3, stock: 6.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₀Cl₂N₄O₆.

(1S,2S,5S)-Ethyl [(2-Hydroxypinan-3-ylene)amino]acetate, CAS: 90473-00-0, stock: 8.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₃NO₃.

(2S,3S)-2-Amino-3-methyl-N-[2-(4-morpholinyl)ethyl]pentanamide Hydrochloride, CAS: 1243259-19-9, stock: 7.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₇Cl₂N₃O₂.

Mitoxantrone-d8, CAS: 1189974-82-0, stock: 8.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀D₈N₄O₆.

MM 47755, CAS: 117620-87-8, stock: 8.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆O₅.

(R)-3,4-DCPG, CAS: 201730-10-1, stock: 1.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉NO₆.

(R)-3-Carboxy-4-hydroxyphenylglycine, CAS: 13861-03-5, stock: 3.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO₅.

Mono N-Desmethyl Disperse Polyester Dark Blue, CAS: 56524-77-7, stock: 7.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂N₂O₄.

(R)-AMPA, CAS: 83654-13-1, stock: 2.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₂O₄.

(r,s)-2-Amino-3-[3-(carboxymethoxy)-5-methyl-isoxazol-4 -yl]propionic Acid Sesquihydrate, CAS: 209977-56-0, stock: 3.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₆•1.5H₂O.

N-(2-Chloroethyl)-1,2-ethanediamine Dihydrochloride, CAS: 5590-29-4, stock: 2.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₃Cl₃N₂.

N-Acetyl-L-cysteine methyl ester, CAS: 7652-46-2, stock: 3.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₃S.

(R,S)-α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid, CAS: 77521-29-0, stock: 7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₂O₄.

n-Hydroxy Succinate, CAS: 8005-40-1, stock: 3.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₂N₂O₂.

(R,S)-α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Hydrobromide, CAS: 171259-81-7, stock: 3.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁BrN₂O₄.

(R,S)-α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid-13C2,15N, CAS: 1219376-36-9, stock: 6.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³C₂H₁₀N¹⁵NO₄.

N-Methyl-9,10-dihydro-9,10-ethanoanthracene-9-carboxamide, CAS: /, stock: 3.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇NO.

(RS)-4-Bromo-homo-ibotenic acid, CAS: 77006-30-5, stock: 9.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇BrN₂O₄.

(S)-(-)-3-Acetylthio-2-methylpropionic Acid, CAS: 76497-39-7, stock: 6.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₃S.

N2-Benzyl-2-deoxyguanosine CEP, CAS: 209785-74-0, stock: 6.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₅₄N₇O₇P.

Naphthacene, CAS: 92-24-0, stock: 4.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₂.

(S)-(-)-5-Fluorowillardiine, CAS: 140187-23-1, stock: 6.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈FN₃O₄.

(S)-AMPA, CAS: 83643-88-3, stock: 5.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₂O₄.

Naphthol AS-GR Phosphate Disodium Salt, CAS: 100929-51-9, stock: 9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈NO₅P  • 2Na.

Normaprotiline Hydrochloride, CAS: 5721-37-9, stock: 6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁N  • (HCl).

(S)-CPW 399, CAS: 389888-02-2, stock: 9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₃O₄.

NSC 117079, CAS: 500363-63-3, stock: 9.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₅N₃O₇S₂.

Nuclear Fast Red, CAS: 6409-77-4, stock: 3.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉NO₇S  • Na.

1-BCP, CAS: 34023-62-6, stock: 7.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅NO₃.

1-Methyl-pyrrolidine-2-carbaldehyde, CAS: 13493-88-4, stock: 9.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO.

Ochromycinone, CAS: 28882-53-3, stock: 7.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄O₄.

1-N-Cbz-hydroxymethyl-piperidine, CAS: 122860-33-7, stock: 1.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₃.

1-Phenyl-5-(pyridin-2-yl)-2(1H)-pyridone, CAS: 381725-50-4, stock: 7.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂N₂O.

1-Phenyl-5-(pyridin-2-yl)-2(1H)-pyridone-d5, CAS: /, stock: 1.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₇D₅N₂O.

2,3-Dihydro-1-oxo-1h-indene-4-carbonitrile, CAS: 60899-34-5, stock: 3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇NO.

Pentacene, CAS: 135-48-8, stock: 2.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₄.

Pentacene-d14 (Major), CAS: 63912-16-3, stock: 9.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂D₁₄.

2-(2,3-Dimethoxyphenyl)propan-2-ol, CAS: 153390-68-2, stock: 3.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆O₃.

2-(2-Cyanophenyl)-1,3,2-dioxaborinane, CAS: 172732-52-4, stock: 4.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀BNO₂.

Perfluoroanthracene, CAS: 1580-19-4, stock: 7.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄F₁₀.

Perylene, CAS: 198-55-0, stock: 4.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₂.

2-Amino-4-trifluoromethylbenzoic Acid Methyl Ester, CAS: 61500-87-6, stock: 2.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈F₃NO₂.

2-Amino-5-chlorobenzenesulfonamide, CAS: 5790-69-2, stock: 3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇ClN₂O₂S.

Phenazine, CAS: 92-82-0, stock: 5.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈N₂.

2-Bromo-6-fluoroaniline, CAS: 65896-11-9, stock: 7.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅BrFN.

Physcion, CAS: 521-61-9, stock: 6.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂O₅.

Physcion 1-β-D-Glucopyranoside, CAS: /, stock: 2.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂O₁₀.

2-Methoxy-5-(pyridin-2-yl)pyridine, CAS: 381725-49-1, stock: 1.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀N₂O.

Physcion 8-β-D-glucoside, CAS: 23451-01-6, stock: 2.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂O₁₀.

Physcion 8-O-β-D-(6’-O-Malonylglucoside), CAS: 1345826-33-6, stock: 1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₄O₁₃.

2-Oxo-3-hydroxy-N-methyl-N-propyl D-Lysergamide(Mixture of Diastereomers), CAS: 249921-57-1, stock: 1.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅N₃O₃.

2-Oxo-3-hydroxy-N-methyl-N-propyl D-Lysergamide-d3 (Mixture of diastereomers), CAS: /, stock: 8.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂D₃N₃O₃.

Physcion-d3, CAS: 1215751-27-1, stock: 8.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₉D₃O₅.

Potassium 9,10-Dioxo-9,10-dihydroanthracene-1,8-disulfonate, CAS: 14938-42-2, stock: 7.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₆K₂O₈S₂.

3,4,5-Trimethoxytoluene, CAS: 6443-69-2, stock: 4.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄O₃.

2-Methoxyethyl 3-amino-6-chloro-5-(ethyl(isopropyl)amino)pyrazine-2-carboxylate, CAS: /, stock: 5.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₁ClN₄O₃.

PSB 0739, CAS: 1052087-90-7, stock: 4.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₁₇N₃Na₂O₈S₂.

Purpurin (85%), CAS: 81-54-9, stock: 8.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₈O₅.

3,4-Dihydroxyphenylacetic Acid Methyl Ester, CAS: 25379-88-8, stock: 4.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O₄.

3-(Isonicotinoylhydrazonomethyl) Rifamycin, CAS: 13292-53-0, stock: 6.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₅₂N₄O₁₃.

3,5-Diamino-6-chloropyrazine-2-carboxylic Acid, CAS: 4878-36-8, stock: 8.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅ClN₄O₂.

3,5-Diamino-6-chloropyrazine-2-carboxylic Acid Methyl Ester, CAS: 1458-01-1, stock: 5.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇ClN₄O₂.

Reactive Blue 19, CAS: 2580-78-1, stock: 8.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₆N₂Na₂O₁₁S₃.

Reactive Blue 4, CAS: 13324-20-4, stock: 2.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₄Cl₂N₆O₈S₂.

3-Bromo-5-(2-pyridyl)-1-phenyl-1,2-dihydropyridin-2-one, CAS: 381248-06-2, stock: 2.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁BrN₂O.

3-Bromo-5-(2-pyridyl)-1-phenyl-1,2-dihydropyridin-2-one-d5, CAS: /, stock: 3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₆D₅BrN₂O.

3-Amino-5,6-dichloro-2-pyrazinecarboxylic Acid Methyl Ester, CAS: 1458-18-0, stock: 6.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅Cl₂N₃O₂.

3-Amino-6-chloro-5-[ethyl(1-methylethyl)amino]-2-pyrazinecarboxylic Acid Methyl Ester, CAS: 14232-37-2, stock: 6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇ClN₄O₂.

Rhein, CAS: 478-43-3, stock: 5.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₈O₆.

Rhein 8-Glucoside, CAS: 34298-86-7, stock: 5.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₈O₁₁.

3-Isopropylcatechol, CAS: 2138-48-9, stock: 8.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂O₂.

3-Isopropylveratrole, CAS: 71720-27-9, stock: 9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆O₂.

5-(N,N-dimethyl)-Amiloride (hydrochloride), CAS: 2235-97-4, stock: 6.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃Cl₂N₇O.

5-(N,N-Dimethyl)-amiloride-d6 Hydrochloride, CAS: /, stock: 1.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆D₆ClN₇O • (HCl).

Rhein Acyl-β-D-glucuronide, CAS: 190605-03-9, stock: 3.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₆O₁₂.

Rhein Disulfate, CAS: 1246815-66-6, stock: 9.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₈O₁₂S₂.

4-(8-Methyl-9H-1,3-dioxolo[4,5-h][2,3]benzodiazepin-5-yl)benzenamine, CAS: 102771-26-6, stock: 4.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅N₃O₂.

4-Cyano-5-fluoro-2-nitroaniline, CAS: 143151-03-5, stock: 1.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄FN₃O₂.

5-(N-Ethyl-N-isopropyl) Amiloride, CAS: 1154-25-2, stock: 9.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈ClN₇O.

5-(N-Methyl-N-isobutyl)-Amiloride, CAS: 96861-65-3, stock: 8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈ClN₇O.

Rhein Methylate, CAS: 6155-37-9, stock: 8.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₀O₆.

Rhein-13C6, CAS: 1330166-42-1, stock: 2.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉¹³C₆H₈O₆.

4-Fluoro-2-nitroaniline, CAS: 364-78-3, stock: 3.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅FN₂O₂.

5-(2-Pyridyl)-1,2-dihydropyridin-2-one, CAS: 381233-78-9, stock: 1.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈N₂O.

5-Deamino-5-oxo Amiloride Hydrochloride, CAS: 1207-29-0, stock: 7.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇ClN₆O₂ •(HCl).

Ruberythric Acid, CAS: 152-84-1, stock: 1.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₆O₁₃.

Rubiginone B2, CAS: 130548-10-6, stock: 7.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆O₄.

5-Amino-1H-indazole-7-carboxylic Acid Methyl Ester, CAS: 885272-08-2, stock: 8.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉N₃O₂.

5-H-Amiloride, CAS: 1203-87-8, stock: 2.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇ClN₆O.

Amiloride Hydrochloride, CAS: 2016-88-8, stock: 9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉Cl₂N₇O.

Saquayamycin B1, CAS: 99260-68-1, stock: 9.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₄O₁₁.

Sennoside A, CAS: 81-27-6, stock: 6.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₃₈O₂₀.

5-Trifluoromethoxyindan-1-one, CAS: 173252-76-1, stock: 5.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇F₃O₂.

6-Cyano-7-nitroquinoxaline-2,3-dione, CAS: 115066-14-3, stock: 7.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₄N₄O₄.

Amiloride Hydrochloride Dihydrate, CAS: 17440-83-4, stock: 8.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈ClN₇O • HCl • 2H  ₂O.

Amiloride-15N3 Hydrochloride, CAS: 1216796-18-7, stock: 7.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉Cl₂N₄¹⁵N₃O.

Sennoside B, CAS: 128-57-4, stock: 1.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₃₈O₂₀.

Sennoside C, CAS: 37271-16-2, stock: 7.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₄₀O₁₉.

6-Nitro-7-sulfamoylbenzo[f]quinoxaline-2,3-Dione, CAS: 118876-58-7, stock: 8.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈N₄O₆S.

6-Nitro-7-sulfamoylbenzo[f]quinoxaline-2,3-dione, Disodium Salt, CAS: 479347-86-9, stock: 8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆N₄Na₂O₆S.

Benzamil Hydrochloride, CAS: 161804-20-2, stock: 2.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄ClN₇O•HCl.

Human ABP1(Amiloride-sensitive amine oxidase [copper-containing]) ELISA Kit (96T), CAS: /, stock: 1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Sennoside Calcium Salt (Mixture of A and B), CAS: /, stock: 4.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₃₆CaO₂₀.

Sennoside D, CAS: 37271-17-3, stock: 6.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₄₀O₁₉.

7-Cyano DAMPA Ethyl Ester, CAS: 1329835-68-8, stock: 9.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈N₈O₂.

7-Hydroxy DAMPA, CAS: 34698-85-6, stock: 2.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅N₇O₃.

Methyl 3-Amino-6-chloro-5-(isobutyl(methyl)amino)pyrazine-2-carboxylate, CAS: /, stock: 1.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇ClN₄O₂.

N-Formylguanidine, CAS: 4471-51-6, stock: 2.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₅N₃O.

Setomimycin, CAS: 69431-87-4, stock: 2.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₂₈O₉.

7-Hydroxy DAMPA Methyl Ester, CAS: 1330264-75-9, stock: 1.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₇O₃.

Simocyclinone D8, CAS: 301845-97-6, stock: 9.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₄₂ClNO₁₈.

Alantolactone, CAS: 546-43-0, stock: 5.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀O₂.

Aminomethanephosphonic Acid, CAS: 1066-51-9, stock: 7.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  CH₆NO₃P.

Skyrin, CAS: 602-06-2, stock: 4.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₁₈O₁₀.

Aminomethanephosphonic Acid-13C,15N, CAS: /, stock: 4.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³CH₆¹⁵NO₃P.

AMPA, CAS: 74341-63-2, stock: 5.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₂O₄.

STA 21, CAS: 111540-00-2, stock: 2.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄O₄.

Tetrafluorophthalic Acid, CAS: 652-03-9, stock: 2.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₂F₄O₄.

Ampalex, CAS: 154235-83-3, stock: 3.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅N₃O.

trans-8,9,10,11-Tetrahydrobenz[a]anthracene-10,11-diol Dibenzoate-d9, CAS: /, stock: 1.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₁₅D₉O₄.

Ampalex-d10, CAS: 1286653-21-1, stock: 8.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₅D₁₀N₃O.

Aniracetam, CAS: 72432-10-1, stock: 1.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO₃.

Triacetyl Aloe-emodin (Impurity A), CAS: 25395-11-3, stock: 1.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₆O₈.

Uniblue A Sodium Salt, CAS: 14541-90-3, stock: 1.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₆N₂O₇S₂ • Na.

BDP 37, CAS: 191744-13-5, stock: 4.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃NO₄.

Bilobalide, CAS: 33570-04-6, stock: 4.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈O₈.

BIX, CAS: 101714-41-4, stock: 3.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇NO₃S.

BW 245C, CAS: 72814-32-5, stock: 8.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₂N₂O₅.

Campanuline, CAS: 5957-66-4, stock: 8.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₀O.

CFM-2, CAS: 178616-26-7, stock: 3.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇N₃O₃.

Chlorfenapyr, CAS: 122453-73-0, stock: 4.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁BrClF₃N₂O.

Cl-HIBO, CAS: 909400-43-7, stock: 3.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇ClN₂O₄.

CMPDA, CAS: 380607-77-2, stock: 6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₈N₂O₄S₂.

CP 465022, CAS: 199655-36-2, stock: 7.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₅Cl₂FN₄O.

Creatine, CAS: 57-00-1, stock: 4.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉N₃O₂.

CX 546, CAS: 215923-54-9, stock: 8.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇NO₃.

DAMPA, CAS: 19741-14-1, stock: 8.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅N₇O₂.

DAMPA Ethyl Ester, CAS: 43111-51-9, stock: 1.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉N₇O₂.

DAMPA Methyl Ester, CAS: 23853-09-0, stock: 5.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₇O₂.

1,8-Diaza-2,9-diketocyclotetradecane, CAS: 56403-09-9, stock: 9.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂N₂O₂.

DAMPA-d3, CAS: 1794780-00-9, stock: 6.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂D₃N₇O₂.

DNQX Disodium Salt, CAS: 1312992-24-7, stock: 6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₂N₄Na₂O₆.

3-Bodipy-propanoylaminocaproic Acid, N-Hydroxysuccinimide Ester, CAS: 217190-09-5, stock: 1.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉BF₂N₄O₅.

6-(6-(6-Aminohexanamido)hexanamido)hexanoic Acid, CAS: 5776-78-3, stock: 8.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₅N₃O₄.

Ethyl 4-Acetamidobenzoate, CAS: 5338-44-3, stock: 6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₃.

6-(N-Trifluoroacetyl)aminocaproic Acid, CAS: 407-91-0, stock: 5.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂F₃NO₃.

6-(N-Trifluoroacetyl)aminocaproic Acid N-Succinimidyl Ester, CAS: 117032-51-6, stock: 5.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅F₃N₂O₅.

Ethyl Imidazole-2-carboxylate, CAS: 33543-78-1, stock: 9.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈N₂O₂.

Eupatilin, CAS: 22368-21-4, stock: 7.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆O₇.

6-Acetamidohexanoic Acid, CAS: 57-08-9, stock: 5.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₃.

6-Acrylamidohexanoic Acid, CAS: 20766-85-2, stock: 3.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅NO₃.

Farampator, CAS: 211735-76-1, stock: 2.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃N₃O₂.

Farampator-d10, CAS: 211735-93-2, stock: 6.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₃D₁₀N₃O₂.

6-Aminocaproic Acid Dimer, CAS: 2014-58-6, stock: 6.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄N₂O₃.

6-Aminohexanoic Acid, CAS: 60-32-2, stock: 6.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂.

gamma-D-Glutamylaminomethylsulfonic acid, CAS: 90237-02-8, stock: 3.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂N₂O₆S.

Guaiol, CAS: 489-86-1, stock: 8.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₆O.

6-​Amino-hexanoic Acid Phenylmethyl Ester, CAS: 05/01/5515, stock: 6.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉NO₂.

6-​Amino-hexanoic Acid Phenylmethyl Ester 4,4’-Dimethoxybenzhydrol, CAS: /, stock: 7.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₃NO₄.

Gualol-D7, CAS: /, stock: 7.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉D₇O.

GYKI 47261 dihydrochloride, CAS: /, stock: 8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇Cl₃N₄.

Carbobenzoxy-ε-aminocaproyl-ε-aminocaproic Acid, CAS: 49701-55-5, stock: 5.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀N₂O₅.

DL-Lysine, CAS: 70-54-2, stock: 8.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄N₂O₂.

GYKI 47261 Dihydrochloride, CAS: 1217049-32-5, stock: 9.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅ClN₄ •  2(HCl).

GYKI 53655 Hydrochloride, CAS: 143692-48-2, stock: 7.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀N₄O₃ •  (HCl).

ε-Aminocaproic Acid Hydrochloride, CAS: 4321-58-8, stock: 1.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄ClNO₂.

ε-Aminocaproic Acid-d10 Hydrochloride, CAS: 1246819-49-7, stock: 4.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄D₁₀ClNO₂.

Human CD52(CAMPATH-1 antigen) ELISA Kit (96T), CAS: /, stock: 7.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

L-Lysine, CAS: 56-87-1, stock: 6.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄N₂O₂.

L-Norleucine, CAS: 327-57-1, stock: 1.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂.

IDRA-21, CAS: 22503-72-6, stock: 8.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉ClN₂O₂S.

L-Norleucine-d9, CAS: 1331889-36-1, stock: 4.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄D₉NO₂.

Methyl 6-Aminohexanoate Hydrochloride, CAS: 1926-80-3, stock: 2.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆ClNO₂.

IEM 1754 dihydrobromide, CAS: 162831-31-4, stock: 5.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₀N₂ • 2HBr.

IEM 1925 dihydrobromide, CAS: 258282-23-4, stock: 5.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₈N₂ • 2HBr.

N-Benzyloxycarbonyl-6-aminocaproic Acid, CAS: 1947-00-8, stock: 3.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₄.

N-Biotinylcaproylaminocaproic Acid, CAS: 89889-51-0, stock: 4.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₈N₄O₅S.

α-(E)-Bisabolene, CAS: 25532-79-0, stock: 6.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄.

JNJ 55511118, CAS: 2036081-86-2, stock: 4.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₈ClF₃N₂O₂.

N-Dihydrocinnamoylaminocaproic Acid, CAS: 178622-38-3, stock: 4.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁NO₃.

N-Dihydrocinnamoylaminocaproic Acid N-Hydroxysuccinimide Ester, CAS: 334616-48-7, stock: 2.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄N₂O₅.

LM22B-10, CAS: 342777-54-2, stock: 3.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₃ClN₂O₄.

LY 404187, CAS: 211311-95-4, stock: 2.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂N₂O₂S.

tert-Butoxycarbonyl-ε-aminocaproic Acid, CAS: 6404-29-1, stock: 3.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₄.

Lysergic Acid Methylpropylamide, CAS: 40158-98-3, stock: 3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅N₃O.

MAP4, CAS: 157381-42-5, stock: 3.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂NO₅P.

Miltirone, CAS: 27210-57-7, stock: 8.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂O₂.

N,N,N-Triethyl-2-oxo-2-[[4-[2-[4(1-oxo-2-propen-1-yl)amino]phenyl]diazenyl]phenylamino]ethanaminium Chloride, CAS: /, stock: 6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₀ClN₅O₂.

N,N’-Diacetyl DAMPA Ethyl Ester, CAS: 1330265-87-6, stock: 2.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃N₇O₄.

N-((2-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)propionamide, CAS: /, stock: 4.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈N₂O₄S.

N-(4-Fluorophenyl)-4-phenyl-1,3-thiazol-2-amine, CAS: 339303-87-6, stock: 1.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁FN₂S.

N-Desmethyl Clozapine, CAS: 6104-71-8, stock: 5.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇ClN₄.

N-tert-Butyloxycarbonyl (S)-(-)-5-Fluorowillardiine, CAS: 1822590-14-6, stock: 6.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆FN₃O₆.

NPEC-caged-(S)-AMPA, CAS: 1257323-84-4, stock: 1.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₃O₈.

Parecoxib, CAS: 198470-84-7, stock: 8.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈N₂O₄S.

PEPA, CAS: 141286-78-4, stock: 3.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆F₂N₂O₄S₂.

Philanthotoxin 74, CAS: 1227301-51-0, stock: 7.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₂N₄O₃ • 2HCl.

SB 239063, CAS: 193551-21-2, stock: 2.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁FN₄O₂.

SYM 2206, CAS: 173952-44-8, stock: 10g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂N₄O₃.

Synthalin Sulfate, CAS: 182285-12-7, stock: 9.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₈N₆.H₂SO₄.

Talampanel, CAS: 161832-65-1, stock: 4.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉N₃O₃.

Threo Ifenprodil Hemitartrate, CAS: 1312991-83-5, stock: 2.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇NO₂.&#₁₈₉;C₄H₆O₆.

Traxoprodil, CAS: 134234-12-1, stock: 8.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅NO₃.

Tricosane, CAS: 638-67-5, stock: 3.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₈.

UBP 301, CAS: 569371-10-4, stock: 5.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄IN₃O₆.

YM 201636, CAS: 371942-69-7, stock: 9.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₁N₇O₃.

YM 90K hydrochloride, CAS: 154164-30-4, stock: 9.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇N₅O₄ •HCl.

ZK 200775(Fanapanel), CAS: 161605-73-8, stock: 5.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅F₃N₃O₆P.

1,2-Dihydro-5-(1-hydroxy-1-methylethyl)-3H-1,2,4-triazol-3-one;, CAS: 53983-48-5, stock: 5.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉N₃O₂.

1,2-Dihydro-5-(1-methylethyl)-3H-1,2,4-triazol-3-one, CAS: 932-63-8, stock: 9.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉N₃O.

4-Amino-N-(1,1-dimethylethyl)-4,5-dihydro-3-(1-methylethyl)-5-oxo-1H-1,2,4-triazole-1-carboxamide, CAS: 129909-90-6, stock: 9.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉N₅O₂.

N-(Carbamoylamino)-2-methylpropanamide, CAS: 1344074-65-2, stock: 3.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁N₃O₂.

N-tert-Butyl-3-(2-hydroxypropan-2-yl)-5-oxo-4,5-dihydro-1H-1,2,4-triazole-1-carboxamide, CAS: 889062-06-0, stock: 6.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈N₄O₃.

N-tert-Butyl-3-(2-hydroxypropan-2-yl)-5-oxo-4,5-dihydro-1H-1,2,4-triazole-1-carboxamide-d3, CAS: /, stock: 5.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅D₃N₄O₃.

N-tert-Butyl-3-isopropyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-1-carboxamide, CAS: 889062-05-9, stock: 2.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈N₄O₂.

N-tert-Butyl-3-isopropyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-1-carboxamide-d6, CAS: 1327292-73-8, stock: 5.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂D₆N₄O₂.

(S)-(-)-4-Amino-2-hydroxybutyric Acid, CAS: 40371-51-5, stock: 9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₃.

1,3-Di-HABA Kanamycin A, CAS: 927821-99-6, stock: 7.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₅₀N₆O₁₅.

1,3’’-Di-HABA Kanamycin A Sulfate, CAS: /, stock: 3.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₅₀N₆O₁₅ xH₂SO₄.

1,6’-Di-HABA Kanamycin A Sulfate, CAS: /, stock: 7.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₅₀N₆O₁₅ xH₂SO₄.

3,5,6’-Tri(N-Benzyloxycarbonyl) Kanamycin A, CAS: 67470-54-6, stock: 3.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₅₄N₄O₁₇.

3-HABA Kanamycin A Sulfate, CAS: /, stock: 3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₃N₅O₁₃ xH₂SO₄.

3’’-HABA Kanamycin A Sulfate, CAS: /, stock: 1.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₃N₅O₁₃ xH₂SO₄.

3’’-[N-(HABA-CBz)] 3,5,6’-Tri(N-Benzyloxycarbonyl) Kanamycin A, CAS: /, stock: 8.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₄H₆₇N₅O₂₁.

5,6’-Di(N-Benzyloxycarbonyl) Kanamycin A, CAS: /, stock: 3.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₈N₄O₁₅.

5-[N-(HABA-Cbz)] 3,6’-Di(N-benzyloxycarbonyl) Kanamycin A, CAS: /, stock: 7.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₆₁N₅O₁₉.

6-O-Des(6-Amino-α-D-gluocopyranosyl) 3-HABA Kanamycin A Sulfate, CAS: /, stock: 7.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₂N₄O₉•xH₂SO₄.

6-O-Des(6-Amino-α-D-gluocopyranosyl) Amikacin Sulfate, CAS: /, stock: 4.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₂N₄O₉•xH₂SO₄.

6’-N-(Benzyloxycarbonyl)kanamycin A Sulfate, CAS: 40372-09-6, stock: 4.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₂N₄O₁₃ xH₂SO₄.

Amikacin, CAS: 37517-28-5, stock: 7.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₃N₅O₁₃.

Amikacin B N,N’-Benzyl Carbamate, CAS: /, stock: 3.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₆N₆O₁₆.

Amikacin B Sulfate, CAS: /, stock: 4.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₄N₆O₁₂ xH₂SO₄.

Amikacin Sulfate, CAS: 39831-55-5, stock: 7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₇N₅O₂₁S₂.

Amikacin Sulfate Salt, CAS: 149022-22-0, stock: 1.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₇N₅O₂₁S₂.

Amikacin-d5 Sulfate, CAS: /, stock: 6.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₂D₅N₅O₂₁S₂.

BB-K 6 Sulfate Salt, CAS: /, stock: 3.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₃N₅O₁₃ . (H₂O₄S)ₓ.

BB-K31, CAS: 50896-99-6, stock: 7.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₃N₅O₁₃.

Bis-2’,3’’-[N-(HABA-CBz)] Bis-6,4’-N-CBz Kanamycin A, CAS: /, stock: 3.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₈H₇₄N₆O₂₃.

Bis-3’’,5-[N-(HABA-Cbz)] 3,6’-Di(N-benzyloxycarbonyl) Kanamycin A, CAS: /, stock: 7.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₈H₇₄N₆O₂₃.

Bis-5,6’-[N-(HABA-CBz)] Kanamycin A, CAS: /, stock: 2.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₆₂N₆O₁₉.

Kanamycin A Sulfate, CAS: 25389-94-0, stock: 2.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₈N₄O₁₅S.

Kanamycin B N-Benzyl Carbamate, CAS: /, stock: 9.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₃N₅O₁₂.

O-3-Amino-3-deoxy-α-D-glucopyranosyl-(1→6)-O-[6-deoxy-6-[[(phenylmethoxy)carbonyl]amino]-α-D-glucopyranosyl-(1→4)]-2-deoxy-N1-[(2S)-2-hydroxy-1-oxo-4-[[(phenylmethoxy)carbonyl]amino]butyl]-N3-[(phenylmethoxy)carbonyl]-D-Streptamine, CAS: 66567-34-8, stock: 8.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₆₁N₅O₁₉.

Tetra-N-benzyloxycarbonylkanamycin A, CAS: 5605-66-3, stock: 6.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₆₀N₄O₁₉.

2-Deiodo Amidotrizoic Acid, CAS: 162193-52-4, stock: 2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀I₂N₂O₄.

4-Deiodo-amidotrizoic Acid, CAS: 162193-53-5, stock: 8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀I₂N₂O₄.

Amidotrizoic Acid, CAS: 117-96-4, stock: 2.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉I₃N₂O₄.

Amidotrizoic Acid Dihydrate, CAS: 50978-11-5, stock: 8.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃I₃N₂O₆.

Amidotrizoic Acid-d6, CAS: 1189668-69-6, stock: 4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₃D₆I₃N₂O₄.

Meglumine Diatrizoate, CAS: 131-49-7, stock: 2.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆I₃N₃O₉.

N-Desacetyl Amido Amidotrizoic Acid, CAS: 1713-07-1, stock: 4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇I₃N₂O₃.

N-Desacetyl Amido Amidotrizoic Acid-13C,15N2, CAS: /, stock: 4.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₇I₃¹⁵N₂O₃.

2-Amino-3,5-dibromo-benzenemethanol, CAS: 50739-76-9, stock: 2.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇Br₂NO.

4-(6,8-Dibromo-3(4H)-quinazolinyl)-cyclohexanol, CAS: 1797894-71-3, stock: 8.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆Br₂N₂O.

4-Aminophenol-d7, CAS: 285132-88-9, stock: 1.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆D₇NO.

Ambroxol, CAS: 18683-91-5, stock: 3.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈Br₂N₂O.

Ambroxol Cyclic Impurity Hydrochloride, CAS: 15942-08-2, stock: 7.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉Br₂ClN₂O.

Ambroxol Cyclic Impurity-d5 Dihydrochloride, CAS: 1794752-24-1, stock: 8.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅D₅Br₂Cl₂N₂O.

Ambroxol Hydrochloride, CAS: 23828-92-4, stock: 9.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉Br₂ClN₂O.

Ambroxol O-glucuronide, CAS: 1241045-91-9, stock: 1.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₆Br₂N₂O₇.

Ambroxol O-glucuronide-d5, CAS: /, stock: 3.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁D₅Br₂N₂O₇.

cis-Ambroxol Hydrochloride, CAS: 1384955-66-1, stock: 8.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈Br₂N₂O • (HCl).

cis-[2-(4-tert-Butyloxycarbonylamino)cyclohexyloxy]tetrahydro-2H-pyran, CAS: 1322625-95-5, stock: 8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₉NO₄.

cis-[2-(4-tert-Butyloxycarbonylamino)cyclohexyloxy]tetrahydro-2H-pyran-d5, CAS: 1322626-64-1, stock: 8.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄D₅NO₄.

rac-cis-Ambroxol, CAS: 107814-37-9, stock: 7.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈Br₂N₂O.

rac-cis-Ambroxol-d5, CAS: 1217679-83-8, stock: 2.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃D₅Br₂N₂O.

rac-trans-Ambroxol-d5, CAS: /, stock: 3.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃D₅Br₂N₂O.

Theophylline-7-acetic Acid, CAS: 652-37-9, stock: 7.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₄O₄.

trans-4-[[(2-Amino-3,5-dibromophenyl)methylene]amino]cyclohexanol(Ambroxol Impurity C), CAS: 50910-53-7, stock: 2.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆Br₂N₂O.

trans-4-[[(2-Amino-5-bromophenyl)methyl]amino]-cyclohexanol, CAS: 101900-43-0, stock: 8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉BrN₂O.

trans-4-[[(2-Aminophenyl)methyl]amino]cyclohexanol Hydrobromide, CAS: /, stock: 8.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₂O  •HBr.

trans-[2-(4-tert-Butyloxycarbonylamino)cyclohexyloxy]tetrahydro-2H-pyran, CAS: 1322625-81-9, stock: 2.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₉NO₄.

trans-[2-(4-tert-Butyloxycarbonylamino)cyclohexyloxy]tetrahydro-2H-pyran-d5, CAS: 1322626-69-6, stock: 5.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄D₅NO₄.

2-Amino-3-benzoyl-5-chlorobenzeneacetamide, CAS: 78281-71-7, stock: 5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃ClN₂O₂.

2-Amino-3-benzoyl-5-chlorobenzeneacetamide-d5, CAS: /, stock: 5.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₈D₅ClN₂O₂.

3-Desbenzoyl-3-hydroxybenzyl Nepafenac, CAS: 1246956-18-2, stock: 2.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆N₂O₂.

6-Chloro Nepafenac, CAS: /, stock: 1.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃ClN₂O₂.

7-Benzoyloxindole, CAS: 51135-38-7, stock: 8.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁NO₂.

Amfenac Acyl-β-D-Glucuronide, CAS: /, stock: 9.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁NO₉.

Amfenac Ethyl Ester, CAS: 61941-57-9, stock: 8.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇NO₃.

Amfenac Methyl Ester, CAS: 61941-58-0, stock: 7.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅NO₃.

Amfenac Sodium Hydrate, CAS: 61618-27-7, stock: 5.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄NNaO₄.

Amfenac-d5 Sodium Hydrate, CAS: /, stock: 6.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₉D₅NNaO₄.

Amino-3-benzoylbenzoic Acid, CAS: /, stock: 8.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁NO₃.

Nepafenac, CAS: 78281-72-8, stock: 6.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄N₂O₂.

Nepafenac-d5, CAS: 1246814-53-8, stock: 5.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₉D₅N₂O₂.

(R)-Ambrisentan, CAS: 1007358-76-0, stock: 8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂N₂O₄.

(R)-Ambrisentan-d3, CAS: /, stock: 3.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉D₃N₂O₄.

(S)-2-Hydroxy-3-methoxy-3,3-diphenylpropionic Acid, CAS: 178306-52-0, stock: 3.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆O₄.

(S)-4-Hydroxymethyl Ambrisentan, CAS: 1106685-66-8, stock: 4.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂N₂O₅.

2-((2,2-Diphenylvinyl)oxy)-4,6-dimethylpyrimidine, CAS: 1639429-81-4, stock: 9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈N₂O.

2-Hydroxy-3-methoxy-3,3-diphenylpropanoic Acid Methyl Ester, CAS: 178306-47-3, stock: 7.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈O₄.

2-Hydroxy-3-methoxy-3,3-diphenylpropanoic Acid-d3 Methyl Ester, CAS: 1046116-52-2, stock: 8.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅D₃O₄.

3,3-Diphenyl-oxiranecarboxylic Acid Methyl Ester, CAS: 76527-25-8, stock: 7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄O₃.

3-Methyl-3-phenyl-2-oxiranecarboxylic Acid Methyl Ester, CAS: 03/04/5441, stock: 8.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₃.

4,6-Dimethoxy-β-methyl-3-phenoxy Ambrisentan (Mixture of Diastereomers), CAS: 159308-03-9, stock: 9.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂N₂O₆.

4,6-Dimethoxy-β-methyl-3-phenoxy Ambrisentan-d5, CAS: 1346597-40-7, stock: 7.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₇D₅N₂O₆.

4-Hydroxymethyl Ambrisentan Acyl Glucuronide, CAS: 1106685-77-1, stock: 1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₀N₂O₁₁.

Ambrisentan, CAS: 177036-94-1, stock: 9.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂N₂O₄.

Ambrisentan Acyl β-D-Glucuronide, CAS: 1106685-58-8, stock: 7.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₀N₂O₁₀.

Ambrisentan N-Oxide, CAS: /, stock: 3.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂N₂O₅.

Ambrisentan sodium salt, CAS: 1386915-48-5, stock: 2.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁N₂NaO₄.

Ambrisentan-d10, CAS: 1046116-27-1, stock: 4.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₂D₁₀N₂O₄.

α-Hydroxy-β-methyl-β-phenoxy-benzenepropanoic Acid Methyl Ester (Mixture of Diasteriomers), CAS: /, stock: 4.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈O₄.

α-[(4,6-Dimethoxy-2-pyrimidinyl)oxy]-β-methyl-β-phenoxy-benzenepropanoic Acid Methyl Ester (Mixture of Diasteriomers), CAS: /, stock: 5.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄N₂O₆.

rac 4-Hydroxymethyl Ambrisentan, CAS: 1106685-84-0, stock: 3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂N₂O₅.

rac 4-Hydroxymethyl Ambrisentan-d3, CAS: 1287096-42-7, stock: 5.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉D₃N₂O₅.

rac Ambrisentan, CAS: 713516-99-5, stock: 1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂N₂O₄.

rac Ambrisentan Methyl Ester, CAS: 1240470-84-1, stock: 2.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄N₂O₄.

rac Ambrisentan-d3, CAS: 1189479-60-4, stock: 2.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉D₃N₂O₄.

rac Ambrisentan-d3 Methyl Ester, CAS: 1329837-75-3, stock: 6.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₁D₃N₂O₄.

rac O-Demethyl Ambrisentan, CAS: 1106685-85-1, stock: 1.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀N₂O₄.

(+)-(3R,4R)-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine, CAS: 119193-19-0, stock: 9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉NO.

(-)-(3S,4S)-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine, CAS: 145678-87-1, stock: 10g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉NO.

(2R,3R,4R)-Alvimopan, CAS: 342639-35-4, stock: 8.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₂N₂O₄.

(2S,3S,4S)-Alvimopan, CAS: /, stock: 1.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₂N₂O₄.

(rac)-4-(3-Isopropoxyphenyl)-3,4-dimethylpiperidine Hydrochloride, CAS: /, stock: 4.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₆ClNO.

1,3-Dimethylpiperidin-4-one, CAS: 4629-80-5, stock: 8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃NO.

3,4-cis-Dimethyl-4-(3-hydroxyphenyl)piperidine, CAS: 59381-63-4, stock: 3.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉NO.

ADL 08-0011, CAS: 156130-41-5, stock: 9.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉NO₃.

ADL 08-0011-d5, CAS: /, stock: 5.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄D₅NO₃.

Alvimopan, CAS: 156053-89-3, stock: 4.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₂N₂O₄.

Alvimopan Acyl-β-D-glucuronide, CAS: 1260616-95-2, stock: 10g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₀N₂O₁₀.

Alvimopan β-D-Glucuronide, CAS: /, stock: 4.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₀N₂O₁₀.

Alvimopan Sulfate Disodium Salt, CAS: /, stock: 9.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₀N₂Na₂O₇S.

Alvimopan-d5, CAS: 1217616-62-0, stock: 9.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₇D₅N₂O₄.

Alvimopan-d7 Hydrate, CAS: /, stock: 4.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₇D₇N₂O₅.

ent-Alvimopan, CAS: /, stock: 7.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₂N₂O₄.

Amaranth (>85%), CAS: 915-67-3, stock: 7.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₁N₂Na₃O₁₀S₃.

Azo Rubine (Technical Grade), CAS: 3567-69-9, stock: 7.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₂N₂NaO₇S₂.

Ethyl Palmitate, CAS: 628-97-7, stock: 6.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₆O₂.

Ethyl Palmitate-d31, CAS: 1215721-57-5, stock: 5.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₅D₃₁O₂.

Ethyl Palmitate-d5, CAS: 1215397-47-9, stock: 9.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₁D₅O₂.

1,1’-(2,5-Cyclohexadiene-1,4-diylidenedinitrilo)di-guanidine, CAS: 1945-63-7, stock: 6.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₈.

2,2’-(2,5-Cyclohexadiene-1,4-diylidene)bis-hydrazinecarboximidamide Sulfate, CAS: 89473-29-0, stock: 8.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄N₈O₄S.

2-(4-Oxo-2,5-cyclohexadien-1-ylidene)hydrazinecarboximidamide Sulfate, CAS: 1048649-86-0, stock: 2.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₄O₅S.

2-[4-[(Aminothioxomethyl)hydrazono]-2,5-cyclohexadien-1-ylidene]-hydrazinecarboxamide, CAS: 67381-67-3, stock: 6.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₆OS.

Ambazone, CAS: 539-21-9, stock: 9.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N₇S.

Desulfo Oxo-ambazone, CAS: 61566-10-7, stock: 5.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N₇O.

1-Adamantanamine Sulfate, CAS: 31377-23-8, stock: 4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  2(C₁₀H₁₇N)  •  H₂SO₄.

Amantadine Hydrochloride, CAS: 665-66-7, stock: 1.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈ClN.

Amantadine-d15 Hydrochloride, CAS: /, stock: 6.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₃D₁₅ClN.

1-Chloro-3-phenylpropane, CAS: 104-52-9, stock: 3.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁Cl.

3-Phenyl-1-propanol, CAS: 122-97-4, stock: 4.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂O.

4-Hydroxy Alverine, CAS: 142047-94-7, stock: 1.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₇NO.

4-Hydroxy Alverine β-D-Glucuronide, CAS: /, stock: 6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₅NO₇.

4-Hydroxy Alverine-d5, CAS: 1216415-67-6, stock: 3.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂D₅NO.

Alverine Citrate, CAS: 5560-59-8, stock: 2.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₅NO₇.

Alverine-d5 Citrate, CAS: 1215327-00-6, stock: 3.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₀D₅NO₇.

(+)-Isoaltenuene, CAS: 887751-92-0, stock: 5.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆O₆.

(-)-Altenuene, CAS: 889101-41-1, stock: 4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆O₆.

(2S,3S,4aR,6R,8aR)-2,3,4a,5,6,8a-Hexahydro-7-iodo-2,3-dimethoxy-2,3,6-trimethyl-1,4-benzodioxin-6-ol, CAS: 888723-97-5, stock: 9.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₁IO₅.

(2S,3S,4aR,6S,8aR)-2,3,4a,5,6,8a-Hexahydro-7-iodo-2,3-dimethoxy-2,3,6-trimethyl-1,4-benzodioxin-6-ol, CAS: 888723-91-9, stock: 5.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₁IO₅.

(2S,3S,4aR,6S,8R,8aR)-Octahydro-6,8-dihydroxy-2,3-dimethoxy-2,3-dimethyl-1,4-benzodioxin-6-carboxylic Acid Methyl Ester, CAS: 176798-26-8, stock: 8.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₄O₈.

(2S,3S,4aR,8aR)-2,3,4a,8a-Tetrahydro-2,3-dimethoxy-2,3-dimethyl-1,4-benzodioxin-6(5H)-one, CAS: 286936-09-2, stock: 8.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈O₅.

(2S,3S,4aR,8aR)-2,3,4a,8a-Tetrahydro-7-iodo-2,3-dimethoxy-2,3-dimethyl-1,4-benzodioxin-6(5H)-one, CAS: 334700-48-0, stock: 6.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇IO₅.

(2S,3S,4aR,8R,8aR)-Hexahydro-8-hydroxy-2,3-dimethoxy-2,3-dimethyl-1,4-benzodioxin-6(5H)-one, CAS: 286936-08-1, stock: 6.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀O₆.

(6aR,7aR,9S,10S,11aR)-4-Hydroxy-2,9,10-trimethoxy-6a,9,10-trimethyl-6a,7,7a,9,10,11a-hexahydro-5H-benzo[c][1,4]dioxino[2,3-g]chromen-5-one, CAS: 888723-94-2, stock: 1.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆O₈.

5,7-Dihydroxy-2,2-dimethyl-4H-1,3-benzodioxin-4-one, CAS: 137571-73-4, stock: 8.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₅.

5-Hydroxy-7-methoxy-2,2-dimethyl-4H-1,3-benzodioxin-4-one, CAS: 532394-23-3, stock: 7.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₅.

7-Methoxy-2,2-dimethyl-4H-1,3-benzodioxin-4-one, CAS: 888723-96-4, stock: 9.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₄.

Dehydroaltenusin, CAS: /, stock: 3.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂O₆.

Trifluoromethanesulfonic Acid 7-Methoxy-2,2-dimethyl-4-oxo-4H-1,3-benzodioxin-5-yl Ester, CAS: 532394-17-5, stock: 8.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁F₃O₇S.

2-[3-(Hydroxymethyl)-5-methyl-4-triazolyl]-5-chlorobenzophenone, CAS: 38150-27-5, stock: 9.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄ClN₃O₂.

2’-Benzoyl-2,4’-dichloroacetanilide, CAS: 4016-85-7, stock: 2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁Cl₂NO₂.

3-Amino-6-chloro-4-(4-pyridinyl)-2-quinolinone Hydrazone, CAS: 1346606-48-1, stock: 9.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂ClN₅.

3-Amino-6-chloro-4-phenylcarbostyril, CAS: 5220-83-7, stock: 2.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁ClN₂O.

4-(2-Benzoyl-4-chlorophenyl)-5-methyl-4H-1,2,4-triazole-3-carboxaldehyde, CAS: 36916-20-8, stock: 2.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₂ClN₃O₂.

5-Chloro-2-(3-methyl-4H-1,2,4-triazol-4-yl)benzophenone, CAS: 36916-19-5, stock: 7.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂ClN₃O.

7-Chloro-1-methyl-5-phenyl-[1,2,4]triazolo[4,3-a]quinolin-4-amine, CAS: 448950-89-8, stock: 8.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₃ClN₄.

8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine, CAS: 28910-91-0, stock: 4.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₂ClFN₄.

(4-((Pyrrolidin-1-ylsulfonyl)methyl)phenyl)carbamic Acid tert-Butyl Ester, CAS: /, stock: 3.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄N₂O₄S.

1-((4-Aminobenzenemethane)sulfonyl)pyrrolidine, CAS: 334981-10-1, stock: 8.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O₂S.

1-(5-((Pyrrolidin-1-ylsulfonyl)methyl)-1H-indol-3-yl)ethanone, CAS: /, stock: 3.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈N₂O₃S.

2-Hydroxyalmotriptan, CAS: 1309457-19-9, stock: 8.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅N₃O₃S.

3-(Phenylthio)-5-((pyrrolidin-1-ylsulfonyl)methyl)-1H-indole, CAS: /, stock: 4.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀N₂O₂S₂.

3-(Prop-1-en-2-yl)-5-((pyrrolidin-1-ylsulfonyl)methyl)-1H-indole-1-carboxylic Acid tert-Butyl Ester, CAS: /, stock: 9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈N₂O₄S.

3-Acetyl-5-((pyrrolidin-1-ylsulfonyl)methyl)-1H-indole-1-carboxylic Acid tert-Butyl Ester, CAS: /, stock: 9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆N₂O₅S.

3-Des[2-(Dimethylamino)ethyl]-3-[1-methyl-1-(methylamino)ethyl] Almotriptan, CAS: 1391053-74-9, stock: 3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅N₃O₂S.

3-[2-(Dimethylamino)ethyl]-5-[(1-pyrrolidinylsulfonyl)methyl]-1H-indole-1-methanol, CAS: 1018676-02-2, stock: 4.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₇N₃O₃S.

4-(1-Pyrrolidinylsulforylmenthyl)phenylhydrazine Hydrochloride, CAS: 334981-11-2, stock: 4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈ClN₃O₂S.

5-[(1-Pyrrolidinylsulfonyl)methyl]-1H-indole, CAS: 1599442-14-4, stock: 1.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₂O₂S.

Almotriptan Dimer Impurity, CAS: 1330166-13-6, stock: 7.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₁N₅O₂S.

Almotriptan Hydrochloride, CAS: 154323-46-3, stock: 3.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₆ClN₃O₂S.

Almotriptan Malate, CAS: 181183-52-8, stock: 6.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₁N₃O₇S.

Almotriptan Metabolite M2, CAS: 603137-41-3, stock: 4.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅N₃O₄S.

Almotriptan N-Oxide Hydrochloride Salt, CAS: 1391054-49-1, stock: 2.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₆ClN₃O₃S.

Almotriptan-d6 Hydrochloride, CAS: 1794782-57-2, stock: 4.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀D₆ClN₃O₂S.

Didesmethyl Almotriptan, CAS: 181178-24-5, stock: 6.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁N₃O₂S.

Didesmethyl Almotriptan-d4, CAS: 1346604-75-8, stock: 7.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇D₄N₃O₂S.

N-(4-Methoxybenzyl)-4-((pyrrolidin-1-ylsulfonyl)methyl)aniline, CAS: /, stock: 6.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄N₂O₃S.

N-Desmethyl Almotriptan, CAS: 334981-12-3, stock: 4.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃N₃O₂S.

N-Desmethyl Almotriptan-d3, CAS: 1346604-71-4, stock: 3.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀D₃N₃O₂S.

N-Methyl-4-((pyrrolidin-1-ylsulfonyl)methyl)aniline, CAS: /, stock: 6.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂O₂S.

2,5-Dimethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one, CAS: /, stock: 2.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄N₂O.

2,5-Dimethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one-d3, CAS: /, stock: 2.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁D₃N₂O.

3,4-Didehydro Alosetron, CAS: 122852-86-2, stock: 1.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆N₄O.

6-Hydroxy Alosetron, CAS: 128486-89-5, stock: 5.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈N₄O₂.

6-Hydroxy Alosetron-d3, CAS: /, stock: 5.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅D₃N₄O₂.

7-Hydroxy Alosetron, CAS: 863485-44-3, stock: 6.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈N₄O₂.

7-Hydroxy Alosetron-d3, CAS: /, stock: 1.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅D₃N₄O₂.

Alosetron Hydrochloride, CAS: 122852-69-1, stock: 9.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉ClN₄O.

Alosetron M5, CAS: 863485-46-5, stock: 9.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈N₄O₂.

Alosetron M5-d3, CAS: /, stock: 1.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅D₃N₄O₂.

Alosetron N-β-D-Glucuronide, CAS: 863485-56-7, stock: 5.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆N₄O₇.

Alosetron-13CD3 Hydrochloride, CAS: /, stock: 1.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆¹³CH₁₆D₃ClN₄O.

Alosetron-d3 Hydrochloride, CAS: 1189919-71-8, stock: 8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆D₃ClN₄O.

N-Desmethyl Alosetron, CAS: 122852-63-5, stock: 2.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆N₄O.

N-Desmethyl Alosetron-d4, CAS: /, stock: 6.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₁₂D₄N₄O.

(2Z)-1-Chloro-6,6-dimethyl-2-hepten-4-yne, CAS: 635708-74-6, stock: 7.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃Cl.

(E)-2-(6,6-Dimethyl-2-hepten-4-ynyl)-1H-isoindole-1,3(2H)-dione, CAS: 123926-46-5, stock: 8.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇NO₂.

(E)-6,6-Dimethyl-2-hepten-4-ynal, CAS: 138139-82-9, stock: 4.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂O.

(E)-6,6-Dimethylhept-2-en-4-yn-1-ol, CAS: 173200-56-1, stock: 3.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄O.

(E)-N-Methyl-N-(3-phenyl-2-propenyl)-2-naphthalenemethanamine, CAS: 98977-54-9, stock: 9.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁N.

(E)-Naftifine, CAS: 65472-88-0, stock: 9.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁N.

(Z)-Naftifine, CAS: 65473-08-7, stock: 6.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁N.

1,1,1-Trimethyl-N-2-propen-1-ylsilanamine, CAS: 10519-97-8, stock: 5.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₅NSi.

1,3-Bis(2-propen-1-ylamino)-2-propanol, CAS: 264141-29-9, stock: 8.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈N₂O.

1,3-Bis(allylamino)-2-propanol Dihydrochloride, CAS: 1101184-94-4, stock: 7.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈N₂O • 2(HCl).

1,3-Bis(allylamino)-2-propanol Dihydrochloride-D5, CAS: /, stock: 2.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃D₅N₂O • 2(HCl).

1-(4-(Aminomethyl)naphthalen-1-yl)-N,N-dimethylmethanamine, CAS: /, stock: 1.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈N₂.

1-Bromopropyn-3-ol, CAS: 2060-25-5, stock: 1.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₃BrO.

2-Isopentenylamine Hydrochloride, CAS: 26728-58-5, stock: 1.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁N  •HCl.

2-Methylallylamine, CAS: 2878-14-0, stock: 6.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉N.

3-Methylbenzothiophene, CAS: 1455-18-1, stock: 5.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈S.

6,6-Dimethyl-2,4-heptadiyn-1-ol, CAS: 114311-73-8, stock: 8.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂O.

Allylamine, CAS: 107-11-9, stock: 8.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₇N.

Allylcyclohexylamine, CAS: 6628-00-8, stock: 7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇N.

Bisallylamine, CAS: 124-02-7, stock: 2.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁N.

Carboxy Terbinafine, CAS: 99473-14-0, stock: 1.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃NO₂.

Carboxy Terbinafine-d7, CAS: 1246833-21-5, stock: 1.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₆D₇NO₂.

Cinnamylamine Hydrochloride, CAS: 5586-89-0, stock: 6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂ClN.

Diallylamine Hydrochloride, CAS: 6147-66-6, stock: 4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁N • HCl.

Hydroxy Terbinafine, CAS: 162227-13-6, stock: 2.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅NO.

Hydroxy Terbinafine β-D-Glucuronide, CAS: 99473-12-8, stock: 6.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₃NO₇.

Methyl-1-naphthalenemethylamine-d3, CAS: 1033720-13-6, stock: 2.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀D₃N.

N,N,1-Trimethyl-3,3-diphenylallylamine Hydrochloride, CAS: 55011-89-7, stock: 1.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂ClN.

N,N,1-Trimethyl-3,3-diphenylallylamine-d10 Hydrochloride, CAS: /, stock: 2.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₂D₁₀ClN.

N,N-Bis-Boc-N-allylamine, CAS: 115269-99-3, stock: 7.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₃NO₄.

N-(E)-3-Tributyltinallyl-1-naphthalene-d7-methylamine, CAS: 1310383-84-6, stock: 9.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₄D₇NSn.

N-Allyldibutylamine, CAS: 53826-28-1, stock: 3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₃N.

N-​(1,​1-​dimethylethyl)​-2-​Propen-​1-​amine, CAS: 16486-68-3, stock: 6.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅N.

N-​Ethyl-​2-​methyl-2-​propen-​1-​amine, CAS: 18328-90-0, stock: 1.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃N.

N-​Methyl-​N-​(3-​phenyl-​2-​propyn-​1-​yl)​-1-​naphthalenemethanami​ne, CAS: 98977-91-4, stock: 6.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₉N.

N-Desmethyl cis-Terbinafine, CAS: 114311-72-7, stock: 6.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃N.

N-Desmethyl Terbinafine, CAS: 99473-11-7, stock: 3.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃N.

N-Desmethyl Terbinafine Hydrochloride, CAS: 152830-98-3, stock: 9.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄ClN.

N-Desmethyl Terbinafine-d7, CAS: 1246833-28-2, stock: 2.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆D₇N.

N-Desmethylcarboxy Terbinafine, CAS: 99473-15-1, stock: 9.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁NO₂.

N-Desmethylcarboxy Terbinafine-d7, CAS: 1185238-58-7, stock: 1.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₄D₇NO₂.

N-Desmethylcarboxy Terbinafine-d7 Methyl Ester, CAS: 1185245-14-0, stock: 4.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₆D₇NO₂.

N-Desmethylhydroxyterbinafine, CAS: 162227-14-7, stock: 5.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃NO.

N-[(2E)-6,6-Dimethyl-2-hepten-4-yn-1-yl]-N,4-dimethyl-1-naphthalenemethanamine Hydrochloride, CAS: 877265-33-3, stock: 5.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈ClN.

N-[(2E)-6,6-Dimethyl-2-hepten-4-yn-1-yl]-N,4-dimethyl-1-naphthalenemethanamine-d3 Hydrochloride, CAS: /, stock: 1.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅D₃ClN.

N-[(2E)-6,6-Dimethyl-2-hepten-4-yn-1-yl]-N-methyl-2-naphthalenemethanamine Hydrochloride, CAS: 877265-30-0, stock: 9.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆ClN.

N-[(2E)-6,6-Dimethyl-2-hepten-4-yn-1-yl]-N-methyl-2-naphthalenemethanamine-d3 Hydrochloride, CAS: /, stock: 2.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃D₃ClN.

N-[(2E)-6,6-Dimethyl-2-hepten-4-ynyl]-N-methylaminomethyl Terbinafine, CAS: /, stock: 4.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₂N₂.

Naftifine Hydrochloride, CAS: 65473-14-5, stock: 5.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂ClN.

Naftifine N-Oxide (90%), CAS: /, stock: 9.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁NO.

Naftifine-d3 Hydrochloride, CAS: 1246833-81-7, stock: 8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₉D₃ClN.

Poly(allylamine Hydrochloride), CAS: 71550-12-4, stock: 9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  (C₃H₇N •  HCl)n.

Sevelamer Hydrochloride (Technical Grade), CAS: 152751-57-0, stock: 3.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  (C₃H₇N)m• ( C₃H₅ClO)n• ( HCl)ₓ.

Sevelamer-(d5)n Hydrochloride, CAS: 1794791-45-9, stock: 9.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  (C₃H₇N)m• ( C₃D₅ClO)n• ( HCl)ₓ.

Terbinafine Dimer Impurity Dihydrochloride Salt, CAS: /, stock: 8.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₂Cl₂N₂.

Terbinafine Hydrochloride, CAS: 78628-80-5, stock: 2.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆ClN.

Terbinafine-d7 Hydrochloride, CAS: 1185240-27-0, stock: 9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₉D₇ClN.

tert-Butylethyne, CAS: 917-92-0, stock: 8.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀.

Triallylamine, CAS: 102-70-5, stock: 2.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅N.

[(1S)-3-Hydroxy-1-methylpropyl]carbamic Acid 1,1-Dimethylethyl Ester, CAS: 106539-36-0, stock: 2.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₉NO₃.

(E)-3-[(2-Cyano-3-ethoxy-3-oxo-1-propenyl)amino]-1H-pyrazole-4-carboxylic Acid Ethyl Ester, CAS: 52632-17-4, stock: 6.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₄O₄.

(E/Z)-3-[(2-Cyano-3-ethoxy-3-oxo-1-propenyl)amino]-1H-Pyrazole-4-carboxylic Acid Ethyl Ester, CAS: 321571-07-7, stock: 1.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₄O₄.

2,4-Dimethoxy-6-morpholinopyrimidine-5-carbaldehyde-13C, CAS: /, stock: 9.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀¹³CH₁₅N₃O₄.

3-(4H-1,2,4-Triazol-4-yl)-1H-pyrazole-4-carboxamide, CAS: 1346604-13-4, stock: 5.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₆O.

3-(Formylamino)-1H-pyrazole-4-carboxamide, CAS: 22407-20-1, stock: 7.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆N₄O₂.

3-(Formylamino)-1H-pyrazole-4-carboxylic Acid Ethyl Ester, CAS: 31055-19-3, stock: 1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉N₃O₃.

3-Amino-4-carbamoylpyrazole Hemisulfate, CAS: 27511-79-1, stock: 5.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆N₄O•1/2H₂O₄S.

3-Amino-4-cyanopyrazole, CAS: 16617-46-2, stock: 2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄N₄.

4,6-Dihydroxypyrazolo[3,4-d]pyrimidine, CAS: 2465-59-0, stock: 2.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₄O₂.

4,6-Dihydroxypyrazolo[3,4-d]pyrimidine-13C,15N2, CAS: 1217036-71-9, stock: 6.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₄N₂¹⁵N₂O₂.

4,6-Dimethoxy-1H-pyrazolo[3,4-d]pyrimidine, CAS: 98277-30-6, stock: 3.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₄O₂.

4,6-Dimethoxy-1H-pyrazolo[3,4-d]pyrimidine-13C,15N2, CAS: /, stock: 3.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³CH₈N₂¹⁵N₂O₂.

4-Chloro-2,6-dimethoxypyrimidine-5-carbaldehyde, CAS: 134221-52-6, stock: 5.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇ClN₂O₃.

4-Hydroxy-1-phenylpyrazolo[3,4-d]pyrimidine, CAS: 21314-17-0, stock: 2.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈N₄O.

5-Amino-4-pyrazolecarboxamide, CAS: 5334-31-6, stock: 6.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆N₄O.

7-Aminopyrazolo[1,5-a]pyrimidine-3,6-dicarboxylic Acid 3,6-Diethyl Ester, CAS: 43024-67-5, stock: 5.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₄O₄.

7N-[1-(2-Carboxy)ethyl]allopurinol, CAS: 34397-00-7, stock: 1.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈N₄O₃.

9-Methylallopurinol, CAS: 5334-56-5, stock: 5.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₄O.

Allopurinol, CAS: 315-30-0, stock: 5.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₄O.

Allopurinol riboside, CAS: 16220-07-8, stock: 7.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₄O₅.

Allopurinol-13C,15N2, CAS: /, stock: 4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₄N₂¹⁵N₂O.

Allopurinol-13C,15N2, D2, CAS: /, stock: 3.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₂D₂N₂¹⁵N₂O.

Allopurinol-d2, CAS: 916979-34-5, stock: 5.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₂D₂N₄O.

Butyric Anhydride, CAS: 106-31-0, stock: 5.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄O₃.

Ethyl 3-Amino-4-pyrazolecarboxylate, CAS: 6994-25-8, stock: 1.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉N₃O₂.

(4R,5S,6S)-4-Methoxy-4,6-dimethyltetrahydro-2H-pyran-2,5-diol, CAS: 2089577-97-7, stock: 5.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆O₄.

12-Deoxy-α-Aza-8α-homoerythromycin A, CAS: /, stock: 5.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₆₈N₂O₁₂.

12-Deoxyerythromycin 9-Oxime, CAS: 53274-43-4, stock: 1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₆₈N₂O₁₂.

3’-Des(dimethylamino)-3’-keto Azithromycin, CAS: 612069-25-7, stock: 1.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₆₅NO₁₃.

3’-N,N-Di(desmethyl) Azithromycin, CAS: 612069-27-9, stock: 7.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₆₈N₂O₁₂.

3’-N,N-Di(desmethyl)-3’-N-formyl Azithromycin, CAS: 765927-71-7, stock: 9.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₆₈N₂O₁₃.

3’-N,N-Didesmethyl-N-(methoxycarbonyl) Azithromycin, CAS: /, stock: 1.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₇₀N₂O₁₄.

3’-N-Desmethyl-3’-N-formyl Azithromycin, CAS: 612069-28-0, stock: 7.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₇₀N₂O₁₃.

3’-N-Desmethyl-3’-N-tosyl Azithromycin, CAS: 612069-31-5, stock: 6.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₇₆N₂O₁₄S.

3’-N-Didesmethyl-3’-N-tosyl Azithromycin, CAS: 2095879-65-3, stock: 8.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₇₅N₃O₁₅S.

3’-N-[[4-(Acetylamino)phenyl]sulfonyl]-3’-N-demethyl Azithromycin, CAS: 612069-30-4, stock: 1.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₇₇N₃O₁₅S.

3’-N-[[4-(Acetylamino)phenyl]sulfonyl]-3’-N-demethyl Azithromycin-d4, CAS: /, stock: 6.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₇₃D₄N₃O₁₅S.

4’-Hydroxy Azithromycin, CAS: 756825-20-4, stock: 3.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₇₂N₂O₁₃.

9-Deoxo-9a-aza-9a-homo Erythromycin A(Desmethyl Azithromycin), CAS: 76801-85-9, stock: 5.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₇₀N₂O₁₂.

9-Oxo Azithromycin B, CAS: /, stock: 4.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₆₈N₂O₁₂.

9a-aza-9a-homo Erythromycin A (~90%), CAS: 76820-32-1, stock: 2.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₆₈N₂O₁₃.

Azithromycin, CAS: 83905-01-5, stock: 5.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₇₂N₂O₁₂.

Azithromycin B, CAS: 307974-61-4, stock: 9.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₇₂N₂O₁₁.

Azithromycin Dihydrate, CAS: 117772-70-0, stock: 9.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₇₆N₂O₁₄.

Azithromycin N-Ethyl, CAS: 92594-45-1, stock: 1.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₇₄N₂O₁₂.

Azithromycin N-Oxide, CAS: 90503-06-3, stock: 4.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₇₂N₂O₁₃.

Azithromycin-13CD3, CAS: /, stock: 6.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇¹³CH₆₉D₃N₂O₁₂.

Azithromycin-d3, CAS: 163921-65-1, stock: 8.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₆₉D₃N₂O₁₂.

Azithromycin-d5, CAS: /, stock: 5.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₆₇D₅N₂O₁₂.

Chloramphenicol 2-(O-tert-Butyldimethylsilyl)methyl 1-Acetate, CAS: 864529-27-1, stock: 1.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₈Cl₂N₂O₆Si.

Chloramphenicol O-tert-Butyldimethylsilyl Ether, CAS: 864529-25-9, stock: 2.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₆Cl₂N₂O₅Si.

Descladinose 6-N-Desmethyl Azithromycin, CAS: 111247-94-0, stock: 10g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₆N₂O₉.

Descladinose Azithromycin, CAS: 117693-41-1, stock: 2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₈N₂O₉.

Descladinose Azithromycin-d3, CAS: /, stock: 9.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₅D₃N₂O₉.

Erythromycin A Oxime (Roxithromycin Impurity C), CAS: 13127-18-9, stock: 3.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₆₈N₂O₁₃.

N-Desmethyl 13(4-C,4-O-methylene)-pyranosyl Azithromycin, CAS: 217500-75-9, stock: 2.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₇₀N₂O₁₂.

N-Desmethyl Azithromycin B, CAS: 857078-26-3, stock: 9.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₇₀N₂O₁₁.

N’-Desmethyl Azithromycin, CAS: 172617-84-4, stock: 7.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₇₀N₂O₁₂.

(R)-Azelastine Hydrochloride, CAS: 153408-28-7, stock: 9.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅Cl₂N₃O.

(R)-Azelastine N-Oxide (Mixture of Diastereomers), CAS: 1346617-18-2, stock: 4.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄ClN₃O₂.

(S)-Azelastine Hydrochloride, CAS: 153408-27-6, stock: 4.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅Cl₂N₃O.

(S)-Azelastine N-Oxide (Mixture of Diastereomers), CAS: 1346617-06-8, stock: 3.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄ClN₃O₂.

2-[(4-Chlorophenyl)acetyl]benzoic Acid, CAS: 53242-76-5, stock: 5.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁ClO₃.

3-(4-Chlorobenzal)phthalide, CAS: 20526-97-0, stock: 3.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₉ClO₂.

4-[(3-Chlorophenyl)methyl]-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1(2H)-phthalazinone, CAS: 37933-01-0, stock: 4.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄ClN₃O.

4-[(4-Chlorophenyl)methyl]-1(2H)-phthalazinone, CAS: 53242-88-9, stock: 8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁ClN₂O.

4-[(4-Chlorophenyl)methyl]-2-[2-(1-methyl-2-pyrrolidinyl)ethyl]-1(2H)-phthalazinone, CAS: 756415-37-9, stock: 8.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄ClN₃O.

Azelastine, CAS: 58581-89-8, stock: 2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄ClN₃O.

Azelastine Hydrochloride, CAS: 79307-93-0, stock: 8.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅Cl₂N₃O.

Azelastine N-Oxide (Mixture of Diastereomers), CAS: 640279-88-5, stock: 8.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄ClN₃O₂.

Azelastine-13C,d3, CAS: 758637-88-6, stock: 1.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁¹³CH₂₁D₃ClN₃O.

Azelastine-13C,d3 N-Oxide (Mixture of Diastereomers), CAS: 1346602-76-3, stock: 2.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁¹³CH₂₁D₃ClN₃O₂.

Azelastine-d3, CAS: 758637-88-6, stock: 5.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁D₃ClN₃O.

Benzoyl Hydrazine, CAS: 613-94-5, stock: 5.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O.

N-Desmethyl Azelastine, CAS: 47491-38-3, stock: 9.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂ClN₃O.

N-Desmethyl Azelastine-d4, CAS: /, stock: 6.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₈D₄ClN₃O.

N’-(1-Methylazepan-4-yl)benzohydrazine, CAS: 117078-69-0, stock: 1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂ClN₃O.

N’-(1-Methylazepan-4-yl)benzohydrazine-d5, CAS: 1346599-80-1, stock: 1.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇D₅ClN₃O.

Phthalazone, CAS: 119-39-1, stock: 2.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆N₂O.

(+)-L-Alliin, CAS: 556-27-4, stock: 9.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₃S.

Allicin (90%)-d10, CAS: /, stock: 8.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆D₁₀OS₂.

Allicin (~90%), CAS: 539-86-6, stock: 3.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀OS₂.

Allyl Methyl Sulfide, CAS: 10152-76-8, stock: 7.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈S.

(2R,5R)-Avibactam Sodium Salt, CAS: 1797133-98-2, stock: 5.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₃NaO₆S.

(2S)-5-[(Phenylmethoxy)imino]-2-piperidinecarboxylic Acid Ethyl Ester, CAS: 1416134-60-5, stock: 3.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀N₂O₃.

(2S,5R)-5-[(Phenylmethoxy)amino]-2-piperidinecarboxamide, CAS: 1416134-49-0, stock: 6.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉N₃O₂.

(2S,5R)-5-[(Phenylmethoxy)amino]-2-piperidinecarboxylic Acid Ethyl Ester Ethanedioate, CAS: 1416134-48-9, stock: 9.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂N₂O₃ (C₂H₂O₄).

(2S,5R)-5-[(Phenylmethoxy)amino]-2-piperidinecarboxylic Acid Methyl Ester, CAS: 1416134-73-0, stock: 8.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂O₃.

(2S,5R)-6-(Benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide, CAS: 1192651-49-2, stock: 6.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇N₃O₃.

(2S,5R)-6-(Benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide-d4, CAS: /, stock: 8.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃D₄N₃O₃.

(2S,5R)-6-Hydroxy-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide, CAS: 1383814-64-9, stock: 6.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁N₃O₃.

(2S,5R)-Benzyl 5-((Benzyloxy)amino)piperidine-2-carboxylate Oxalate, CAS: 1171080-45-7, stock: 3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O₃ • C ₂H₂O₄.

(2S,5S)-Avibactam Sodium Salt, CAS: 2064219-26-5, stock: 2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₃NaO₆S.

5R-(N-Fmoc)-(5-benzyloxyamino) L-Pipecolic Amide, CAS: /, stock: 7.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₉N₃O₄.

5R-(N-Fmoc)-5[N-(benzyloxy)-N-(carbonylimidazole)]amino L-Pipecolic Amide, CAS: /, stock: 8.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₁N₅O₅.

5R-(N-Sulfonyloxy)amino L-Pipecolic Amide Sodium Salt, CAS: /, stock: 9.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂N₃NaO₅S.

6-Chloro-N-[(1,1-dimethylethoxy)carbonyl]-5-[(phenylmethoxy)imino]-L-norleucine Phenylmethyl Ester, CAS: 1133931-73-3, stock: 5.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₁N₂O₅Cl.

Avibactam Butylammonium Salt, CAS: /, stock: 2.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂N₄O₆S.

Avibactam Namido-sulfonyl Disodium Salt, CAS: /, stock: 3.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉N₃Na₂O₉S₂.

Avibactam Sodium Salt, CAS: 1192491-61-4, stock: 9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₃NaO₆S.

Avibactam-13C5,15N Sodium Salt, CAS: /, stock: 6.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₅H₁₀N₂¹⁵NNaO₆S.

Avibactam-d4 Sodium Salt, CAS: /, stock: 9.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆D₄N₃NaO₆S.

Avibactam-d4 Sodium Salt, CAS: /, stock: 8.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆D₄N₃NaO₆S.

ent-Avibactam Sodium Salt, CAS: 396731-20-7, stock: 3.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₃NaO₆S.

(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 3-((2’-(1H-Diazirin-3-yl)-[1,1’-biphenyl]-4-yl)methyl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylate, CAS: 1800532-35-7, stock: 5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₀N₄O₆.

1-​[(2’-​Carbamoylbiphenyl-​4-​yl) methyl]​-​2-​ethoxybenzimidazole-​7-​carboxylic Acid, CAS: 1696392-11-6, stock: 7.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁N₃O₄.

1-[[2’-(Aminoiminomethyl)[1,1’-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic Acid, CAS: 1442400-65-8, stock: 3.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₂N₂O₃.

1-[[2’-(Aminoiminomethyl)[1,1’-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic Acid-d5, CAS: /, stock: 6.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₇D₅N₂O₃.

2-Ethoxy-1-[[2’-[(hydroxyamino)iminomethyl][1,1’-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid Methyl Ester, CAS: 147403-65-4, stock: 4.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₄N₄O₄.

2-Ethoxy-d5-1-[[2’-[(hydroxyamino)iminomethyl][1,1’-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid Methyl Ester, CAS: 1795133-18-4, stock: 8.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₉D₅N₄O₄.

3-Amino-2-[[(2’-cyano[1,1’-biphenyl]-4-yl)methyl]amino]benzoic Acid Ethyl Ester, CAS: 136285-69-3, stock: 4.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₁N₃O₂.

Azilsartan, CAS: 147403-03-0, stock: 1.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₀N₄O₅.

Azilsartan Amide Medoxomil, CAS: 1696392-12-7, stock: 9.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₅N₃O₇.

Azilsartan Amidoxime, CAS: 1449029-77-9, stock: 1.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₆N₄O₇.

Azilsartan Dimer, CAS: 1604812-35-2, stock: 7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₂₈N₄O₁₁.

Azilsartan Hydroxy Acid, CAS: 1397836-49-5, stock: 6.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₂N₄O₄.

Azilsartan Kamedoxomil, CAS: 863031-24-7, stock: 5.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₃KN₄O₈.

Azilsartan Medoxomil, CAS: 863031-21-4, stock: 9.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₄N₄O₈.

Azilsartan Medoxomil-D5, CAS: /, stock: 7.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₁₉D₅N₄O₈.

Azilsartan Methyl Ester, CAS: 147403-52-9, stock: 2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₂N₄O₅.

Azilsartan-d4, CAS: 1794817-45-0, stock: 4.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₆D₄N₄O₅.

Azilsartan-d5, CAS: 1346599-45-8, stock: 8.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₅D₅N₄O₅.

Azilsartan-d5 Methyl Ester, CAS: 1794766-42-9, stock: 7.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₁₇D₅N₄O₅.

Desethyl Azilsartan Medoxomil, CAS: 1417576-00-1, stock: 1.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₀N₄O₈.

Ethyl 2-​Ethoxy-​1-​((2’-​(5-​oxo-​2,​5-​dihydro-​1,​2,​4-​oxadiazol-​3-​yl)​-​[1,​1’-​biphenyl]​-​4-​yl)​methyl)​-​1H-​benzo[d]​imidazole-​7-​carboxylate, CAS: 1403474-70-3, stock: 6.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₄N₄O₅.

Methyl Ester Candersartan Reduzate, CAS: 136304-78-4, stock: 6.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉N₃O₂.

N-Ethyl Azilsartan Medoxomil, CAS: 1417576-01-2, stock: 5.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₂₈N₄O₈.

N-[2-Ethoxy-d5-1-[[2’-[(hydroxyamino)methyl][1,1’-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid Methyl Ester]carbamic Acid 2-Ethylhexyl Ester, CAS: 1795131-16-6, stock: 7.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₅D₅N₄O₆.

O-Desethyl Azilsartan, CAS: 1442400-68-1, stock: 8.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₆N₄O₅.

O-Desethyl Azilsartan-d4, CAS: /, stock: 8.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₂D₄N₄O₅.

1-Methyl-4-nitro-5-thioimidazole, CAS: 6339-54-4, stock: 7.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅N₃O₂S.

1-Methyl-4-nitroimidazole, CAS: 3034-41-1, stock: 5.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅N₃O₂.

5-Amino-1-methyl-4-nitroimidazole, CAS: 4531-54-8, stock: 7.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆N₄O₂.

5-Chloro-1-methyl-4-nitroimidazole, CAS: 4897-25-0, stock: 4.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄ClN₃O₂.

5-Hydroxy-1-methyl-4-nitroimidazole Sodium Salt (>90%), CAS: 35681-68-6, stock: 3.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄N₃NaO₃.

Azathioprine, CAS: 446-86-6, stock: 9.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇N₇O₂S.

Azathioprine Sodium Salt, CAS: 55774-33-9, stock: 3.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇N₇O₂SNa.

Azathioprine-13C4, CAS: 1346600-71-2, stock: 10g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³C₄H₇N₇O₂S.

Azathioprine-d3, CAS: /, stock: 8.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₄D₃N₇O₂S.

Thiamiprine, CAS: 5581-52-2, stock: 8.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈N₈O₂S.

Thiouric Acid Sodium Salt Dihydrate, CAS: /, stock: 3.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇N₄NaO₄S.

Thiouric Acid-13C3 Sodium Salt Dihydrate, CAS: /, stock: 1.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₃H₇N₄NaO₄S.

(S)-4-((3-Chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)pyrimidine-5-carboxylic Acid, CAS: 330785-84-7, stock: 9.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁ClN₄O₄.

2-​Pyrimidinemethanol, CAS: 42839-09-8, stock: 9.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆N₂O.

3-(S)-Hydroxypyrrolidinylavanafil, CAS: 330785-58-5, stock: 2.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆ClN₇O₄.

3-Chloro-4-methoxybenzylamine, CAS: 115514-77-7, stock: 6.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀ClNO.

4-(3-Chloro-4-methoxybenzylamino)-5-ethoxycarbonyl-2-methylthiopyrimidine, CAS: 330785-81-4, stock: 9.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈ClN₃O₃S.

4-(S)-Hydroxypyrrolidinylavanafil, CAS: 330785-54-1, stock: 4.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆ClN₇O₄.

Avanafil, CAS: 330784-47-9, stock: 6.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆ClN₇O₃.

Avanafil-13C5,15N, CAS: 1276495-36-3, stock: 7.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³C₅H₂₆ClN₆¹⁵NO₃.

Avanafil-d5, CAS: /, stock: 5.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₁D₅ClN₇O₃.

Des(2-hydroxymethylpyrrolidino) 2-[(2-Hydroxymethyl,-3-carboxy)propylamino]avanafil, CAS: /, stock: 8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆ClN₇O₅.

(±)-Atovaquone Impurity C-d5, CAS: /, stock: 2.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₂D₅ClO₃.

1-Chlorodecane, CAS: 1002-69-3, stock: 2.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₁Cl.

1-[trans-4-(4-Chlorophenyl)cyclohexyl] Ester Ethanedioic Acid-d5, CAS: /, stock: 3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅ClO₄.

2-((1R,4R)-4-(4-Chlorophenyl)cyclohexyl)-1-oxo-1H-indene-3-carboxylic Acid, CAS: /, stock: 5.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉ClO₃.

2-Chloro-3-[4-(4-chlorophenyl)cyclohexyl-d5]-1,4-naphthalenedione, CAS: 1189507-64-9, stock: 9.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₃D₅Cl₂O₂.

3-Chloro-1,4-dihydro-1,4-dioxo-2-naphthalenecarboxylic Acid 4-(4-Chlorophenyl)cyclohexyl Ester, CAS: 215672-88-1, stock: 4.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₈Cl₂O₄.

(-)-Hycosamine, CAS: 101-31-5, stock: 6.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃NO₃.

3-Chloro-1,4-dihydro-1,4-dioxo-2-naphthalenecarboxylic Acid 4-Phenylcyclohexyl Ester, CAS: /, stock: 7.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₉ClO₄.

(-)-Hycosamine-d3, CAS: /, stock: 7.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀D₃NO₃.

(±)-Atropine-D3, CAS: /, stock: 7.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀D₃NO₃.

4-(4-Chlorophenyl)-3-cyclohexene-1-carboxylic Acid, CAS: 165317-79-3, stock: 4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃ClO₂.

4-(4-Chlorophenyl)-3-cyclohexene-1-carboxylic Acid-d4, CAS: /, stock: 8.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉D₄ClO₂.

(S)-(1R,3r,5S)-8-Isopropyl-8-azabicyclo[3.2.1]octan-3-yl 3-Hydroxy-2-phenylpropanoate, CAS: 183626-76-8, stock: 6.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₇NO₃.

3α-Phenylacetoxy Tropane, CAS: 1690-22-8, stock: 6.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁NO₂.

Atovaquone, CAS: 95233-18-4, stock: 2.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉ClO₃.

Atovaquone-d4, CAS: 1163294-17-4, stock: 2.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₅D₄ClO₃.

3α-Phenylacetoxy Tropane-d5, CAS: /, stock: 7.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆D₅NO₂.

Atovaquone-d5, CAS: 1329792-63-3, stock: 1.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₄D₅ClO₃.

cis-2-Chloro-3-((1r,4r)-4-phenylcyclohexyl)naphthalene-1,4-dione, CAS: /, stock: 2.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉ClO₂.

Ambutonium Bromide, CAS: 115-51-5, stock: 2.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₇BrN₂O.

cis-4-(4-Chlorophenyl)cyclohexanecarboxylic Acid, CAS: 1346600-43-8, stock: 9.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅ClO₂.

Ambutonium Bromide-d5, CAS: /, stock: 3.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂D₅BrN₂O.

Anisotropine Methylbromide, CAS: 80-50-2, stock: 2.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₂BrNO₂.

cis-Atovaquone-d5 (contains 10% trans isomer), CAS: 1217612-80-0, stock: 5.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₄D₅ClO₃.

Deschloro Atovaquone, CAS: 92458-44-1, stock: 1.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀O₃.

Apoatropine Hydrochloride, CAS: 5978-81-4, stock: 2.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂ClNO₂.

O-Methyl Atovaquone-13C,d3, CAS: /, stock: 4.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂¹³CH₁₈D₃ClO₃.

Apoatropine-d5, CAS: /, stock: 8.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆D₅NO₂.

trans-2-Chloro-3-((1r,4r)-4-phenylcyclohexyl)naphthalene-1,4-dione, CAS: /, stock: 8.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉ClO₂.

trans-2-Oxo-2-((4-phenylcyclohexyl)oxy)acetic Acid, CAS: /, stock: 8.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆O₄.

Atropine, CAS: 51-55-8, stock: 8.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃NO₃.

Atropine Sulfate Monohydrate, CAS: 5908-99-6, stock: 1.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₀N₂O₁₁S.

trans-4-Phenylcyclohexanecarboxylic Acid, CAS: 1466-73-5, stock: 8.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆O₂.

Atropine-d5, CAS: /, stock: 4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈D₅NO₃.

Butethamate Citrate Salt, CAS: 13900-12-4, stock: 4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₅NO₂ • ( C₆H₈O₇).

trans-4-Phenylcyclohexanol, CAS: 5769-13-1, stock: 7.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O.

trans-​4-​(4-​Chlorophenyl)​cyclohexanecarboxyli​c Acid, CAS: 49708-81-8, stock: 8.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅ClO₂.

Homatropine Hydrochloride, CAS: 637-21-8, stock: 2.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁NO₃ • HCl.

Homatropine Methylbromide, CAS: 80-49-9, stock: 6.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄BrNO₃.

Ipratropium Bromide Monohydrate, CAS: 66985-17-9, stock: 5.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂BrNO₄.

Ipratropium-d3 Iodide, CAS: /, stock: 9.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₇D₃INO₃.

Ipratropium-d7 Bromide, CAS: /, stock: 5.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃D₇BrNO₃.

N-Isopropyl Noratropine, CAS: 22235-81-0, stock: 1.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₇NO₃.

N-Isopropyl Noratropine-d7, CAS: /, stock: 6.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀D₇NO₃.

N-Isopropylnortropine Methobromide (Impurity), CAS: 58005-18-8, stock: 6.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂BrNO.

N-Isopropylnortropine Methobromide-D3 (Impurity), CAS: /, stock: 7.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉D₃BrNO.

N-Methylatropine Bromide, CAS: 2870-71-5, stock: 9.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆BrNO₃.

Noratropine Hydrochloride, CAS: 75559-01-2, stock: 1.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂ClNO₃.

Nortropine, CAS: 538-09-0, stock: 2.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃NO.

Nortropine Hydrochloride, CAS: 14383-51-8, stock: 4.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄ClNO.

rac Homatropine Hydrobromide, CAS: 51-56-9, stock: 5.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂BrNO₃.

rac Homatropine Hydrobromide-d3, CAS: /, stock: 4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉D₃BrNO₃.

2,4-Dichloro-6-isopropylamino-1,3,5-triazine, CAS: 04/10/3703, stock: 4.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈Cl₂N₄.

2-Amino-4-(isopropyl-d7-amino)-6-chloro-triazine, CAS: 1216649-31-8, stock: 7.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃D₇ClN₅.

2-Amino-4-isopropylamino-6-chlorotriazine, CAS: 6190-65-4, stock: 1.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀ClN₅.

4-Amino-2-chloro-1,3,5-triazine, CAS: 7709-13-9, stock: 9.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₃ClN₄.

Ammeline, CAS: 645-92-1, stock: 2.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₅N₅O.

Ammeline-13C3 Hydrochloride, CAS: 1794936-94-9, stock: 2.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₃H₆ClN₅O.

Atrazine, CAS: 1912-24-9, stock: 7.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄ClN₅.

Atrazine Glutathione Adduct, CAS: 24429-05-8, stock: 6.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₀N₈O₆S.

Atrazine Mercapturate, CAS: 138722-96-0, stock: 1.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₂N₆O₃S.

Atrazine-13C4, CAS: /, stock: 6.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₄H₁₄ClN₅.

Atrazine-15N, CAS: 287476-17-9, stock: 8.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄ClN₅.

Atrazine-d5, CAS: 163165-75-1, stock: 4.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉D₅ClN₅.

Atrazine-hydroxydesethyl, CAS: 19988-24-0, stock: 6.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁N₅O.

Desethyldesisopropyl Atrazine, CAS: 3397-62-4, stock: 6.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₄ClN₅.

Desethyldesisopropyl Atrazine-13C3, CAS: 1216850-33-7, stock: 7.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₃H₄ClN₅.

Desisopropyl Atrazine, CAS: 1007-28-9, stock: 6.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈ClN₅.

Desisopropyl Atrazine-d5, CAS: 1189961-78-1, stock: 7.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃D₅ClN₅.

Diethylamine Hydrochloride, CAS: 660-68-4, stock: 3.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₂ClN.

Hydroxy Atrazine, CAS: 2163-68-0, stock: 7.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅N₅O.

Hydroxy Atrazine-d5, CAS: 1276197-25-1, stock: 1.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀D₅N₅O.

N-Nitrosoatrazine, CAS: 56525-09-8, stock: 2.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃ClN₆O.

N-tert-Butyloxycarbonyl Glutathione-S-dechloro-atrazine Dimethyl Diester, CAS: /, stock: 4.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₂N₈O₈S.

(E)-2-(2-(6-((2-(Methylcarbamoyl)phenyl)sulfonyl)-1H-indazol-3-yl)vinyl)pyridine 1-Oxide, CAS: /, stock: 4.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈N₄O₄S.

(E)-6-((2-(Methylcarbamoyl)phenyl)sulfonyl)-3-(2-(1-oxidopyridin-2-yl)vinyl)-1H-indazole 1-Oxide, CAS: /, stock: 8.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈N₄O₅S.

(E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole, CAS: 886230-77-9, stock: 1.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈IN₃O.

Axitinib Acid, CAS: 319462-34-5, stock: 5.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₅N₃O₂S.

Axitinib Lactose Adduct, CAS: /, stock: 3.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₈N₄O₁₁S.

Axitinib-N-β-D-glucuronide, CAS: /, stock: 5.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₆N₄O₇S.

(1R,1’R, 2’S)-2-Desmethyl Cisatracurium Besylate, CAS: /, stock: 4.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₂H₆₉N₂O₁₂⁺ • 2(C ₆H₅O₃S⁻).

(1R,2R)-2-(3-(tert-butoxy)-3-oxopropyl)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium benzenesulfonate (1:1), CAS: 1075727-00-2, stock: 1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₀NO₆⁺ • (C₆H₅O₃S⁻).

(1R,2R,1’R,2’S)-Atracurium Besylate, CAS: /, stock: 8.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₃H₇₂N₂O₁₂²⁺  • 2(C ₆H₅O₃S⁻).

(1R,2R,1’S,2’R)-Cisatracurium Dibesylate, CAS: /, stock: 5.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₃H₇₂N₂O₁₂²⁺ • 2(C ₆H₅O₃S⁻).

(1R,2S)-1-[(3,4-Dimethoxyphenyl)methyl]-2-[3-(1,1-dimethylethoxy)-3-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-isoquinolinium Benzenesulfonate (1:1), CAS: 1075727-02-4, stock: 7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₀NO₆⁺  • ( C₆H₅O₃S⁻).

(1R,2S)-2-(2-Carboxyethyl)-1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-isoquinolinium Benzenesulfonate, CAS: /, stock: 9.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₂NO₆ • (C ₆H₅O₃S⁻) • x(  C₆H₆O₃S).

(1R,2S,1’S,2’S)-Cisatracurium Dibesylate, CAS: /, stock: 7.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₃H₇₂N₂O₁₂²⁺ • 2(C ₆H₅O₃S⁻).

(1R,​2R)​-1-​[(3,​4-​dimethoxyphenyl)​methyl]​-​1,​2,​3,​4-​tetrahydro-​6,​7-​dimethoxy-​2-​(3-​methoxy-​3-​oxopropyl)​-​2-​methylisoquinolium Benzenesulfonate, CAS: 1075726-88-3, stock: 2.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₉NO₉S.

(cis-trans)-Atracurium Dibesylate Mixture, CAS: /, stock: 7.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₃H₇₂N₂O₁₂•2(C₆H₅O₃S).

(R)-(-)-Norlaudanosine N-5-Hydroxypentyl Propionate, CAS: /, stock: 2.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₉NO₇.

(R)-(-)-Norlaudanosine N-Propanoic Acid, CAS: /, stock: 6.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉NO₆.

(R)-cis-5ξ-Methyl Atracurium Dibesylate, CAS: 1193104-82-3, stock: 9.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₄H₇₄N₂O₁₂•2(C₆H₅O₃S).

(R)-Laudanosine, CAS: 85-63-2, stock: 4.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇NO₄.

(R)-Laudanosine N-3-((5-Hydroxypentyl)oxy)-3-oxopropyl Benzenesulfonate, CAS: 1100676-16-1, stock: 3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₄₇NO₁₀S.

(R)-Laudanosine N-Carboxyethyl Benzenesulfonate, CAS: 1075727-06-8, stock: 3.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₇NO₉S.

(R)-Laudanosine N-Carboxyethyl-d3 Iodide, CAS: 1075727-07-9, stock: 7.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉D₃INO₆.

(R)-Laudanosine-d3, CAS: 1146949-54-3, stock: 6.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄D₃NO₄.

(R)-Laudanosine-d3 N-3-((5-Hydroxypentyl)oxy)-3-oxopropyl Benzenesulfonate, CAS: /, stock: 1.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₄₄D₃NO₁₀S.

(R)-N-Methyl-Laudanosine Iodide, CAS: 41431-32-7, stock: 2.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₀INO₄.

(R)-tert-Butyl-N-butanoate Norlaudanosine Oxalate, CAS: 1075726-71-4, stock: 5.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₉NO₁₀.

(R)-tert-Butyl-N-butanoate Norlaudanosine Oxalate, CAS: 1075726-70-3, stock: 3.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₇NO₆.

(R)-trans-Atracurium Besylate (>85%), CAS: 96946-46-2, stock: 2.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₅H₈₂N₂O₁₈S₂.

(R)-trans-Atracurium Besylate-d4, CAS: /, stock: 6.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₅H₇₈D₄N₂O₁₈S₂.

(R,cis)-7-Methyl Atracurium Dibesylate, CAS: 1193104-80-1, stock: 1.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₄H₇₄N₂O₁₂•2(C₆H₅O₃S).

(R,R)-N,N’-Didemethyl Atracurium Oxalate, CAS: 96687-52-4, stock: 9.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₂H₆₈N₂O₁₁•C₂H₂O₄.

(R,R,S,S)-Cisatracurium Dibesylate, CAS: /, stock: 8.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₃H₇₂N₂O₁₂²⁺ • 2( C₆H₅O₃S⁻).

(S)-Laudanosine, CAS: 2688-77-9, stock: 7.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇NO₄.

(S)-Laudanosine (S)-α-Hydroxybenzeneacetate, CAS: /, stock: 3.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇NO₄  • C ₈H₈O₃.

(S)-Laudanosine-d3, CAS: /, stock: 5.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄D₃NO₄.

2-(9-Hydroxy-3-oxo-4-oxanonyl)-2-methyl-1,2,3,4-tetrahydropapaverinium, CAS: 87046-72-8, stock: 1.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₂NO₇.

5-Hydroxypentyl Acrylate, CAS: 57198-94-4, stock: 1.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄O₃.

7-Methyl Atracurium Dimesylate (Mixture of Diastereomers), CAS: 64229-01-2, stock: 2.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₄H₇₄N₂O₁₂•2(CH₃O₃S).

Atracurium Besylate, CAS: 64228-81-5, stock: 8.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₅H₈₂N₂O₁₈S₂.

cis-1-[(3,4-Dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-2-[3-oxo-3-[[5-[(1-oxo-2-propenyl)oxy]pentyl]oxy]propyl]-isoquinolinium-d3 Benzenesulfonate, CAS: /, stock: 7.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₆D₃NO₁₁S.

Cis-Cis-Atracurium-3-oxopropoxy Dibesylate, CAS: /, stock: 2.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₈H₈₆N₂O₂₀S₂.

Cis-Cis-Atracurium-3-oxopropoxy-d6 Dibesylate, CAS: /, stock: 4.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₈H₈₀D₆N₂O₂₀S₂.

Cisatracurium Besylate (~90%), CAS: 96946-42-8, stock: 7.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₅H₈₂N₂O₁₈S₂.

Cisatracurium-20-methyl Dibenzenesulfonate, CAS: 1193104-85-6, stock: 4.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₆H₈₄N₂O₁₈S₂.

Cisatracurium-d6-20-methyl Dibenzenesulfonate, CAS: /, stock: 6.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₆H₇₈D₆N₂O₁₈S₂.

Desmethyl Cisatracurium Besylate, CAS: /, stock: 2.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₈H₇₄N₂O₁₅S.

DL-Laudanosine, CAS: 1699-51-0, stock: 3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇NO₄.

Hexane-2,6-diol, CAS: 928-40-5, stock: 4.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄O₂.

N-(5-(Propionyloxy)pentyl Acrylate) (R)-trans-Laudanosine Benzenesulfonate, CAS: /, stock: 8.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₉NO₁₁S.

N-(5-(Propionyloxy)pentyl Acrylate) rac-cis-Laudanosine Benzenesulfonate, CAS: 155913-31-8, stock: 4.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₉NO₁₁S.

N-(5-(Propionyloxy)pentyl Acrylate) rac-trans-Laudanosine Benzenesulfonate, CAS: 155913-32-9, stock: 3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₉NO₁₁S.

N-Desmethyl-transatracurium Besylate (~80%), CAS: /, stock: 7.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₈H₇₄N₂O₁₅S.

R-Tetrahydropapaverine N-Acetyl-L-leucinate, CAS: 141109-12-8, stock: 3.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅NO₄ •  C₈H₁₅NO₃.

rac-N-Methyl-Laudanosine Iodide, CAS: 24948-17-2, stock: 2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₀INO₄.

(R)-3-Azido-1-phenyl-1-(2-methylphenoxy)propane, CAS: 1217813-19-8, stock: 5.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₃O.

(R)-3-Azido-1-phenyl-1-(2-methylphenoxy-d7)propane, CAS: 1217603-70-7, stock: 7.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₀D₇N₃O.

(R)-3-Chloro-1-phenyl-1-(2-methylphenoxy)propane, CAS: 114446-47-8, stock: 8.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇ClO.

(R)-3-Chloro-1-phenyl-1-(2-methylphenoxy-d7)propane, CAS: 1217765-70-2, stock: 5.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₀D₇ClO.

(R)-3-Chloro-1-phenyl-1-[2-methyl-4-[(tert-butoxycarbonyl)oxy]phenoxy]propane, CAS: 457634-25-2, stock: 3.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅ClO₄.

(S)-(+)-Mandelic Acid, CAS: 17199-29-0, stock: 9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈O₃.

(S)-3-Chloro-1-phenyl-1-[2-methyl-phenoxyl]propane, CAS: 114446-50-3, stock: 6.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇ClO.

3-Fluoro Atomoxetine, CAS: /, stock: 6.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀FNO.

4’-Hydroxy Atomoxetine, CAS: 435293-66-6, stock: 3.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁NO₂.

4’-Hydroxy Atomoxetine β-D-Glucuronide, CAS: 540729-08-6, stock: 3.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉NO₈.

4’-Hydroxy Atomoxetine β-D-Glucuronide-d3, CAS: /, stock: 5.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆D₃NO₈.

4’-Hydroxy Atomoxetine-d3, CAS: 1217686-14-0, stock: 7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈D₃NO₂.

Atomoxetine Hydrochloride, CAS: 82248-59-7, stock: 1.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂ClNO.

Atomoxetine-d3, Hydrochloride, CAS: 1217776-38-9, stock: 7.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉D₃ClNO.

Atomoxetine-N-amide, CAS: /, stock: 9.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂N₂O₂.

Bis-(2-benzoylethyl)ether (Atomoxetine Impurity), CAS: /, stock: 6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈O₃.

Desmethyl Atomoxetine Hydrochloride, CAS: 881995-46-6, stock: 2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀ClNO.

Desmethyl Atomoxetine-d7 Hydrochloride Salt, CAS: 1189961-95-2, stock: 7.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃D₇ClNO.

Destolyl Atomoxetine, CAS: 115290-81-8, stock: 1.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅NO.

ent Atomoxetine-d3, Hydrochloride, CAS: 1217703-95-1, stock: 8.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉D₃ClNO.

α-[2-(Methylamino)ethyl]benzyl Alcohol, CAS: 42142-52-9, stock: 3.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅NO.

m-Methyl Atomoxetine Hydrochloride, CAS: 873310-28-2, stock: 1.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂ClNO.

N-Formyl Atomoxetine, CAS: /, stock: 6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁NO₂.

N-Formyl Atomoxetine-D3, CAS: /, stock: 9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈D₃NO₂.

N-Methyl-3-(2-methyl-3-((methylamino)(phenyl)methoxy)phenoxy)-3-phenylpropan-1-amine, CAS: /, stock: 3.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₄N₂O₂.

p-Methyl Atomoxetine Hydrochloride, CAS: 873310-31-7, stock: 5.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂ClNO.

rac 3-Chloro-1-phenyl-1-(2-methylphenoxy)propane, CAS: 881995-47-7, stock: 2.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇ClO.

rac 3-Chloro-1-phenylpropanol, CAS: 18776-12-0, stock: 9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁ClO.

rac Atomoxetine Hydrochloride, CAS: 82857-40-7, stock: 3.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂ClNO.

rac Atomoxetine-d5 Hydrochloride, CAS: 1398065-95-6, stock: 6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇D₅ClNO.

rac N-Methyl Atomoxetine Oxalate, CAS: 107688-86-8, stock: 6.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃NO•C₂H₂O₄.

rac N-Methyl Atomoxetine-d6 Oxalate, CAS: /, stock: 4.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇D₆NO•C₂H₂O₄.

S-(+)-Atomoxetine Hydrochloride, CAS: 82857-39-4, stock: 5.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂ClNO.

Δ5-Avenasterol (E/Z mixture), CAS: 18472-36-1, stock: 3.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₈O.

Δ5-Avenasterol-d4, CAS: /, stock: 5.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₄D₄O.

Δ7-Avenasterol, CAS: 23290-26-8, stock: 7.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₈O.

Δ7-Avenasterol-d4, CAS: /, stock: 8.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₄D₄O.

Astemizole, CAS: 68844-77-9, stock: 3.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₁FN₄O.

Astemizole-d3, CAS: 1189961-39-4, stock: 6.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₈D₃FN₄O.

Astemizole-d5, CAS: /, stock: 10g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₆D₅FN₄O.

N-Ethoxycarbonyl Norastemizole, CAS: 84501-68-8, stock: 3.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅FN₄O₂.

Norastemizole Hydrobromide, CAS: 75970-64-8, stock: 1.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃Br₂FN₄.

O-Desmethyl Astemizole, CAS: 73736-50-2, stock: 4.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₉FN₄O.

O-Desmethyl Astemizole-d5, CAS: /, stock: 5.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₄D₅FN₄O.

(R)-Atenolol, CAS: 56715-13-0, stock: 2.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂N₂O₃.

(R)-Atenolol-d7, CAS: 1309283-25-7, stock: 6.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅D₇N₂O₃.

(S)-Atenolol, CAS: 93379-54-5, stock: 6.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂N₂O₃.

(S)-Atenolol-d7, CAS: 1309283-20-2, stock: 7.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅D₇N₂O₃.

1,3-Bis(2-methoxyphenoxy)-2-propanol, CAS: 16929-60-5, stock: 3.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀O₅.

1,7-Di(2-methoxyphenoxy)-2,6-dihydroxy-4-oxaheptane, CAS: 1797132-23-0, stock: 1.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆O₇.

2-​Methyl-​N-​[4-​(5-​oxazolyl)​phenyl]​benzeneacetamide, CAS: 1626923-39-4, stock: 3.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆N₂O₂.

2-[4-[(2RS)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]acetonitrile; (Atenolol Impurity H), CAS: 29277-73-4, stock: 1.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂O₂.

3-Hydroxy-N-[4-(5-oxazolyl)phenyl]benzeneacetamide, CAS: 1788618-05-2, stock: 6.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄N₂O₃.

4,4’-[(2-Hydroxy-1,3-propanediyl)bis(oxy)]bis-benzeneacetamide(Atenolol Impurity E), CAS: 141650-31-9, stock: 1.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂N₂O₅.

4,4’-[[(1-Methylethyl)imino]bis[(2-hydroxy-3,1-propanediyl)oxy]]bis-benzeneacetamide (Atenolol Impurity F), CAS: 87619-83-8, stock: 8.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₅N₃O₆.

4,4’-[[(1-methylethyl)imino]bis[(2-hydroxy-3,1-propanediyl)oxy]]bis-benzeneacetamide-d7 (Atenolol Impurity F), CAS: /, stock: 7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈D₇N₃O₆.

4-(2,3-Epoxypropoxy)phenylacetamide, CAS: 29122-69-8, stock: 4.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₃.

4-(2-Oxiranylmethoxy)benzeneacetonitrile, CAS: 35198-42-6, stock: 4.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO₂.

4-(3-Amino-2-hydroxypropoxy)phenylacetamide, CAS: 81346-71-6, stock: 3.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O₃.

4-(3-Chloro-2-hydroxypropoxy)benzeneacetamide (Atenolol Impurity D), CAS: 115538-83-5, stock: 2.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄ClNO₃.

4-​Fluoro-​N-​[4-​(5-​oxazolyl)​phenyl]​benzeneacetamide, CAS: 1626077-46-0, stock: 4.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₃FN₂O₂.

4-​Methoxy-​N-​[4-​(5-​oxazolyl)​phenyl]​benzeneacetamide, CAS: 1625346-18-0, stock: 9.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆N₂O₃.

4-​Methyl-​N-​[4-​(5-​oxazolyl)​phenyl]​benzeneacetamide, CAS: 1626182-01-1, stock: 5.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆N₂O₂.

4-Hydroxymandelic Acid, CAS: 1198-84-1, stock: 1.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈O₄.

4-Hydroxyphenylacetamide, CAS: 17194-82-0, stock: 7.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₂.

4-[(2S)-2-Oxiranylmethoxy]benzeneacetamide, CAS: 56715-12-9, stock: 7.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₃.

5-(4-Hydroxyphenyl)-2,2-dimethyl-1,3-dioxolan-4-one, CAS: 173192-07-9, stock: 3.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₄.

Atenolol, CAS: 29122-68-7, stock: 7.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂N₂O₃.

Atenolol β-D-Glucuronide, CAS: 889359-84-6, stock: 7.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀N₂O₉.

Atenolol-d7, CAS: 1202864-50-3, stock: 6.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅D₇N₂O₃.

Atenolol-d7 β-D-Glucuronide, CAS: /, stock: 1.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃D₇N₂O₉.

C-Desmethyl Atenolol, CAS: 1797116-92-7, stock: 2.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₂O₃.

C-Desmethyl Atenolol-d5, CAS: /, stock: 7.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅D₅N₂O₃.

Des(isopropylamino) Atenolol Diol, CAS: 61698-76-8, stock: 5.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₄.

Des(isopropylamino) Atenolol Diol-d5, CAS: /, stock: 3.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀D₅NO₄.

Hydroxyatenolol, CAS: 68373-10-4, stock: 4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂N₂O₄.

Hydroxyatenolol-d7, CAS: /, stock: 6.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅D₇N₂O₄.

α-Hydroxy-4-(2-oxiranylmethoxy)-benzeneacetamide, CAS: 74908-88-6, stock: 8.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₄.

Metoprolol Acid, CAS: 56392-14-4, stock: 5.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁NO₄.

Metoprolol Acid-d5, CAS: 1215404-47-9, stock: 9.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆D₅NO₄.

p-Hydroxymandelamide, CAS: 74908-87-5, stock: 8.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₃.

(2E)-2,3-Dehydroxy Atorvastatin, CAS: 1105067-93-3, stock: 4.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₃FN₂O₄.

(2E)-2,3-Dibromo Atorvastatin, CAS: /, stock: 9.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₃Br₂FN₂O₄.

(2Z)-2,3-Dehydroxy Atorvastatin (>90% Z), CAS: 1191901-60-6, stock: 3.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₃FN₂O₄.

(3R)-4-Cyano-3-hydroxybutanoic Acid Ethyl Ester, CAS: 141942-85-0, stock: 2.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁NO₃.

(3R)-Methyl 4-((1bS,3R)-7-(4-Chlorophenyl)-7-hydroxy-1b-isopropyl-7a-phenyl-1a-(phenylcarbamoyl)hexahydro-1aH-oxireno[2’,3’:3,4]pyrrolo[2,1-b][1,3]oxazin-3-yl)-3-hydroxybutanoate, CAS: /, stock: 9.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₇ClN₂O₇.

(3R)-Methyl 4-((3S)-1b-(4-Chlorophenyl)-7-hydroxy-7-isopropyl-1a-phenyl-7a-(phenylcarbamoyl)hexahydro-1aH-oxireno[2’,3’:3,4]pyrrolo[2,1-b][1,3]oxazin-3-yl)-3-hydroxybutanoate, CAS: /, stock: 3.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₇ClN₂O₇.

(3R,5R)-6-Cyano-3,5-dihydroxy-hexanoic Acid tert-Butyl Ester, CAS: 125971-93-9, stock: 1.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉NO₄.

(3R,5R)-Atorvastatin Sodium Salt, CAS: 134523-01-6, stock: 5.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₄FN₂NaO₅.

(3R,5R)-Methyl 7-(2-(4-Chlorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate, CAS: /, stock: 3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₇ClN₂O₅.

(3R,5R)-tert-Butyl 7-(2-(4-Chlorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate, CAS: /, stock: 2.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₃ClN₂O₅.

(3R,5S)-Atorvastatin Acetonide tert-Butyl Ester, CAS: 947249-30-1, stock: 1.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₇FN₂O₅.

(3R,5S)-Atorvastatin Sodium Salt, CAS: 131275-93-9, stock: 3.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₄FN₂NaO₅.

(3S)-4-Chloro-3-hydroxybutyronitrile, CAS: 127913-44-4, stock: 9.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆ClNO.

(3S,5R)-6-Cyano-3,5-dihydroxy-hexanoic Acid tert-Butyl Ester, CAS: 186508-94-1, stock: 1.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉NO₄.

(3S,5R)-Atorvastatin Calcium Salt, CAS: 887196-25-0, stock: 5.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₆H₆₈CaF₂N₄O₁₀.

(3S,5R)-Atorvastatin Methyl Ester, CAS: 1429437-85-3, stock: 1.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₇FN₂O₅.

(3S,5S)-6-Cyano-3,5-dihydroxyhexanoic Acid 1,1-Dimethylethyl Ester, CAS: 1105067-92-2, stock: 4.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉NO₄.

(3S,5S)-Atorvastatin Acetonide tert-Butyl Ester, CAS: 472967-95-6, stock: 5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₇FN₂O₅.

(3S,5S)-Atorvastatin Calcium Salt, CAS: 1105067-88-6, stock: 9.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₆H₆₈CaF₂N₄O₁₀.

(3S,5S)-Atorvastatin Sodium Salt, CAS: 1428118-38-0, stock: 5.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₄FN₂NaO₅.

(4R,6R)-6-(Cyanomethyl)-2,2-dimethyl-1,3-dioxane-4-acetic Acid 1,1-Dimethylethyl Ester, CAS: 125971-94-0, stock: 8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₃NO₄.

(4R,6S)-6-(Cyanomethyl)-2,2-dimethyl--1,3-dioxane-4-acetic Acid tert-Butyl Ester, CAS: 196085-84-4, stock: 7.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₃NO₄.

(4R,cis)-1,1-Dimethylethyl-6-aminoethyl-2,2-dimethyl-1,3-dioxane-4-acetate, CAS: 125995-13-3, stock: 7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₇NO₄.

(4R,cis)-6-(2-Aminoethyl)-2,2-dimethyl-1,3-dioxane-4-acetic Acid, CAS: 125995-17-7, stock: 5.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉NO₄.

(4S,6R)-6-(Cyanomethyl)-2,2-dimethyl-1,3-dioxane-4-acetic Acid tert-Butyl Ester, CAS: 186508-95-2, stock: 2.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₃NO₄.

(4S,cis)-1,1-Dimethylethyl-6-aminoethyl-2,2-dimethyl-1,3-dioxane-4-acetate, CAS: 947586-93-8, stock: 9.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₇NO₄.

(4S,trans)-1,1-Dimethylethyl-6-aminoethyl-2,2-dimethyl-1,3-dioxane-4-acetate, CAS: 1105067-89-7, stock: 4.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₇NO₄.

(5R)-6-Cyano-5-hydroxy-3-oxo-hexanoic Acid tert-Butyl Ester, CAS: 125988-01-4, stock: 6.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇NO₄.

(5S)-6-Cyano-5-hydroxy-3-oxohexanoic Acid tert-Butyl Ester, CAS: 312745-90-7, stock: 9.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇NO₄.

(6-{2-[3-(4-Phenylcarbamoyl)-5-(4-fluoro-phenyl)-2-isopropyl-4-phenyl-d5-pyrrol-1-yl]-ethyl}-2,2-dimethyl-[1,3]-dioxane-4-yl)-acetic Acid, tert-Butyl Ester, CAS: 265989-34-2, stock: 5.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₂D₅FN₂O₅.

(±)-Atovaquone Impurity C, CAS: 1809464-27-4, stock: 9.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₇ClO₃.

(βR,δR)-3-Carboxy-5-(4-fluorophenyl)-β,δ-dihydroxy-2-(1-methylethyl)-4-phenyl-1H-Pyrrole-1-heptanoic Acid, CAS: 1821498-27-4, stock: 9.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₀FNO₆.

(βR,δR)-Atorvastatin tert-Butyl Ester (>90%), CAS: 134395-00-9, stock: 9.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₃FN₂O₅.

(βS,δS)-Atorvastatin tert-Butyl Ester, CAS: 1428118-12-0, stock: 9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₃FN₂O₅.

(R)​-​(-​)​-​2-​Chloro-​1-​phenylethanol, CAS: 56751-12-3, stock: 9.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉ClO.

1-((3R,5R)-6-Carboxy-3,5-dihydroxyhexyl)-2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrole 1-oxide, CAS: /, stock: 9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₅FN₂O₆.

10-trans-Atorvastatin (Atorvastatin Impurity AT10)((3S,5R)-Atorvastatin Sodium Salt), CAS: /, stock: 4.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₄FN₂NaO₅.

10-trans-Atorvastatin Acetonide tert-Butyl Ester, CAS: 1105067-90-0, stock: 4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₇FN₂O₅.

10-trans-Atorvastatin tert-Butyl Ester, CAS: 1217751-95-5, stock: 7.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₃FN₂O₅.

1b-(4-Fluorophenyl)hexahydro-β,7-dihydroxy-7-(1-methylethyl)-1a-phenyl-7a-[(phenylamino)carbonyl]-3H-oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic Acid, CAS: 873950-18-6, stock: 7.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₅FN₂O₇.

2,2-Dibromo-1-(4-fluorophenyl)-2-phenylethanone, CAS: /, stock: 8.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉Br₂FO.

2,3-Dehydroxy Atorvastatin Sodium Salt(E/Z Mixture), CAS: /, stock: 5.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₂FN₂NaO₄.

2-(4-Fluorophenyl)-δ-hydroxy-5-(1-methylethyl)-β-oxo-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid, CAS: 1391194-36-7, stock: 6.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₃FN₂O₅.

2-(4-Fluorophenyl)-δ-hydroxy-5-(1-methylethyl)-β-oxo-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid 1,1-Dimethylethyl Ester, CAS: 947262-20-6, stock: 8.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₁FN₂O₅.

2-Benzyloxy Atorvastatin Acetonide, CAS: 1246820-45-0, stock: 4.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₄₅FN₂O₆.

2-Benzyloxy Atorvastatin Acetonide tert-Butyl Ester, CAS: 265989-39-7, stock: 9.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₅₃FN₂O₆.

2-Benzyloxy Atorvastatin-d5 Acetonide tert-Butyl Ester, CAS: 265989-41-1, stock: 2.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₄₈D₅FN₂O₆.

2-Fluoro Atorvastatin Sodium Salt, CAS: 1346598-86-4, stock: 9.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₄FN₂NaO₅.

2-Fluoro Atorvastatin Sodium Salt-d5, CAS: /, stock: 9.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₉D₅FN₂NaO₅.

2-Fluoro Atorvastatin tert-Butyl Ester, CAS: 1099474-28-8, stock: 9.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₇FN₂O₅.

2-Fluoro-α-(2-methyl-1-oxopropyl)-γ-oxo-N,β-diphenyl-benzenebutanamide, CAS: 1797905-42-0, stock: 5.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₄FNO₃.

2-Hydroxy Atorvastatin Acetonide tert-Butyl Ester, CAS: 265989-40-0, stock: 3.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₇FN₂O₆.

2-Hydroxy Atorvastatin Acyl-β-D-glucuronide 60%, contains up to 35% lactone, CAS: /, stock: 3.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₄₃FN₂O₁₂.

2-Hydroxy Atorvastatin Calcium Salt, CAS: 265989-46-6, stock: 1.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₆H₆₈CaF₂N₄O₁₂.

2-Hydroxy Atorvastatin Dihydrate Monosodium Salt, CAS: 1421760-64-6, stock: 6.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₈FN₂NaO₈.

2-Hydroxy Atorvastatin Lactone, CAS: 163217-74-1, stock: 4.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₃FN₂O₅.

2-Hydroxy Atorvastatin Lactone-d5, CAS: 265989-50-2, stock: 8.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₈D₅FN₂O₅.

2-Hydroxy Atorvastatin tert-Butyl Ester, CAS: 1346599-89-0, stock: 2.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₃FN₂O₆.

2-Hydroxy Atorvastatin tert-Butyl Ester-d5, CAS: /, stock: 4.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₃₈D₅FN₂O₆.

2-Hydroxy Atorvastatin-d5 Acetonide tert-Butyl Ester, CAS: 265989-42-2, stock: 6.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₂D₅FN₂O₆.

2-Hydroxy Atorvastatin-d5 Sodium Salt, CAS: /, stock: 9.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₀D₅FN₂O₆ •xNa.

2-tert-Butyl-1,3-diisopropylisourea, CAS: 71432-55-8, stock: 6.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₄N₂O.

2-[2-(4-Fluorophenyl)-2-oxo-1-phenylethylidene]-4-methyl-3-oxo-N-phenylpentanamide, CAS: 1331869-19-2, stock: 6.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₂FNO₃.

3-Dehydroxy 2,3-Dehydro Atorvastatin Lactone, CAS: 442851-50-5, stock: 1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₁FN₂O₃.

3-Fluoro Atorvastatin Sodium Salt, CAS: /, stock: 6.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₄FN₂NaO₅.

3-Fluoro Atorvastatin Sodium Salt-d5, CAS: /, stock: 4.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₉D₅FN₂NaO₅.

3-Fluoro-α-(2-methyl-1-oxopropyl)-γ-oxo-N,β-diphenyl-benzenebutanamide, CAS: 1817798-20-1, stock: 9.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₄FNO₃.

3-Oxo Atorvastatin tert-Butyl Ester, CAS: 134394-98-2, stock: 8.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₁FN₂O₅.

4-​Chloro-​α-​(2-​methyl-​1-​oxopropyl)​-​γ-​oxo-​N,​β-​diphenyl-benzenebutanamide, CAS: 444577-71-3, stock: 5.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₄ClNO₃.

4-Benzyloxy Atorvastatin Acetonide tert-Butyl Ester, CAS: 163217-68-3, stock: 9.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₅₃FN₂O₆.

4-Benzyloxy Atorvastatin-d5 Acetonide tert-Butyl Ester, CAS: 265989-37-5, stock: 9.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₄₈D₅FN₂O₆.

4-Fluoro Atorvastatin Calcium Salt, CAS: 693793-42-9, stock: 5.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₆H₆₆CaF₄N₄O₁₀.

4-Fluoro-α-(2-methyl-1-oxopropyl)-γ-oxo-N,β-diphenyl-benzenebutanamide, CAS: 125971-96-2, stock: 2.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₄FNO₃.

4-Fluoro-α-(2-methyl-1-oxopropyl)-γ-oxo-N,β-diphenyl-d5-benzenebutanamide, CAS: 222412-75-1, stock: 7.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₁₉D₅FNO₃.

4-Hydroxy Atorvastatin Acetonide tert-Butyl Ester, CAS: 265989-36-4, stock: 5.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₇FN₂O₆.

4-Hydroxy Atorvastatin Acyl-β-D-glucuronide 80%, contains up to 20% lactone, CAS: /, stock: 6.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₄₃FN₂O₁₂.

4-Hydroxy Atorvastatin Disodium Salt, CAS: 1276537-18-8, stock: 1.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₃FN₂Na₂O₆.

4-Hydroxy Atorvastatin Hemicalcium Salt, CAS: 1263176-34-6, stock: 5.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₆H₆₈CaF₂N₄O₁₂.

4-Hydroxy Atorvastatin Lactone, CAS: 163217-70-7, stock: 5.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₃FN₂O₅.

4-Hydroxy Atorvastatin Lactone-d5, CAS: 265989-49-9, stock: 1.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₈D₅FN₂O₅.

4-Hydroxy Atorvastatin-d5 Acetonide tert-Butyl Ester, CAS: 265989-38-6, stock: 2.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₂D₅FN₂O₆.

4-Hydroxy Atorvastatin-d5 Calcium Salt, CAS: /, stock: 2.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₈D₅CaFN₂O₆.

4-Hydroxy Atorvastatin-d5 Disodium Salt, CAS: /, stock: 4.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₈D₅FN₂Na₂O₆.

4-Hydroxy Atorvastatin-d5 Hemicalcium Salt, CAS: 265989-45-5, stock: 4.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₆H₅₈D₁₀CaF₂N₄O₁₂.

4-tert-Butyldimethylsilyl Atorvastatin Lactone, CAS: 842162-99-6, stock: 1.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₄₇FN₂O₄Si.

5-(2-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)ethyl)-2,5-dihydrofuran-2-carboxylic Acid, CAS: /, stock: 6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₁FN₂O₄.

5-(4-Fluorophenyl)-2,3-dihydro-3-(1-methylethyl)-2-oxo-N,4-diphenyl-1-[2-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxamide, CAS: /, stock: 8.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₃FN₂O₅.

5-(4-Fluorophenyl)-2-(1-methylethyl)-1-(3-oxopropyl)-N,4-diphenyl-1H-pyrrole-3-carboxamide, CAS: 110862-46-9, stock: 4.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₇FN₂O₂.

5-(4-Fluorophenyl)-2-(1-methylethyl)-1-(3-oxopropyl)-N,4-diphenyl-1H-pyrrole-propanoate tert-Butyl Acetate, CAS: /, stock: 7.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₅FN₂O₃.

5-Dehydroxy (3S)-Atorvastatin, CAS: 887196-26-1, stock: 3.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₅FN₂O₄.

5-Dehydroxy (3S)-Atorvastatin-d5, CAS: /, stock: 6.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₀D₅FN₂O₄.

5-Oxo Atorvastatin, CAS: 1391052-82-6, stock: 6.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₃FN₂O₅.

5-Oxo Atorvastatin tert-Butyl Ester, CAS: /, stock: 3.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₁FN₂O₅.

Allyl Ester of Atorvastatin Cyclic (Fluorophenyl) Impurity, CAS: 1316643-57-8, stock: 5.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₉FN₂O₇.

Allyl Ester of Atorvastatin Cyclic (Isopropyl) Impurity, CAS: 1316295-72-3, stock: 2.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₉FN₂O₇.

Atorvastatin 3-Isopropyl Ether tert-Butyl Ester, CAS: 1797009-04-1, stock: 5.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₉FN₂O₅.

Atorvastatin Acetonide, CAS: 581772-29-4, stock: 2.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₉FN₂O₅.

Atorvastatin Acetonide Acyl-β-D-glucuronide, CAS: /, stock: 7.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₄₇FN₂O₁₁.

Atorvastatin Acetonide tert-Butyl Ester, CAS: 125971-95-1, stock: 9.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₇FN₂O₅.

Atorvastatin Acyl-β-D-glucuronide, CAS: 463962-58-5, stock: 2.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₄₃FN₂O₁₁.

Atorvastatin Allyl Ester, CAS: 915092-85-2, stock: 5.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₉FN₂O₅.

Atorvastatin Calcium Salt, CAS: 134523-03-8, stock: 8.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₆H₆₈CaF₂N₄O₁₀.

Atorvastatin Calcium Salt Trihydrate, CAS: 344423-98-9, stock: 6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  2(C₃₃H₃₄FN₂O₅) • (  Ca) • 3(H ₂O).

Atorvastatin Cyclic (Chlorophenyl) Sodium Salt Impurity, CAS: /, stock: 6.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₄ClN₂NaO₇.

Atorvastatin Cyclic (Fluorophenyl) Sodium Salt Impurity, CAS: 1315629-79-8, stock: 8.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₄FN₂NaO₇.

Atorvastatin Cyclic 1,3-Oxazine (Isopropyl) Methyl Ester Impurity, CAS: /, stock: 3.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₇FN₂O₇.

Atorvastatin Cyclic Sodium Salt (Isopropyl) Impurity, CAS: 1316291-19-6, stock: 3.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₄FN₂NaO₇.

Atorvastatin Epoxy Dephenyl-Methyl Tetrahydrofuran Impurity, CAS: /, stock: 3.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅NO₅.

Atorvastatin Epoxy Pyrrolooxazin Tricyclic Impurity, CAS: /, stock: 2.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₂FN₂NaO₆.

Atorvastatin Epoxy Tetrahydrofuran Impurity, CAS: 873950-19-7, stock: 4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₄FNO₅.

Atorvastatin Epoxydione Impurity, CAS: 148146-51-4, stock: 9.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₂FNO₄.

Atorvastatin Ethyl Ester, CAS: 1146977-93-6, stock: 2.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₉FN₂O₅.

Atorvastatin Lactam Allyl Ester, CAS: 1246812-55-4, stock: 1.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₉FN₂O₆.

Atorvastatin Lactam Lactone, CAS: 1795791-15-9, stock: 8.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₁FN₂O₅.

Atorvastatin Lactam Methyl Ester, CAS: 1795790-02-1, stock: 2.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₇FN₂O₆.

Atorvastatin Lactam Phenanthrene Calcium Salt Impurity(mixture of diastereomers), CAS: 148127-12-2, stock: 4.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₂0.5CaFN₂O₆.

Atorvastatin Lactam Phenanthrene Methyl Ester(Mixture of Diastereomers), CAS: 906552-20-3, stock: 3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₅FN₂O₆.

Atorvastatin Lactam Sodium Salt Impurity, CAS: 148217-40-7, stock: 7.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₄FN₂NaO₆.

Atorvastatin Lactone, CAS: 125995-03-1, stock: 4.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₃FN₂O₄.

Atorvastatin Lactone, CAS: 125995-03-1, stock: 2.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₃FN₂O₄.

Atorvastatin Lactone 3-O-Methyl Ether, CAS: /, stock: 9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₅FN₂O₄.

Atorvastatin Lactone Diepoxide(Mixture of diastereomers), CAS: 1046118-40-4, stock: 3.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₃FN₂O₆.

Atorvastatin Lactone Diepoxide N-Oxide, CAS: /, stock: 5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₃FN₂O₇.

Atorvastatin Methyl Ester, CAS: 345891-62-5, stock: 4.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₇FN₂O₅.

Atorvastatin N-(3,5-Dihydroxy-7-heptanoic Acid)amide, CAS: 1105067-87-5, stock: 9.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₈FN₃O₈•0.5Ca.

Atorvastatin Oxirane Impurity, CAS: 1246818-88-1, stock: 1.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₄FNO₃.

Atorvastatin-Amlodipine Adduct, CAS: 425408-16-8, stock: 6.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₃H₅₈ClFN₄O₉.

Atorvastatin-d5 Calcium Salt, CAS: 222412-82-0, stock: 1.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₆H₅₈D₁₀CaF₂N₄O₁₀.

Atorvastatin-d5 Lactone, CAS: 1217749-86-4, stock: 2.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₈D₅FN₂O₄.

Atorvastatin-d5 Sodium Salt, CAS: 222412-87-5, stock: 3.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₉D₅FN₂NaO₅.

Atorvastatin-d5 Sodium Salt, CAS: /, stock: 6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₉D₅FN₂NaO₅.

Atorvastatin-d5 tert-Butyl Ester, CAS: /, stock: 6.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₃₈D₅FN₂O₅.

cis-Atovaquone, CAS: 137732-39-9, stock: 1.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉ClO₃.

Defluoro Atorvastatin Acetonide tert-Butyl Ester, CAS: 1105067-91-1, stock: 4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₈N₂O₅.

Defluoro Atorvastatin Calcium Salt, CAS: 433289-83-9, stock: 8.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₆H₆₈CaN₄O₁₀.

Defluoro Atorvastatin Sodium Salt, CAS: /, stock: 7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₅N₂NaO₅.

di(2-Hydroxy Atorvastatin-d5) Calcium Salt, CAS: 265989-47-7, stock: 9.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₆H₅₈D₁₀CaF₂N₄O₁₂.

Difluoro Atorvastatin, CAS: 693794-20-6, stock: 8.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₄F₂N₂O₅.

Difluoro Atorvastatin Acetonide tert-Butyl Ester, CAS: 693793-87-2, stock: 5.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₆F₂N₂O₅.

Difluoro Atorvastatin Calcium Salt, CAS: 693793-53-2, stock: 4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₆H₆₈CaF₂N₄O₁₀.

Dihydroxy Diketo Atorvastatin Impurity, CAS: 1046118-44-8, stock: 10g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₄FNO₅.

Lithiodiisopropylamine, CAS: 4111-54-0, stock: 7.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄LiN.

Methyl 4-(1b-(4-Fluorophenyl)-7-hydroxy-7-isopropyl-1a-phenyl-7a-(phenylcarbamoyl)hexahydro-1aH-oxireno[2’,3’:3,4]pyrrolo[2,1-b][1,3]oxazin-4-yl)-3-hydroxybutanoate, CAS: /, stock: 2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₇FN₂O₇.

N,3-Diphenyl-2-(2-methyl-1-oxopropyl)4-oxo-N-benzenebutanamide (Mixture of Diastereomers), CAS: 444577-70-2, stock: 4.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₅NO₃.

N-4-Phenyl α-Benzylidene-d5 Isobutyrylacetamide, CAS: 222412-73-9, stock: 1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄D₅NO₂.

O-Methyl Atorvastatin Calcium Salt, CAS: 887196-29-4, stock: 4.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₇FN₂O₅•0.5Ca.

O-Methyl Atovaquone, CAS: 129700-41-0, stock: 4.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₁ClO₃.

rac-3-Oxo Atorvastatin Sodium Salt, CAS: 1391052-00-8, stock: 1.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₂FN₂NaO₅.

rac-Atorvastatin Calcium, CAS: 363599-71-7, stock: 6.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₆H₇₀CaF₂N₄O₁₀.

Sodium (3R,5R)-7-(2-(4-Chlorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate, CAS: /, stock: 3.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₄ClN₂NaO₅.

tert-Butyl 2-((4R,6R)-6-(2-(2-(3-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)ethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate, CAS: /, stock: 5.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₇FN₂O₅.

tert-Butyl 2-((4R,6R)-6-(2-(2-(4-Chlorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)ethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate, CAS: /, stock: 1.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₇ClN₂O₅.

tert-Butyl 3-Aminopropanoate, CAS: 15231-41-1, stock: 8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₂.

tert-Butyl-4-hydroxy Atorvastatin, CAS: /, stock: 2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₃FN₂O₆.

tert-Butyl-4-hydroxy Atorvastatin-d5, CAS: /, stock: 1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₃₈D₅FN₂O₆.

(2R,3S)-3-(tert-Boc)amino-1,2-epoxy-4-phenylbutane, CAS: 98760-08-8, stock: 6.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁NO₃.

(2R,3S)-3-Boc-amino-1,2-epoxy-4-phenyl-d5-butane, CAS: /, stock: 1.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆D₅NO₃.

(2S,3R)-3-(tert-Butoxycarbonylamino)-1,2-epoxy-4-phenylbutane, CAS: 156474-22-5, stock: 8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁NO₃.

(2S,3R)-Des-N-(methoxycarbonyl)-L-tert-leucine Bis-Boc Atazanavir, CAS: /, stock: 5.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₂N₄O₅.

(2S,3S)-3-Amino-4-phenyl-1-((E)-1-(4-(pyridin-2-yl)benzyl)-2-(4-(pyridin-2-yl)benzylidene)hydrazinyl)butan-2-ol, CAS: /, stock: 4.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₃N₅O.

(2S,3S)-3-Boc-amino-1,2-epoxy-4-phenylbutane, CAS: 98737-29-2, stock: 3.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁NO₃.

(3R,8R,9R,12R)-Atazanavir, CAS: /, stock: 4.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₂N₆O₇.

(3R,8R,9S,12R)-Atazanavir, CAS: 1292296-10-6, stock: 5.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₂N₆O₇.

(3R,8S,9S,12R)-Atazanavir, CAS: 1292296-11-7, stock: 3.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₂N₆O₇.

(3R,8S,9S,12S)-Atazanavir, CAS: 1332981-14-2, stock: 9.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₂N₆O₇.

(3S,6S,7S,15S,16S,19S)-3,19-bis(1,1-dimethylethyl)-7,15-dihydroxy-4,11,18-trioxo-6,16-bis(phenylmethyl)-9,13-bis[[4-(2-pyridinyl)phenyl]methyl]-2,5,9,10,12,13,17,20-Octaazaheneicosanedioic Acid 1,21-dimethyl Ester(Atazanavir  Dimer), CAS: 1911609-86-3, stock: 7.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₁H₇₆N₁₀O₉.

(3S,8R,9R,12S)-Atazanavir, CAS: /, stock: 7.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₂N₆O₇.

(3S,8S,9S,12R)-Atazanavir, CAS: 1332981-16-4, stock: 7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₂N₆O₇.

(R,R)-Des-N-(methoxycarbonyl)-L-tert-leucine Bis-Boc Atazanavir, CAS: /, stock: 6.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₂N₄O₅.

(S,S,S)-Atazanavir Benzylidenehydrazine Carbamate, CAS: /, stock: 3.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₄₆N₆O₄.

1-Boc-2-[4-(2-pyridinyl)benzylidene]hydrazine, CAS: 198904-85-7, stock: 4.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁N₃O₂.

2-[(2S,3S)-3-[(4R)-4-(1,1-Dimethylethyl)-2,5-dioxo-1-imidazolidinyl]-2-hydroxy-4-phenylbutyl]-2-[[4-(2-pyridinyl)phenyl]methyl]hydrazide N-(Methoxycarbonyl)-3-methyl-L-valine((Atazanavir Cyclization product (western half), CAS: 1292296-13-9, stock: 9.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₈N₆O₆.

4-(2-Pyridinyl)benzoic Acid, CAS: 4385-62-0, stock: 7.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉NO₂.

8-epi Atazanavir, CAS: 1292296-09-3, stock: 9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₂N₆O₇.

Atazanavir, CAS: 198904-31-3, stock: 6.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₂N₆O₇.

Atazanavir Bisulfate Salt, CAS: 229975-97-7, stock: 2.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₄N₆O₁₁S.

Atazanavir N13-descarboxymethyl, CAS: 1233885-61-4, stock: 8.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₅₁ClN₆O₅.

Atazanavir N2-Descarboxymethyl, CAS: 1028634-76-5, stock: 9.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₅₀N₆O₅.

Atazanavir-8-(N-methoxycarbonyl)-L-tert-leucine Ester, CAS: /, stock: 3.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₆₅N₇O₁₀.

Atazanavir-d18, CAS: 1092540-52-7, stock: 8.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₃₄D₁₈N₆O₇.

Atazanavir-d4, CAS: 1132747-16-0, stock: 1.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₈D₄N₆O₇.

Atazanavir-d5, CAS: 1132747-14-8, stock: 3.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₇D₅N₆O₇.

Atazanavir-d6, CAS: 1092540-50-5, stock: 4.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₆D₆N₆O₇.

Atazanavir-d9, CAS: 1092540-51-6, stock: 1.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₃D₉N₆O₇.

Des(benzylpyridyl) Atazanavir, CAS: 1192224-24-0, stock: 3.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₃N₅O₇.

Des(benzylpyridyl) Atazanavir-d5, CAS: /, stock: 5.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₈D₅N₅O₇.

Des-N-(methoxycarbonyl)-L-tert-leucine Atazanavir Trihydrochloride, CAS: 198904-87-9, stock: 8.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₉Cl₃N₄O.

Des-N-(methoxycarbonyl)-L-tert-leucine Atazanavir-d5 Trihydrochloride, CAS: 1246817-28-6, stock: 2.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄D₅Cl₃N₄O.

Des-N-(methoxycarbonyl)-L-tert-leucine Bis-Boc Atazanavir, CAS: 198904-86-8, stock: 3.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₂N₄O₅.

Des-N-(methoxycarbonyl)-L-tert-leucine Bis-Boc Atazanavir-d5, CAS: 1217665-60-5, stock: 5.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₇D₅N₄O₅.

(2S,5S)-5-Benzyl-3,6-dioxo-2-piperazineacetic Acid, CAS: 02/10/5262, stock: 6.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄N₂O₄.

Methy (3S,8S,9S)-3-(1,1-Dimethylethyl)-8-hydroxy-13,13-dimethyl-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-12-oxa-2,5,6,10-tetraazatetradecanoic Acid Ester, CAS: 857904-03-1, stock: 5.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₄₇N₅O₆.

Methyl ((S)-1-(((2S,3S)-4-(((S)-4-(tert-butyl)-2,5-dioxoimidazolidin-1-yl)(4-(pyridin-2-yl)benzyl)amino)-3-hydroxy-1-phenylbutan-2-yl)amino)-3,3-dimethyl-1-oxobutan-2-yl)carbamateAtazanavir cyclization product (Eastern half), CAS: /, stock: 9.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₈N₆O₆.

Acesulfame Aspartame Salt, CAS: 106372-55-8, stock: 8.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃N₃O₉S.

Advantame, CAS: 245650-17-3, stock: 1.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀N₂O₇.

N-(Methoxycarbonyl)-3-(methyl-d3)-L-valine-4,4,4,4’,4’,4’-d6, CAS: 1092539-97-3, stock: 5.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆D₉NO₄.

N-(Methoxycarbonyl)-L-tert-leucine, CAS: 162537-11-3, stock: 2.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₄.

N-Acetyl-S-[4-(2-pyridinyl)benzyl]-L-cysteine, CAS: 1391068-09-9, stock: 2.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈N₂O₃S.

N-[(1S,2S)-2-Hydroxy-1-(phenylmethyl)-3-[1-[[4-(2-pyridinyl)phenyl]methyl]hydrazinyl]propyl]carbamic Acid 1,1-Dimethylethyl Ester, CAS: 857904-20-2, stock: 1.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₄N₄O₃.

Aspartame, CAS: 22839-47-0, stock: 4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈N₂O₅.

Aspartame-d3, CAS: 1356841-28-5, stock: 3.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅D₃N₂O₅.

N-[4-(2-Pyridinyl)benzoyl]glycine, CAS: 1391051-80-1, stock: 2.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂N₂O₃.

N-[4-(2-Pyridinyl)benzoyl]glycine-13C2,15N, CAS: 1391053-26-1, stock: 2.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂¹³C₂H₁₂N¹⁵NO₃.

Aspartame-d5, CAS: 1356849-17-6, stock: 7.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃D₅N₂O₅.

L-Aspartyl-L-phenylalanine, CAS: 13433-09-5, stock: 7.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₂O₅.

p-Hydroxyatazanavir, CAS: /, stock: 2.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₂N₆O₈.

p-Hydroxyatazanavir-d4, CAS: /, stock: 3.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₈D₄N₆O₈.

L-Aspartyl-L-phenylalanine Hydrochloride, CAS: /, stock: 7.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₂O₅ xHCl.

L-Aspartyl-L-phenylalanine Trifluoroacetic Acid Salt, CAS: /, stock: 5.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₂O₅ • x(C ₂HF₃O₂).

L-Aspartyl-L-phenylalanine-d5, CAS: /, stock: 9.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁D₅N₂O₅.

L-Phenyl-d5-alanine-2,3,3-d3, CAS: 17942-32-4, stock: 9.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₃D₈NO₂.

L-Phenylalanine, CAS: 63-91-2, stock: 1.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₂.

L-Phenylalanine-13C6, CAS: 180268-82-0, stock: 6.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₆H₁₁NO₂.

L-Phenylalanine-carboxy-13C, CAS: 81201-86-7, stock: 8.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₁NO₂.

L-Phenylalanine-d5, CAS: 56253-90-8, stock: 2.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉D₅H₆NO₂.

N-Acetyl-L-phenylalanine, CAS: 2018-61-3, stock: 9.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₃.

N-​[3-​(3-​hydroxy-​4-​methoxyphenyl)​propyl]​-​L-​α-​aspartyl-L-​Phenylalanine, CAS: 713524-95-9, stock: 2.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈N₂O₇.

N-Benzyloxycarbonyl-O-benzoyl Aspartame, CAS: 07/07/5262, stock: 1.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₀N₂O₇.

N-Benzyloxycarbonyl-O-benzoyl Aspartame-d5, CAS: 1356011-62-5, stock: 2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₅D₅N₂O₇.

Neotame, CAS: 165450-17-9, stock: 3.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀N₂O₅.

Neotame-13C3, CAS: /, stock: 5.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇¹³C₃H₃₀N₂O₅.

Neotame-d3, CAS: /, stock: 8.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₇D₃N₂O₅.

Neotame-d5, CAS: /, stock: 9.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅D₅N₂O₅.

(E)-2-Acetoxy-2’-bromo-5’-chlorostilbene, CAS: 1000890-01-6, stock: 1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂BrClO₂.

(R,R)-Asenapine Maleate, CAS: 135883-16-8, stock: 8.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀ClNO₅.

(S,S)-Asenapine Maleate, CAS: 135883-08-8, stock: 5.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀ClNO₅.

11-Hydroxyasenapine, CAS: 1262639-38-2, stock: 4.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆ClNO₂.

11-Hydroxyasenapine-13CD3, CAS: 1391744-99-2, stock: 6.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆¹³CH₁₃D₃ClNO₂.

2,3,3a,12b-Tetradehydro Asenapine, CAS: 129385-60-0, stock: 1.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₂ClNO.

2,3-Dihydro-1-oxo Asenapine, CAS: 934996-79-9, stock: 1.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₂ClNO₂.

2-Bromophenylacetic Acid, CAS: 18698-97-0, stock: 1.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇BrO₂.

3-[2-(4-Chlorophenoxy)phenyl]-1,5-dihydro-4-hydroxy-1-methyl-2H-pyrrol-2-one, CAS: 934996-78-8, stock: 9.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄ClNO₃.

9-BBN Dimer, CAS: 21205-91-4, stock: 5.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₀B₂.

Asenapine, CAS: 65576-45-6, stock: 9.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆ClNO.

Asenapine 11-Hydroxysulfate, CAS: 1399103-21-9, stock: 5.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆ClNO₅S.

Asenapine 11-Hydroxysulfate-13CD3, CAS: 1391745-00-8, stock: 4.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆¹³CH₁₃D₃ClNO₅S.

Asenapine Citrate, CAS: 1411867-74-7, stock: 3.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄ClNO₈.

Asenapine α-D-Glucopyranuronic Acid Methyl Ester 2,3,4-Tris(2-methylpropanoate), CAS: /, stock: 7.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₅ClNO₁₀.

Asenapine Maleate, CAS: 85650-56-2, stock: 1.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀ClNO₅.

Asenapine N-β-D-Glucuronide Trifluoroacetic Acid Salt(Mixture of Diastereomers), CAS: /, stock: 4.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₅ClF₃NO₉.

Asenapine N-Oxide, CAS: 128949-51-9, stock: 6.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆ClNO₂.

Asenapine-13C,d3, CAS: 1217729-73-1, stock: 9.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆¹³CH₁₃D₃ClNO.

Asenapine-13C,d3 α-D-Glucopyranuronic Acid Methyl Ester 2,3,4-Tris(2-methylpropanoate), CAS: /, stock: 3.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅¹³CH₄₂D₃ClNO₁₀.

Asenapine-13C,d3 Maleate, CAS: /, stock: 6.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀¹³CH₁₇D₃ClNO₅.

Asenapine-13C,d3 N-β-D-Glucuronide Trifluoroacetic Acid Salt, CAS: /, stock: 7.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄¹³CH₂₂D₃ClF₃NO₉.

Asenapine-d3, CAS: 1180843-72-4, stock: 8.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₃D₃ClNO.

Asenapine-d7 (Major), CAS: /, stock: 5.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₉D₇ClNO.

cis-Asenapine, CAS: 65621-78-5, stock: 8.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆ClNO.

cis-Asenapine Maleate, CAS: 85650-55-1, stock: 3.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆ClNO•C₄H₄O₄.

Dechloro Asenapine Ethanedioate, CAS: 1366179-39-6, stock: 1.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇NO  •C₂H₂O₄.

Methyl 2-(2-Bromophenyl)acetate, CAS: 57486-69-8, stock: 10g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BrO₂.

N-Desmethyl Asenapine Hydrochloride, CAS: 1170701-78-6, stock: 6.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅Cl₂NO.

N-Desmethyl Asenapine α-D-Glucopyranuronic Acid Methyl Ester 2,3,4-Tris(2-methylpropanoate), CAS: /, stock: 6.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₄₂ClNO₁₀.

N-Desmethyl Asenapine N-Carbamoyl Glucuronide, CAS: 128923-28-4, stock: 6.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₂ClNO₉.

N-Desmethyl Asenapine-d4 Hydrochloride, CAS: 1246820-54-1, stock: 2.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁D₄Cl₂NO.

trans-N-Methyl-3-(2-hydroxyphenyl)-4-(2-bromo-5-chlorophenyl)pyrrolidine, CAS: 1000890-02-7, stock: 2.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇BrClNO.

1-[2-[4-[[[3-[[[[2-(Heptylthio)ethyl]amino]carbonyl]amino]phenyl]sulfonyl]amino]phenyl]hydrazide] 2,2,3,3-Tetrafluoro-butanedioic Acid, CAS: 179098-76-1, stock: 4.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₃F₄N₅O₆S₂.

2,3-Dihydrothieno[3,4-b][1,4]dioxine-5,7-dicarboxylic Acid, CAS: 18361-03-0, stock: 1.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆O₆S.

2,3-Diketogulonic Acid Potassium Salt (Technical Grade), CAS: 2062656-92-0, stock: 5.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇KO₇.

2,6-Di-O-palmitoyl-L-ascorbic Acid, CAS: 4218-81-9, stock: 2.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₆₈O₈.

2,6-Dichlorophenolindophenol, CAS: 956-48-9, stock: 5.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₇Cl₂NO₂.

2-(5-Amino-3-methyl-pyrazol-1-yl)-benzoic Acid, CAS: 298684-24-9, stock: 1.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁N₃O₂.

2-O-a-D-Glucopyranosyl-L-ascorbic Acid, CAS: 129499-78-1, stock: 1.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈O₁₁.

2-Phospho-L-ascorbic Acid Trisodium Salt, CAS: 66170-10-3, stock: 1.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆Na₃O₉P.

3-O-Ethyl-L-ascorbic Acid, CAS: 86404-04-8, stock: 4.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂O₆.

Acephate, CAS: 30560-19-1, stock: 2.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀NO₃PS.

Acephate-d6, CAS: 2109699-73-0, stock: 9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄D₆NO₃PS.

Ascorbic Acid 2-sulfate Dipotassium Salt Dihydrate, CAS: /, stock: 7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆K₂O₉S  • 2(H₂O).

Ascorbic Acid Acetonide, CAS: 15042-01-0, stock: 4.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂O₆.

Ascorbyl Palmitate, CAS: 137-66-6, stock: 5.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₈O₇.

Ascorbyl Tetraisopalmitate, CAS: 183476-82-6, stock: 3.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇₀H₁₂₈O₁₀.

Calcium Ascorbate Dihydrate, CAS: 5743-28-2, stock: 2.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₁₂Ca•2[H₂O].

Calcium D-Arabinonate, CAS: 22373-09-7, stock: 7.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₆•1/2Ca.

D(-​)​-​Isoascorbic Acid (Erythorbic Acid), CAS: 89-65-6, stock: 8.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈O₆.

D-Allono-1,4-lactone, CAS: 29474-78-0, stock: 5.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₆.

Hydroxocobalamin Hydrochloride, CAS: 58288-50-9, stock: 4.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₂H₈₉CoN₁₃O₁₅P •HCl.

Iron(III) meso-Tetraphenylporphine Chloride, CAS: 16456-81-8, stock: 9.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₂₈ClFeN₄.

L-Ascorbic Acid, CAS: 50-81-7, stock: 3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈O₆.

L-Ascorbic Acid 2-(Dihydrogen Phosphate) Cyclohexanamine-13C6, CAS: /, stock: 3.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₆H₂₂NO₉P.

L-Ascorbic acid 2-(Dihydrogen Phosphate) Magnesium Salt (Technical Grade), CAS: 113170-55-1, stock: 2.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉O₉P xMg.

L-Ascorbic Acid 2-(Dihydrogen phosphate) N,N-Dicyclohexylcyclohexanamine, CAS: 65718-26-5, stock: 6.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₂NO₉P.

L-Ascorbic Acid 3-Sulfate, CAS: 22430-27-9, stock: 9.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈O₉S.

L-Ascorbic Acid 3-Sulfate-13C6, CAS: /, stock: 6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C¹³C₆H₁₀O₈S.

L-Ascorbic Acid 6-Stearate, CAS: 10605-09-1, stock: 1.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₂O₇.

L-Ascorbic Acid-1,2-13C2, CAS: /, stock: 3.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₂H₈O₆.

L-Ascorbic Acid-1,3-13C2, CAS: /, stock: 1.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₂H₈O₆.

L-Ascorbic Acid-1,6-13C2, CAS: /, stock: 7.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₂H₈O₆.

L-Ascorbic Acid-1-13C, CAS: 178101-88-7, stock: 5.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₈O₆.

L-Ascorbic Acid-13C6, CAS: 1331939-77-5, stock: 4.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₈O₆.

L-Ascorbic Acid-2-13C, CAS: 178101-89-8, stock: 5.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₈O₆.

L-Ascorbic Acid-3-13C, CAS: /, stock: 6.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₈O₆.

L-Ascorbic Acid-5-13C, CAS: /, stock: 3.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₈O₆.

L-Ascorbic acid-6,6’-d2, CAS: /, stock: 5.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆D₂O₆.

L-Ascorbic Acid-6-13C, CAS: 149153-08-2, stock: 2.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₈O₆.

L-Dehydro Ascorbic Acid, CAS: 490-83-5, stock: 6.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆O₆.

L-Dehydro Ascorbic Acid-13C6, CAS: 1217529-45-7, stock: 6.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₆O₆.

L-Gulono-1,4-lactone, CAS: 1128-23-0, stock: 1.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₆.

L-Gulono-1,4-lactone-13C6, CAS: /, stock: 1.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  13C₆H₁₀O₆.

L-Gulose, CAS: 6027-89-0, stock: 5.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₆.

L-Sorbosone, CAS: 49865-02-3, stock: 1.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₆.

L-threo-Hex-​2-​enaric acid 1,​4-Lactone, CAS: 66757-69-5, stock: 5.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆O₇.

L-threo-Hex-​2-​enaric acid 1,​4-Lactone 6-Methyl Ester, CAS: 122046-79-1, stock: 5.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈O₇.

L-threo-Hex-​2-​enaric acid 1,​4-Lactone Dihydrate Tripotassium Salt, CAS: /, stock: 8.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃K₃O₁₀S  • 2(H₂O).

L-Threonolactone, CAS: 21730-93-8, stock: 3.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆O₄.

L-Threose (~0.2 M in Water), CAS: 95-44-3, stock: 4.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈O₄.

Niacinamide Ascorbate, CAS: 1987-71-9, stock: 1.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂O₇.

Phenyl 1-thio-β-D-glucopyranosiduronic Acid Methyl Ester 2,3,4-Triacetate, CAS: 62812-42-4, stock: 9.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂O₉S.

Sodium Ascorbate, CAS: 134-03-2, stock: 1.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇NaO₆.

(3R,4R,4aS,7R,8S,8aR)-Hexahydro-3-hydroxy-4,7-dimethyl-8-(3-oxobutyl)-1,2-benzodioxin-8a(3H)-carboxaldehyde, CAS: 149588-86-3, stock: 6.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄O₅.

11,18:18,21-Diepoxy-17-hydroxy-pregn-4-ene-3,20-dione, CAS: /, stock: 6.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆O₅.

11β,17,21-Trihydroxy-3,20-dioxo-cyclic-18,11-hemiacetal Pregn-4-en-18-al Triacetate, CAS: /, stock: 5.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₄O₉.

11β,18-Epoxy-17-hydroxy-18,21-(methylenedioxy)-pregn-4-ene-3,20-dione, CAS: /, stock: 2.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈O₆.

11β-hydroxy-17,20:20,21-bis(methylenedioxy)-3-oxo-18-oxime Pregn-4-en-18-al, CAS: 4777-80-4, stock: 7.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₁NO₇.

11β-Hydroxy-17,20:20,21-bis(methylenedioxy)pregn-4-en-3-one Nitrite, CAS: 4777-79-1, stock: 1.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₁NO₇.

18-Oxocortisol, CAS: 2410-60-8, stock: 3.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈O₆.

1-[(Chloromethoxy)methyl]-2-[(hydroxyimino)methyl]-pyridinium Chloride, CAS: 27123-11-1, stock: 8.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀Cl₂N₂O₂.

Asoxime Chloride, CAS: 34433-31-3, stock: 4.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆Cl₂N₄O₃.

Asoxime-d4 Chloride, CAS: /, stock: 7.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂D₄Cl₂N₄O₃.

(2E)-2-[1-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4-mercapto-3-piperidinylidene]-acetic Acid Ethyl Ester Hydrochloride, CAS: 204206-07-5, stock: 9.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄FNO₃S • (HCl).

(2E)-[4-Bromo-1-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-3-piperidinylidene]-acetic Acid Ethyl Ester, CAS: 239466-57-0, stock: 7.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃BrFNO₃.

1-Hydroxy-o-carborane, CAS: 23987-99-7, stock: 5.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₁₂B₁₀O.

1-Tritylpiperidin-4-one, CAS: 112257-60-0, stock: 8.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₃NO.

2-(2-Heptyn-1-ylthio)phenol, CAS: 210350-98-4, stock: 5.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆OS.

2-(2-Heptynylthio)phenol Acetate, CAS: 209125-28-0, stock: 7.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈O₂S.

2-(Acetyloxy)benzoic Acid 3-(hydroxymethyl)phenyl Ester, CAS: 287118-98-3, stock: 4.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄O₅.

2-(Acetyloxy)benzoic Acid 4-(Chloromethyl)phenyl Ester, CAS: 410071-22-6, stock: 8.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃ClO₄.

2-(Acetyloxy)benzoic Acid 4-(Hydroxymethyl)phenyl Ester, CAS: 175077-14-2, stock: 1.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄O₅.

2-acetoxybenzoic 2-hydroxybenzoic Anhydride, CAS: /, stock: 6.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂O₆.

2-Heptynyl Bromide, CAS: 18495-26-6, stock: 4.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁Br.

2-[[2-(Acetyloxy)benzoyl]oxy]benzoic Acid 2-Carboxyphenyl Ester, CAS: 85531-16-4, stock: 8.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₆O₈.

2-[[2-(Acetyloxy)benzoyl]oxy]benzoic Acid 2-[(2-Carboxyphenoxy)carbonyl]phenyl Ester, CAS: 85539-30-6, stock: 9.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₀O₁₀.

2-[[2-[[2-(Acetyloxy)benzoyl]oxy]benzoyl]oxy]benzoic Acid 2-[(2-Carboxyphenoxy)carbonyl]phenyl Ester, CAS: 85531-19-7, stock: 4.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₂₄O₁₂.

2-[[2-[[2-(Acetyloxy)benzoyl]oxy]benzoyl]oxy]benzoic Acid 2-[[2-[(2-carboxyphenoxy)carbonyl]phenoxy]carbonyl]phenyl Ester, CAS: 85531-20-0, stock: 1.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₂₈O₁₄.

3,5-Diiodosalicylic Acid, CAS: 133-91-5, stock: 4.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄I₂O₃.

3-Acetoxybenzoic Acid, CAS: 6304-89-8, stock: 4.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O₄.

4,5-Diphenyl-1H-imidazole-2-propanoic Acid, CAS: 55217-15-7, stock: 5.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆N₂O₂.

4,5-Diphenyl-2-oxazolepropanamide, CAS: 24248-49-5, stock: 6.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆N₂O₂.

4-Hydroxyisophthalic Acid, CAS: 636-46-4, stock: 7.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆O₅.

Acetic Anhydride-1,1’-13C2, CAS: 90980-78-2, stock: 4.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₂H₆O₃.

Acetylsalicylic Acid, CAS: 50-78-2, stock: 6.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O₄.

Acetylsalicylic Acid Acyl-β-D-glucuronide, CAS: 24719-72-0, stock: 8.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆O₁₀.

Acetylsalicylic Acid Sodium Salt, CAS: 493-53-8, stock: 9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇NaO₄.

Acetylsalicylic Acid-d3, CAS: 921943-73-9, stock: 2.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅D₃O₄.

Acetylsalicylic Acid-d4, CAS: 97781-16-3, stock: 1.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₄D₄O₄.

Acetylsalicylic Acid-d7, CAS: /, stock: 6.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉HD₇O₄.

Acetylsalicylic Anhydride, CAS: 1466-82-6, stock: 1.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄O₇.

Acetylsalicylic Anhydride-d8, CAS: /, stock: 3.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₆D₈O₇.

Acetylsalicylsalicylic Acid, CAS: 530-75-6, stock: 6.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂O₆.

Aspirin-L-argininie, CAS: 37466-21-0, stock: 5.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂N₄O₆.

Benzyl 2-((2-((2-Acetoxybenzoyl)oxy)benzoyl)oxy)benzoate, CAS: /, stock: 10g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₂O₈.

D-Lactose Monohydrate, CAS: 64044-51-5, stock: 1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄O₁₂.

DL-Lysine Acetylsalicylate, CAS: 62952-06-1, stock: 1.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂N₂O₆.

Guaimesal, CAS: 81674-79-5, stock: 3.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄O₅.

Hydralazine Lactosone Ring-opened Adduct, CAS: /, stock: 3.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆N₄O₁₀.

m-Salicylic Acid, CAS: 99-06-9, stock: 7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆O₃.

Methyl Salicylate β-D-O-Glucuronide Methyl Ester, CAS: 226932-59-8, stock: 8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈O₉.

Methyl Salicylate β-D-O-Glucuronide Triacetate Methyl Ester, CAS: 101231-54-3, stock: 3.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄O₁₂.

NO-Aspirin, CAS: 287118-97-2, stock: 7.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃NO₇.

NO-Aspirin 1, CAS: 175033-36-0, stock: 8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃NO₇.

Oxaprozin, CAS: 21256-18-8, stock: 7.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅NO₃.

Oxaprozin-d10, CAS: /, stock: 5.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₅D₁₀NO₃.

Penta-salicyclic Acid, CAS: 85539-31-7, stock: 9.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₂₂O₁₁.

Phenacetin, CAS: 62-44-2, stock: 6.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₂.

Phenacetin-d3, CAS: 60902-27-4, stock: 3.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀D₃NO₂.

Phenacetin-d5, CAS: 69323-74-6, stock: 5.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈D₅NO₂.

Salicyl Sulfate Disodium Salt, CAS: 56343-01-2, stock: 5.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆Na₂O₆S.

Salicylic Acid, CAS: 69-72-7, stock: 7.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆O₃.

Salicylic Acid β-D-O-Glucuronide, CAS: 7695-70-7, stock: 8.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄O₉.

Salicylic Acid β-D-O-Glucuronide-d4, CAS: /, stock: 8.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀D₄O₉.

Salsalate, CAS: 552-94-3, stock: 9.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀O₅.

Salsalate-d8, CAS: /, stock: 5.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂D₈O₅.

Sunset Yellow FCF, CAS: 2783-94-0, stock: 9.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₀N₂Na₂O₇S₂.

Talniflumate, CAS: 66898-62-2, stock: 6.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₃F₃N₂O₄.

Tartrazine, CAS: 1934-21-0, stock: 9.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₉N₄Na₃O₉S₂.

Tetra-salicyclic Acid, CAS: 85531-18-6, stock: 4.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₁₈O₉.

trans R-138727-d4, (Prasugrel-d4 Metabolite)(Mixture of Diastereomers), CAS: /, stock: 7.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆D₄FNO₃S.

Tri-Salicylic Acid, CAS: 85531-17-5, stock: 5.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₄O₇.

Triflusal, CAS: 322-79-2, stock: 8.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇F₃O₄.

Triflusal-13C6, CAS: 1276355-35-1, stock: 6.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₆H₇F₃O₄.

(1S,2R)-cis-4-Cyclohexene-1,2-dicarboxylic Acid 1-Monomethyl Ester, CAS: 88335-93-7, stock: 4.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂O₄.

(2S,2’S)-2,2’-(Ethane-1,2-diylbis(azanediyl))disuccinic Acid, CAS: 20846-91-7, stock: 7.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆N₂O₈.

(3R)-3-(Benzoylamino)-4-oxo-pentanoic Acid Methyl Ester, CAS: 1246820-00-7, stock: 7.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅NO₄.

(3S)​-​3-​{[(Benzyloxy)​carbonyl]​amino}​-​4-​tert-​butoxy-​4-​oxobutanoic acid Dicyclohexylamine Salt, CAS: 17335-87-4, stock: 6.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₄N₂O₆.

(±)-Aspartic Acid, CAS: 617-45-8, stock: 3.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇NO₄.

(R)-(-)-2-Amino-2-methylbutanedioic Acid Hydrochloride Salt, CAS: 143282-42-2, stock: 4.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀ClNO₄.

(R)-Dimethyl Bromosuccinate, CAS: 99147-12-3, stock: 6.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉BrO₄.

(S)-(+)-2-Amino-2-methylbutanedioic Acid Hydrochloride Salt, CAS: 143282-41-1, stock: 10g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀ClNO₄.

(S)-3-(((Benzyloxy)carbonyl)amino)-5-isopropoxy-5-oxopentanoic Acid, CAS: 5545-52-8, stock: 1.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁NO₆.

(S)-4-Oxoazetidine-2-carboxylic Acid, CAS: 16404-94-7, stock: 7.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅NO₃.

1-Deoxy-1-(L-aspartyl)-D-fructose, CAS: 31105-02-9, stock: 8.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₉.

1-[1,1-Dimethylethoxy)​carbonyl]​-​4-piperidinepropanoic Acid Methyl Ester, CAS: 162504-75-8, stock: 4.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₅NO₄.

3-Hydroxyaspartic Acid, CAS: 71653-06-0, stock: 1.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇NO₅.

4-(3-Trifluoromethylphenyl)benzoic Acid, CAS: 195457-70-6, stock: 7.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉F₃O₂.

4-Nitrophenyl 1H-Indole-3-acetic Acid Ester, CAS: 5157-45-9, stock: 2.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂N₂O₄.

8-Aminooctanoic Acid, CAS: 1002-57-9, stock: 5.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇NO₂.

Alitame, CAS: 80863-62-3, stock: 4.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₅N₃O₄S.

Alitame-d3, CAS: /, stock: 4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂D₃N₃O₄S.

Amastatin Hydrochloride, CAS: 100938-10-1, stock: 6.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₉ClN₄O₈.

Arginino-succinic Acid Disodium Salt (>80%), CAS: 918149-29-8, stock: 1.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆N₄Na₂O₆.

Arginino-succinic Acid-d3 Disodium Salt, CAS: /, stock: 2.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃D₃N₄Na₂O₆.

Aspartic Acid Diethyl Ester, CAS: 43101-48-0, stock: 5.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₄.

Aspartic Acid α-Methyl Ester, CAS: 17812-32-7, stock: 9.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉NO₄.

Aspartic acid(otbu)-allyl ester hydrochloride, CAS: 218938-66-0, stock: 3.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀ClNO₄.

Benzyl (2S)-4-Oxoazetidine-2-carboxylate, CAS: 72776-05-7, stock: 4.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO₃.

Boc-Asp(Ofm)-OH, CAS: 117014-32-1, stock: 6.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅NO₆.

Boc-Asp-OFm, CAS: 129046-87-3, stock: 9.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅NO₆.

Boc-D-Asp(OBn)-OH, CAS: 51186-58-4, stock: 3.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁NO₆.

Boc-D-Asp(OcHx)-OH, CAS: 112898-18-7, stock: 3.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₅NO₆.

Boc-L-Asp(OcHx)-OH, CAS: 73821-95-1, stock: 7.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₅NO₆.

Boc-L-aspartic acid beta-benzyl ester chloromethylketone, CAS: 172702-58-8, stock: 1.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂ClNO₅.

Boc-L-aspartic Acid β-Methyl Ester, CAS: 59768-74-0, stock: 9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₆.

Butyl Isocyanate, CAS: 111-36-4, stock: 5.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉NO.

D,L-2-Amino-3-phosphonopropionic Acid, CAS: 5652-28-8, stock: 4.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₈NO₅P.

D,L-threo-β-Hydroxy Aspartic Acid, CAS: 4294-45-5, stock: 2.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇NO₅.

D-Aspartic Acid, CAS: 1783-96-6, stock: 5.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇NO₄.

D-Aspartic Acid 1-(1,1-Dimethylethyl) Ester, CAS: 148823-36-3, stock: 2.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₄.

D-Aspartic Acid 1-Methyl Ester, CAS: 65414-78-0, stock: 3.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉NO₄.

D-Aspartic Acid 4-(1,1-Dimethylethyl) Ester, CAS: 64960-75-4, stock: 6.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₄.

D-Aspartic Acid 4-Methyl Ester Hydrochloride, CAS: 22728-89-8, stock: 7.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀ClNO₄.

D-Aspartic acid alpha-amide, CAS: 200260-37-3, stock: 4.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈N₂O₃.

D-Aspartic Acid Dibenzyl Ester 4-Toluenesulfonate Salt, CAS: 4079-64-5, stock: 9.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉NO₄ • C ₇H₈O₃S.

D-Aspartic Acid Dimethyl Ester Hydrochloride, CAS: 69630-50-8, stock: 1.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂ClNO₄.

D-Aspartic Acid Sodium Salt, CAS: 10329-81-4, stock: 3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆NNaO₄.

D-​Aspartic acid diethyl ester hydrochloride, CAS: 112018-26-5, stock: 8.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₄ • HCl.

D-Valine Benzyl Ester p-Toluenesulfonate, CAS: 17662-84-9, stock: 5.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₅NO₅S.

Dansyl-DL-aspartic Acid, CAS: 42808-07-1, stock: 6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₂O₆S.

Dibenzyl L-Aspartate, CAS: 2791-79-9, stock: 5.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉NO₄.

Diethyl Maleate, CAS: 141-05-9, stock: 8.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂O₄.

(3R)-Methyl-2-[2-(2,5,5-trimethyl-1,3-dioxan-2-yl)ethyl]cyclohexanone (Mixture of Diastereomers), CAS: 1246812-34-9, stock: 5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₈O₃.

Dimethyl Hydroxyaspartate, Mixture of Diastereomers, CAS: 471242-80-5, stock: 5.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₅.

Dimethyl L-Aspartate Hydrochloride, CAS: 32213-95-9, stock: 4.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₄.HCl.

(5R)-5-Methyl-2-(phenylthio)cyclohexanone (Mixture of Diastereomers), CAS: 101693-93-0, stock: 7.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆OS.

11-Azaartemisinin, CAS: 162791-23-3, stock: 4.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃NO₄.

Dimethyl N-tert-Butoxycarbonyl-3-hydroxyaspartate, Mixture of Diastereomers, CAS: 471242-81-6, stock: 6.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉NO₇.

Dithiobutylamine Hydrochloride, CAS: 1363376-98-0, stock: 6.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₁NS₂ •  (HCl).

2-Chloroethyl Chloroformate, CAS: 627-11-2, stock: 7.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₄Cl₂O₂.

3-Chloro-2-methylaniline, CAS: 87-60-5, stock: 3.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈ClN.

Dl-Aspartic Acid Dimethyl Ester Hydrochloride, CAS: 14358-33-9, stock: 5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₄ •  HCl.

DL-Aspartic Acid Hemimagnesium Salt, CAS: 1187-91-3, stock: 9.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆NO₄.

3-Hydroxy Deoxy Dihydro Artemisinin, CAS: 126641-61-0, stock: 4.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄O₅.

3-Hydroxy Deoxy Dihydro Artemisinin-d3, CAS: /, stock: 9.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁D₃O₅.

DL-TBOA, CAS: 205309-81-5, stock: 1.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₅.

Eledoisin-related peptide, CAS: 2990-43-4, stock: 5.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₈N₈O₆S.

Ethylenediamine-N,N,N’,N’-tetraacetic Acid Tetraaspartic Acid Octa[amido[N-(2-aminoethyl)maleimide]], CAS: /, stock: 2.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇₄H₈₄N₂₂O₂₈.

Feglymycin, CAS: 209335-49-9, stock: 9.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉₅H₉₇N₁₃O₃₀.

4’-((tert-Butoxycarbonyl)amino)-[1,1’-biphenyl]-4-carboxylic Acid, CAS: 222986-59-6, stock: 8.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉NO₄.

6-Methoxy-1,2,3,4-tetrahydroisoquinoline, CAS: 42923-77-3, stock: 4.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO.

Fmoc-Asp(OAll)-OH, CAS: 146982-24-3, stock: 6.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁NO₆.

Fmoc-asp(obzl)-oh, CAS: 86060-84-6, stock: 2.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₃NO₆.

Fmoc-Asp(OMe)-OH, CAS: 145038-53-5, stock: 1.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉NO₆.

Fmoc-Asp-OtBu, CAS: 129460-09-9, stock: 9.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅NO₆.

9-epi-Artemisinin, CAS: 113472-97-2, stock: 7.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂O₅.

9-Phenanthrenemethanol, CAS: 4707-72-6, stock: 4.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂O.

Fmoc-d-asp(otbu)-OH, CAS: 112883-39-3, stock: 4.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅NO₆.

Fmoc-D-Asp(OtBu)-Opfp, CAS: 200335-75-7, stock: 3.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₄NO₆F₅.

Amorphadiene, CAS: 92692-39-2, stock: 5.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄.

Anhydro Dihydro Artemisinin, CAS: 82596-30-3, stock: 8.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂O₄.

Fmoc-L-aspartic Acid beta-Cyclohexyl Ester, CAS: 130304-80-2, stock: 3.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₇NO₆.

Fmoc-L-aspartic Acid β-tert-butyl Ester, CAS: 71989-14-5, stock: 9.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅NO₆.

Glycyl-DL-aspartic Acid, CAS: 79731-35-4, stock: 9.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀N₂O₅.

Glycyl-L-aspartic Acid, CAS: 05/12/4685, stock: 5.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀N₂O₅ • H ₂O.

H-D-ASP(OBZL)-OH, CAS: 13188-89-1, stock: 9.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₄.

Human anti-NMDAR Antibody(anti-N-methyl-D-aspartic Acid receptor Antibody) ELISA Kit (96T), CAS: /, stock: 2.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Hypertrehalosemic Hormone (Phormia Terrae-novae), CAS: 129204-82-6, stock: 9.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₆₂N₁₀O₁₃.

Iberiotoxin, CAS: 129203-60-7, stock: 8.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇₉H₂₇₄N₅₀O₅₅S₇.

Indole-3-acetyl-L-aspartic Acid, CAS: 2456-73-7, stock: 8.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄N₂O₅.

Indole-3-butyryl-L-aspartic Acid, CAS: 101289-65-0, stock: 3.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₂O₅.

Artemisinic Alcohol, CAS: 125184-95-4, stock: 6.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄O.

β-Benzyl L-Aspartic Acid N-carboxyanhydride, CAS: 13590-42-6, stock: 9.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁NO₅.

L-(-)-threo-3-Hydroxyaspartic acid, CAS: 7298-99-9, stock: 5.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇NO₅.

Arteether, CAS: 75887-54-6, stock: 8.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₈O₅.

Artemisinic O-methanesulfonate, CAS: /, stock: 3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₆O₃S.

Artemisinin, CAS: 63968-64-9, stock: 9.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂O₅.

L-Asparagine-d3 Hydrate, CAS: /, stock: 3.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅D₃N₂O₃ • (H ₂O).

Artemisinin-d3, CAS: 176652-07-6, stock: 8.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉D₃O₅.

L-Aspartic Acid, CAS: 56-84-8, stock: 6.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇NO₄.

L-Aspartic Acid 1-Benzyl Ester, CAS: 7362-93-8, stock: 6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₄.

Artemisitene, CAS: 101020-89-7, stock: 7.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀O₅.

L-Aspartic Acid 1-tert-Butyl Ester Hydrochloride, CAS: 176164-02-6, stock: 1.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆ClNO₄.

L-Aspartic Acid 4-Methyl Ester Hydrochloride, CAS: 16856-13-6, stock: 8.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀ClNO₄.

Artesunate, CAS: 88495-63-0, stock: 9.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₈O₈.

Artesunate-d3, CAS: 1316303-44-2, stock: 1.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₅D₃O₈.

L-Aspartic Acid 4-tert-Butyl 1-Methyl Ester Hydrochloride, CAS: 2673-19-0, stock: 8.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₄ • (HCl).

L-Aspartic Acid 4-tert-Butyl Ester, CAS: 3057-74-7, stock: 5.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₄.

α-Arteether, CAS: 82534-75-6, stock: 7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₈O₅.

Artesunate-d4, CAS: 1316753-15-7, stock: 5.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄D₄O₈.

Deoxy Arteether, CAS: 112297-79-7, stock: 1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₈O₄.

L-Aspartic Acid b-Benzyl Ester a-Amide Hydrochloride, CAS: 199118-68-8, stock: 8.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂O₃ •HCl.

L-Aspartic Acid beta-tert-Butyl Ester alpha-Amide Hydrochloride, CAS: 92786-68-0, stock: 1.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆N₂O₃ •HCl.

Deoxy Artemisinin, CAS: 72826-63-2, stock: 3.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂O₄.

Deoxy Artemisinin-d3, CAS: /, stock: 2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉D₃O₄.

L-Aspartic Acid Calcium Salt Hydrochloride, CAS: 92533-40-9, stock: 3.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆CaClNO₄.

Deoxydihydro Artemisinin β-D-Glucuronide (Mixture of Isomers)-D3, CAS: /, stock: 6.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₉D₃O₁₀.

Deoxydihydroartemisinin (α,β Mixture), CAS: 72807-92-2, stock: 9.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄O₄.

L-Aspartic Acid Di-tert-butyl Ester Hydrochloride, CAS: 1791-13-5, stock: 1.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃NO₄ • (HCl).

L-Aspartic Acid Dibenzyl Ester p-Toluenesulfonate Salt, CAS: 2886-33-1, stock: 8.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₇O₇S.

Deoxydihydroartemisinin Acetate, CAS: 90935-12-9, stock: 5.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₆O₅.

Deoxydihydroartemisinin-d3, CAS: /, stock: 2.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁D₃O₄.

L-Aspartic Acid Diethyl Ester Hydrochloride, CAS: 16115-68-7, stock: 9.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₄ • HCl.

L-Aspartic Acid Ion Di-tetramethylammonium, CAS: /, stock: 6.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅NO₄²⁻ • C ₈H₂₄N₂²⁺.

Dihydro Artemisinin 2,2,2-Trichloro-ethanimidic Acid, CAS: 281669-07-6, stock: 4.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄Cl₃NO₅.

L-Aspartic Acid β-(7-Amido-4-methylcoumarin), CAS: 133628-73-6, stock: 9.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄N₂O₅.

Dihydro Artemisinin Dimer, CAS: 150358-71-7, stock: 2.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₆O₉.

L-Aspartic Acid Potassium Salt, CAS: 1115-63-5, stock: 5.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆NO₄K.

L-Aspartic Acid Sodium Salt Monohydrate, CAS: 323194-76-9, stock: 4.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆NO₄Na  •  H₂O.

Dihydro Artemisinin β-D-Glucuronide (Mixture of Isomers), CAS: 198976-06-6, stock: 5.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₂O₁₁.

L-Aspartic Acid-15N, CAS: 3715-16-0, stock: 9.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇¹⁵NO₄.

L-Aspartic Acid-d3, CAS: 3842-25-9, stock: 5.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄D₃NO₄.

Dihydro Artemisinin β-D-Glucuronide (Mixture of Isomers)-D3, CAS: /, stock: 4.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₉D₃O₁₁.

Dihydro Artemisinin Tetrahydrofuran Acetate, CAS: 198817-95-7, stock: 8.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄O₅.

L-Ornithine L-Aspartate Salt, CAS: 3230-94-2, stock: 2.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂N₂O₂  •     C₄H₇NO₄.

(αR)-3-Amino-4-hydroxy-α-[[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]methyl]benzenemethanol, CAS: 245759-62-0, stock: 8.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄N₂O₃.

Dihydro Artemisinin Tetrahydrofuran Acetate-d3, CAS: /, stock: 7.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁D₃O₅.

Magnesium L-Aspartate Salt, CAS: 18962-61-3, stock: 5.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂MgN₂O₈.

meso-2,3-Diaminosuccinic Acid, CAS: 23220-52-2, stock: 1.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈N₂O₄.

Arformoterol Tartrate, CAS: 200815-49-2, stock: 4.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₀N₂O₁₀.

N-(2-Succinyl) Fluvoxamine, CAS: 259526-43-7, stock: 7.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₅F₃N₂O₆.

Arformoterol Tartrate-d6, CAS: /, stock: 10g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄D₆N₂O₁₀.

Dihydroartemisinic Acid, CAS: 85031-59-0, stock: 8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄O₂.

N-Acetyl -L-Aspartic Acid-d3, CAS: 1383929-94-9, stock: 6.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆D₃NO₅.

N-[2-Hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl](phenylmethyl)amino]ethyl]phenyl]formamide, CAS: 1337876-26-2, stock: 4.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₀N₂O₄.

Dihydroartemisinin (α,β Mixture), CAS: 131175-87-6, stock: 9.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄O₅.

N-Acetyl-D,L-Aspartic Acid 2,3,3-D3, CAS: 89829-69-6, stock: 4.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆D₃NO₅.

N-Acetyl-DL-aspartic Acid, CAS: 2545-40-6, stock: 4.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉NO₅.

N-[2-Hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]acetamide, CAS: /, stock: 7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆N₂O₄.

N-[2-Hydroxy-5-[(1S)-1-hydroxy-2-[[(1S)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]acetamide, CAS: 725719-13-1, stock: 9.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆N₂O₄.

Diphenylacetic Acid, CAS: 117-34-0, stock: 4.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂O₂.

N-Acetyl-L-aspartic Acid, CAS: 997-55-7, stock: 8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉NO₅.

N-Acetyl-L-aspartic Acid-d3, CAS: 284665-15-2, stock: 7.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆D₃NO₅.

N-[5-[(1R)-1-Hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl](phenylmethyl)amino]ethyl]-2-(phenylmethoxy)phenyl]formamide, CAS: 188690-83-7, stock: 2.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₆N₂O₄.

N-​[(1,​1-​Dimethylethoxy)​carbonyl]​-​L-​Aspartic acid 4-​(Phenylmethyl) Ester, CAS: 7536-58-5, stock: 1.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁NO₆.

N-Benzylaspartic Acid, CAS: 5555-22-6, stock: 4.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₄.

Methyl Artemisinate, CAS: 82869-24-7, stock: 9.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄O₂.

Methyl Phosphorodichloridate, CAS: 677-24-7, stock: 6.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  CH₃Cl₂O₂P.

3-(2-Chloropropionyl)amino-4-methyl-2-methoxycarbonylthiophene, CAS: 23964-56-9, stock: 4.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂ClNO₃S.

N-Benzyloxycarbonyl-D-aspartic Acid 4-Benzyl Ester, CAS: 5241-62-3, stock: 3.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉NO₆.

N-Benzyloxycarbonyl-L-aspartic Acid 4-Benzyl Ester, CAS: 29880-21-5, stock: 8.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉NO₆.

N-(2-Hydroxyethyl)-11-azaartemisinin, CAS: 255731-00-1, stock: 8.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₇NO₅.

N-Amino-11-azaartemisinin, CAS: 1086409-78-0, stock: 4.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄N₂O₄.

3-[[[[2-[(Tetrahydro-2H-pyran-2-yl)oxy]ethyl]amino]carbonyl]amino]-2-thiophenecarboxylic Acid, CAS: 1265892-01-0, stock: 8.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₅S.

4-Methyl-3-[[1-oxo-2-(propylamino)propyl]amino]-2-thiophenecarboxylic Acid, CAS: 114176-52-2, stock: 9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂O₃S.

N-Benzyloxycarbonyl-L-aspartic Acid β-tert-Butyl Ester Dicyclohexylamine Salt, CAS: 23632-70-4, stock: 6.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₄N₂O₆.

N-Boc-D-aspartic Acid, CAS: 62396-48-9, stock: 8.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅NO₆.

N-Hydroxy-11-azaartemisinin, CAS: 1086409-82-6, stock: 8.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃NO₅.

Phenylselenyl Bromide, CAS: 34837-55-3, stock: 1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅BrSe.

4-Methyl-3-[[1-oxo-2-(propylamino)propyl]amino]-2-thiophenecarboxylic Acid-d3, CAS: /, stock: 6.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅D₃N₂O₃S.

N-Boc-D-aspartic Acid 1-tert-Butyl Ester, CAS: 77004-75-2, stock: 5.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₃NO₆.

N-Boc-glutamic Acid Tert-butyl Ester, CAS: 24277-39-2, stock: 8.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₅NO₆.

Piperaquine Tetraphosphate, CAS: 911061-10-4, stock: 2.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₂Cl₂N₆•4H₃PO₄.

Piperaquine-d6 Tetraphosphate, CAS: 1261394-71-1, stock: 9.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₆D₆Cl₂N₆•4H₃PO₄.

4-Methyl-3-[[1-oxo-2-(propylamino)propyl]amino]-2-thiophenecarboxylic Acid-d7, CAS: /, stock: 6.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁D₇N₂O₃S.

N-Boc-L-aspartic Acid, CAS: 13726-67-5, stock: 7.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅NO₆.

N-Boc-L-Aspartic Acid 4-tert-Butyl Ester Dicyclohexylammonium Salt, CAS: 08/12/1913, stock: 8.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₆N₂O₆.

Toxaphene, CAS: 8001-35-2, stock: 1.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈Cl₈.

Articaine, CAS: 23964-58-1, stock: 6.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₂O₃S.

Articaine Hydrochloride, CAS: 23964-57-0, stock: 2.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₁ClN₂O₃S.

N-Carbamoyl-DL-aspartic Acid, CAS: 923-37-5, stock: 3.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈N₂O₅.

N-Carbobenzoxy-dl-aspartic acid, CAS: 4515-21-3, stock: 4.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO₆.

Articaine-d3 Hydrochloride, CAS: /, stock: 7.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇D₃N₂O₃S•HCl.

Articaine-d7 Hydrochloride, CAS: /, stock: 3.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃D₇N₂O₃S•HCl.

N-Carbobenzyloxy-D-aspartic Acid, CAS: 78663-07-7, stock: 2.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO₆.

N-Carbobenzyloxy-L-aspartic Acid 1-Benzyl Ester, CAS: 4779-31-1, stock: 2.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉NO₆.

Methyl 3-[2-(Isopropylamino)propanamido]-4-methylthiophene-2-carboxylate, CAS: 1796888-45-3, stock: 6.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₂O₃S.

Methyl 4-Methyl-3-[2-(propylamino)acetamido)thiophene-2-carboxylate, CAS: 1712677-79-6, stock: 9.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂O₃S.

N-Cbz-L-aspartic Acid, CAS: 1152-61-0, stock: 3.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO₆.

N-Cbz-L-Aspartic Acid 1-Methyl Ester, CAS: 4668-42-2, stock: 9.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅NO₆.

N-Fmoc-D-aspartic Acid, CAS: 136083-57-3, stock: 1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇NO₆.

N-Fmoc-L-aspartic Acid, CAS: 119062-05-4, stock: 3.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇NO₆.

N-Methyl-DL-aspartic Acid, CAS: 17833-53-3, stock: 5.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉NO₄.

N-Succinyl-5-aminoimidazole-4-carboxamide Ribose 2’,3’,5’-Triacetate, CAS: /, stock: 1.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄N₄O₁₂.

N-Succinyl-5-aminoimidazole-4-carboxamide Ribose 5’-Phosphate, CAS: 3031-95-6, stock: 9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉N₄O₁₂P.

N-Succinyl-5-aminoimidazole-4-carboxamide Ribose 5’-Phosphate Dibarium Salt-d3, CAS: /, stock: 4.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂D₃Ba₂N₄O₁₂P.

N-Succinyl-5-aminoimidazole-4-carboxamide Ribose Dibenzyl Ester 2’,3’,5’-Triacetate, CAS: /, stock: 1.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₆N₄O₁₂.

N-Succinyl-5-aminoimidazole-4-carboxamide Ribose Disodium Salt, CAS: /, stock: 9.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₄Na₂O₉.

N-tert-Boc-L-aspartic Acid tert-Butyl Ester, CAS: 34582-32-6, stock: 6.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₃NO₆.

N-tert-Butoxycarbonyl-L-aspartic Acid α-Benzyl Ester, CAS: 30925-18-9, stock: 7.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁NO₆.

N-tert-Butyloxycarbonyl-L-aspartic Acid β-tert-Butyl Ester, CAS: 1676-90-0, stock: 2.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₃NO₆.

N-Tosyl-L-aspartic Acid, CAS: 4816-82-4, stock: 7.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₆S.

N-[(1,1-Dimethylethoxy)carbonyl]-D-aspartic Acid 1-Methyl Ester, CAS: 137130-65-5, stock: 5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₆.

N-[(1-Ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridin-3-yl)carbonyl]-D-aspartic Acid, CAS: 1212087-50-7, stock: 3.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₃O₆.

N-[(4-Fluorophenyl)sulfonyl]-D-aspartic Acid 1,4-Dimethyl Ester, CAS: 1218918-76-3, stock: 3.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄FNO₆S.

N-[2-(4-Methoxyphenyl)-1-methylethyl]aspartic Acid(Mixture of Diastereomers), CAS: /, stock: 2.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₅.

N-[2-(4-Methoxyphenyl)-1-methylethyl]aspartic Acid Diethyl Ester, CAS: /, stock: 8.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₇NO₅.

N-[2-(4-Methoxyphenyl)-1-methylethyl]aspartic Acid-d3, CAS: /, stock: 3.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆D₃NO₅.

N-[2-(Indol-3-yl-2,4,5,6,7-d5)acetyl]-L-aspartic-15N Acid, CAS: 1201012-71-6, stock: 7.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉D₅N¹⁵NO₅.

N-[[3-(Phosphonomethyl)phenyl]methyl]-glycine, CAS: 140151-39-9, stock: 4.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄NO₅P.

N6-Succinyl Adenosine, CAS: 4542-23-8, stock: 7.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇N₅O₈.

NMDA, CAS: 6384-92-5, stock: 6.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉NO₄.

Peforelin Trifluoroacetic Acid Salt, CAS: /, stock: 7.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₉H₇₄N₁₈O₁₄ · x(CF₃CO₂H).

Phenyl Dichlorophosphate, CAS: 770-12-7, stock: 7.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅Cl₂O₂P.

Phenylthiohydantoin-aspartic Acid, CAS: 5624-13-5, stock: 1.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀N₂O₃S.

Phomopsin A, CAS: 64925-80-0, stock: 1.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₅ClN₆O₁₂.

PKI (5-24), PKA Inhibitor, CAS: 99534-03-9, stock: 6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉₄H₁₄₈N₃₂O₃₁.

Poly-L-Aspartic Acid Sodium Salt, CAS: 31871-95-1, stock: 5.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  (C₄H₅NO₃)n•Na.

Talaporfin-13C4-15N, CAS: /, stock: 4.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄¹³C₄H₄₁N₄¹⁵NO₉.

TFB-TBOA, CAS: 480439-73-4, stock: 7.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇F₃N₂O₆.

Z-Asp-OtBu, CAS: 47307-26-6, stock: 5.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁NO₆.

Z-D-Asp(oall)-oh, CAS: 1272755-66-4, stock: 7.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇NO₆.

Z-L-Aspartic Acid beta-N-Hydroxysuccinimide Ester alpha-Methyl Ester, CAS: 54743-84-9, stock: 3.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈N₂O₈.

Z-L-aspartic acid-di-tert-butyl ester, CAS: 42417-76-5, stock: 6.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₉NO₆.

(7-(4-{4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butoxy}butoxy)-3,4-dihydroquinolin-2(1H)-one), CAS: 1796928-63-6, stock: 4.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₅Cl₂N₃O₃.

(7-(4-{4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butoxy}butoxy-d8)-3,4-dihydroquinolin-2(1H)-one), CAS: /, stock: 6.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₇D₈Cl₂N₃O₃.

1,1’-(2-Bromoethylidene)bis[2,3-dichloro-4-methoxy-benzene, CAS: 397301-38-1, stock: 9.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃BrCl₄O₂.

1,1’-Ethylidenebis[2,3-dichloro-4-methoxy-benzene, CAS: 397301-41-6, stock: 4.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄Cl₄O₂.

1,1’-[Ethylidenebis(2,3-dichloro-4,1-phenylene)]bis[4-methyl-piperazine, CAS: 519138-47-7, stock: 3.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀Cl₄N₄.

1,4-Bis[3,4-dihydro-2(1H)-quinolinon-7-oxy]butane, CAS: 882880-12-8, stock: 6.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄N₂O₄.

1,4-Bis[3,4-dihydro-2(1H)-quinolinon-7-oxy]butane-d8, CAS: 1346599-01-6, stock: 2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₆D₈N₂O₄.

1-(2,3-Dichlorophenyl)-4-(4-hydroxybutyl)piperazine Hydrochloride, CAS: 1797132-04-7, stock: 2.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁Cl₃N₂O.

1-(2,3-Dichlorophenyl)piperazine 1-Oxide, CAS: 902456-05-7, stock: 7.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂Cl₂N₂O.

1-(3-Buten-1-yl)-4-(2,3-dichlorophenyl)-piperazine, CAS: 1424857-93-1, stock: 5.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈Cl₂N₂.

1-(3-Buten-1-yl)-4-(2,3-dichlorophenyl)-piperazine-d8, CAS: /, stock: 6.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀D₈Cl₂N₂.

1-(4-Bromobutyl)-3,4-dihydro-7-hydroxy-2(1H)-quinolinone, CAS: 1424857-68-0, stock: 1.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆BrNO₂.

1-(4-Bromobutyl)-3,4-dihydro-7-hydroxy-2(1H)-quinolinone 7-Benzyl Ester, CAS: /, stock: 9.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂BrNO₂.

1-Benzoyl-4-(2,3-dichlorophenyl)piperazine, CAS: 902456-03-5, stock: 7.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆Cl₂N₂O.

1-Hydroxy-3,4-dihydroquinolin-2(1H)-one, CAS: 771-19-7, stock: 1.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO₂.

1-[4-[(1,2,3,4-Tetrahydro-2-oxo-7-quinolinyl)oxy]butyl] Aripiprazole, CAS: 1424857-63-5, stock: 5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₂Cl₂N₄O₄.

1-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl-7-hydroxy-3,4-dihydro Carbostyril (Aripiprazole Impurity), CAS: 1797983-65-3, stock: 3.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇Cl₂N₃O₂.

1-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl-7-hydroxy-3,4-dihydro Carbostyril-d8, CAS: /, stock: 4.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₉D₈Cl₂N₃O₂.

1-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]-7-hydroxy-1,2,3,4-tetrahydro-carbostyril, CAS: 1391054-74-2, stock: 4.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉Cl₂N₃O₂.

1-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]-7-hydroxy-1,2,3,4-tetrahydro-carbostyril-d8, CAS: 1794789-13-1, stock: 8.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₁D₈Cl₂N₃O₂.

2,3-Dichloro-α-(2,3-dichloro-4-methoxyphenyl)-4-methoxy-benzeneacetic Acid Ethyl Ester, CAS: 316382-53-3, stock: 2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆Cl₄O₄.

2,3-Dichlorophenylpiperazine, CAS: 41202-77-1, stock: 6.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂Cl₂N₂.

2-Chloro-n-(3-methoxyphenyl)acetamide, CAS: 17641-08-6, stock: 9.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀ClNO₂.

2-Deschloro Aripiprazole, CAS: 203395-82-8, stock: 6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈ClN₃O₂.

2-Deschloro Aripiprazole-d8, CAS: /, stock: 5.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₀D₈ClN₃O₂.

3,4-Dihydro-7-(3’carboxy)propoxy-2(1H)-(quinolinone-2,2,3,3,6,8-d6), CAS: /, stock: 9.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉D₆NO₄.

3,4-Dihydro-7-(3’carboxy)propoxy-2(1H)-quinolinone, CAS: 58899-27-7, stock: 9.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅NO₄.

3,4-Dihydro-7-(3’carboxy)propoxy-2(1H)-quinolinone Ethyl Ester, CAS: 87032-94-8, stock: 7.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉NO₄.

3,4-Dihydro-7-(3’carboxy)propoxy-2(1H)-quinolinone-d4, CAS: /, stock: 9.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁D₄NO₄.

3,4-Dihydro-7-(3’carboxy)propoxy-2(1H)-quinolinone-d8, CAS: /, stock: 2.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₇D₈NO₄.

3,4-Dihydro-7-(4-hydroxybutoxy)-2(1H)-quinolinone, CAS: 889443-20-3, stock: 6.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₃.

3,4-Dihydro-7-hydroxyquinoline-2(1H)-one, CAS: 22246-18-0, stock: 9.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO₂.

3,4-Dihydro-7-hydroxyquinoline-2(1H)-one-d6, CAS: 1215336-37-0, stock: 6.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₃D₆NO₂.

3-((2-Oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy)propyl Acetate, CAS: 1712737-75-1, stock: 1.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇NO₄.

4-(2,3-Dichlorophenyl)-1-piperazinecarboxylic Acid 1,1-Dimethylethyl Ester-d8, CAS: /, stock: 4.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂D₈Cl₂N₂O₂.

4-Chlorobutanal Dimethyl Acetal 90%, CAS: 29882-07-3, stock: 2.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃ClO₂.

4-[(1,2,3,4-Tetrahydro-2-oxo-7-quinolinyl)oxy]butanenitrile, CAS: 58899-49-3, stock: 5.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄N₂O₂.

5-Hydroxy-3,4-dihydro-2(1H)-quinolinone, CAS: 30389-33-4, stock: 8.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO₂.

7-(3-Buten-1-yloxy)-3,4-dihydro-2(1H)-quinolinone, CAS: 1359829-23-4, stock: 4.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅NO₂.

7-(3-Buten-1-yloxy)-3,4-dihydro-2(1H)-quinolinone-d6, CAS: /, stock: 5.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉D₆NO₂.

Arbutin, CAS: 497-76-7, stock: 1.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₇.

7-(4-(4-Chlorobutoxy)butoxy)-3,4-dihydroquinolin-2(1H)-one, CAS: /, stock: 4.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄ClNO₃.

Arbutin monoester, CAS: 159946-47-1, stock: 5.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₆O₈.

7-(4-(4-Hydroxybutoxy)butoxy)-3,4-dihydroquinolin-2(1H)-one, CAS: /, stock: 7.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅NO₄.

7-(4-Bromobutoxy)-3,4-dihydroquinolin-2-one, CAS: 129722-34-5, stock: 1.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆BrNO₂.

Arbutin-13C6, CAS: /, stock: 4.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₆H₁₆O₇.

7-(4-Bromobutoxy)-3,4-dihydroquinolin-2-one-d8, CAS: 1215336-46-1, stock: 3.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈D₈BrNO₂.

7-(4-Bromobutoxy)-quinoline-2(1H)-one, CAS: 203395-59-9, stock: 2.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄BrNO₂.

Deoxyarbutin, CAS: 53936-56-4, stock: 1.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₃.

α-Arbutin, CAS: 84380-01-8, stock: 5.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₇.

7-(4-Chlorobutoxy)-3,4-dihydro-2(1H)-quinolinone, CAS: 120004-79-7, stock: 1.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆ClNO₂.

7-(4-Iodobutoxy)-3,4-dihydroquinolin-2-one, CAS: 952308-47-3, stock: 1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆INO₂.

α-Arbutin-13C6, CAS: /, stock: 3.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₆H₁₆O₇.

7-(4-Iodobutoxy)-3,4-dihydroquinolin-2-one-d8, CAS: 1346599-53-8, stock: 10g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈D₈INO₂.

7-(4-Methoxybutoxy)-3,4-dihydroquinolin-2(1H)-one, CAS: 1770391-64-4, stock: 1.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₃.

7-(Benzyloxy)-3,4-dihydrocarbostyril, CAS: 92962-89-5, stock: 7.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅NO₂.

7-Hydroxyquinoline-(1H)-2-one, CAS: 70500-72-0, stock: 3.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇NO₂.

8-(2,3-Dichlorophenyl)-8-aza-5-azoniaspiro[4.5]decane Bromide, CAS: 795313-24-5, stock: 3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉BrCl₂N₂.

8-(2,3-Dichlorophenyl)-8-aza-5-azoniaspiro[4.5]decane-d8 Bromide, CAS: /, stock: 8.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁D₈BrCl₂N₂.

8-Hydroxy-3,4-dihydro-2(1H)-quinolinone, CAS: 52749-50-5, stock: 8.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO₂.

Aripiprazole, CAS: 129722-12-9, stock: 9.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇Cl₂N₃O₂.

Aripiprazole Dimer, CAS: 1797986-18-5, stock: 4.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₅₆Cl₄N₆O₄.

Aripiprazole lauroxil, CAS: 1259305-29-7, stock: 4.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₅₁N₃O₄Cl₂.

Aripiprazole N,N-Dioxide, CAS: 573691-13-1, stock: 8.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇Cl₂N₃O₄.

Aripiprazole N1-Oxide, CAS: 573691-09-5, stock: 8.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇Cl₂N₃O₃.

Aripiprazole N4-Oxide, CAS: 573691-11-9, stock: 1.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇Cl₂N₃O₃.

Aripiprazole-d8, CAS: 1089115-06-9, stock: 6.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₉D₈Cl₂N₃O₂.

Aripiprazole-d8 (Butyl-d8), CAS: 1089115-04-7, stock: 1.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₉D₈Cl₂N₃O₂.

Aripiprazole-d8 N,N-Dioxide, CAS: 1346603-98-2, stock: 6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₉D₈Cl₂N₃O₄.

Aripiprazole-d8 N1-Oxide, CAS: 1346600-34-7, stock: 2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₉D₈Cl₂N₃O₃.

Aripiprazole-d8 N4-Oxide, CAS: 1346600-39-2, stock: 1.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₉D₈Cl₂N₃O₃.

Dehydro Aripiprazole, CAS: 129722-25-4, stock: 8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅Cl₂N₃O₂.

Dehydro Aripiprazole Hydrochloride, CAS: 1008531-60-9, stock: 7.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆Cl₃N₃O₂.

Dehydro Aripiprazole-d8, CAS: /, stock: 6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₇D₈Cl₂N₃O₂.

Dehydro Aripiprazole-d8 Hydrochloride, CAS: 1215383-78-0, stock: 6.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₈D₈Cl₃N₃O₂.

Deschloroaripiprazole, CAS: 203395-81-7, stock: 7.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈ClN₃O₂.

Deschloroaripiprazole-d8, CAS: /, stock: 7.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₀D₈ClN₃O₂.

Desethylene Aripiprazole, CAS: 1216394-63-6, stock: 5.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅Cl₂N₃O₂.

N-(2,3-Dichlorophenyl)piperazine Hydrochloride, CAS: 119532-26-2, stock: 3.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃Cl₃N₂.

N-(7-Butoxy-3,4-dihydroquinolin-2(1H)-one) Aripiprazole Bromide, CAS: /, stock: 2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₃BrCl₂N₄O₄.

OPC 14714, CAS: 203395-84-0, stock: 8.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈BrN₃O₂.

OPC 4392 Hydrochloride Salt, CAS: /, stock: 8.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉N₃O₂ (free base).

Arbidol, CAS: 131707-23-8, stock: 1.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆BrClN₂O₃S.

Arbidol Sulfoxide, CAS: 151455-33-3, stock: 6.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅BrN₂O₄S.

Arbidol-d6, CAS: /, stock: 2.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀D₆BrClN₂O₃S.

Arbidol-d6 Sulfoxide, CAS: /, stock: 9.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉D₆BrN₂O₄S.

Arbitol Sulfone, CAS: 151455-32-2, stock: 3.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅BrN₂O₅S.

Arbitol Sulfone-d6, CAS: /, stock: 2.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉D₆BrN₂O₅S.

RUK-P1, CAS: /, stock: 9.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈BrNO₅S.

RUK-P2, CAS: /, stock: 9.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀BrN₃O₃S.

Umifenovir, CAS: 131707-25-0, stock: 8.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅BrN₂O₃S.

(2R,​3S,​4S)​-​3,​4-​bis(benzyloxy)​-​2-​((benzyloxy)​methyl)​tetrahydrothiophene, CAS: 187590-77-8, stock: 6.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₈O₃S.

1,4-Dideoxy-1,4-imino-D-arabinitol Hydrochloride, CAS: 100991-92-2, stock: 7.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₃ • HCl.

1-Octene-d13, CAS: /, stock: 2.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₃D₁₃.

1-Pentene-4,4,5,5,5-d5, CAS: 80820-43-5, stock: 3.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅D₅.

2,3,5-Tri-O-benzyl-D-arabinitol, CAS: 14233-53-5, stock: 7.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₀O₅.

2-Acetamido-1,4-imino-1,2,4-trideoxy-L-arabinitol, CAS: 944329-24-2, stock: 9.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄N₂O₃.

3-(D-Glucopentitol-1-yl)-1,2,4-triazolo[3,4-a]phthalazine, CAS: 79364-50-4, stock: 4.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₄O₅.

5-Deoxy-D-arabinitol, CAS: 67968-44-9, stock: 1.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂O₄.

D-Arabinitol, CAS: 488-82-4, stock: 10g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂O₅.

D-Arabinitol-1,2-13C2, CAS: /, stock: 9.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₂H₁₂O₅.

D-Arabinitol-1-13C, CAS: /, stock: 5.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₁₂O₅.

D-Arabinitol-13C5, CAS: /, stock: 7.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₅H₁₂O₅.

D-Arabinitol-2-13C, CAS: /, stock: 3.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₁₂O₅.

D-Arabinitol-5-13C, CAS: /, stock: 7.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₁₂O₅.

D-Lyxono-1,4-lactone, CAS: 15384-34-6, stock: 1.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈O₅.

L-Arabinitol, CAS: 7643-75-6, stock: 2.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂O₅.

L-Lyxono-1,4-lactone, CAS: 104196-15-8, stock: 5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈O₅.

Salacinol, CAS: 200399-47-9, stock: 2.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈O₉S₂.

3α-Hydroxydesoxy Artemether, CAS: 174097-70-2, stock: 3.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₆O₅.

9-Desmethylene 9-Oxo-artemisitene, CAS: 150930-12-4, stock: 6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈O₆.

Artemether, CAS: 71963-77-4, stock: 6.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₆O₅.

Artemether Succinate Dimer, CAS: /, stock: 8.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₀O₁₂.

Artemether Tetrahydrofuran Acetate, CAS: 181528-64-3, stock: 1.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₆O₅.

Artemether- 13C, d3, CAS: /, stock: 8.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅¹³CH₂₃D₃O₅.

Artemether-d3, CAS: 93787-85-0, stock: 6.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃D₃O₅.

Artemisinin-d4, CAS: /, stock: 7.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈D₄O₅.

Artemisitene-d2, CAS: /, stock: 3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈D₂O₅.

Dihydro Artemisinin, CAS: 71939-50-9, stock: 6.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄O₅.

Dihydro Artemisinin-13C,d4, CAS: /, stock: 1.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄¹³CH₂₀D₄O₅.

Dihydro Artemisinin-d3, CAS: 176774-98-4, stock: 1.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁D₃O₅.

α-Artemether, CAS: 71939-51-0, stock: 7.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₆O₅.

α-Artemether-d3, CAS: 93861-34-8, stock: 4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃D₃O₅.

(2R)-Arimoclomol Maleic Acid, CAS: 289893-26-1, stock: 1.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄ClN₃O₇.

(2R)-Arimoclomol-d10 Maleic Acid, CAS: /, stock: 6.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄D₁₀ClN₃O₇.

(2S)-Arimoclomol Maleic Acid, CAS: 289893-28-3, stock: 7.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄ClN₃O₇.

(2S)-Arimoclomol-d10 Maleic Acid, CAS: /, stock: 6.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄D₁₀ClN₃O₇.

2-Hydroxy-4-azoniaspiro[3.5]nonane Chloride, CAS: 15285-58-2, stock: 5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆ClNO.

3-Cyanopyridine N-Oxide, CAS: 14906-64-0, stock: 5.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₂O.

Arimoclomol, CAS: 289893-25-0, stock: 8.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀ClN₃O₃.

N-Hydroxy-1-oxy-nicotinamidine, CAS: 92757-16-9, stock: 4.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇N₃O₂.

rac-Arimoclomol Maleic Acid, CAS: 289893-24-9, stock: 8.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄ClN₃O₇.

rac-Arimoclomol Maleic Acid-d10, CAS: /, stock: 1.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄D₁₀ClN₃O₇.

(+/-)-9-HETE, CAS: 79495-85-5, stock: 4.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₃.

(+/-)5-HETE, CAS: 73307-52-5, stock: 3.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₃.

(5Z,8Z,11Z,14Z)-Ethyl 16-(3-Ethyloxiran-2-yl)hexadeca-5,8,11,14-tetraenoate, CAS: /, stock: 3.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₄O₃.

(5Z,8Z,11Z,14Z)-Ethyl 17-Oxoheptadeca-5,8,11,14-tetranoate, CAS: /, stock: 9.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₈O₃.

(5Z,8Z,11Z,14Z)-Ethyl 18-Bromo-17-hydroxyicosa-5,8,11,14-tetraenoate, CAS: /, stock: 7.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₅BrO₃.

(5Z,8Z,11Z,14Z)-Ethyl Icosa-5,8,11,14-tetraenoate-d5, CAS: /, stock: 1.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₁D₅O₂.

(5Z,​8Z,​11Z,​14Z)​-5,​8,​11,​14-​Eicosatetraenoic Acid 2-​[[(1,​1-​Dimethylethoxy)​carbonyl]​amino]​ethyl Ester, CAS: 1453807-04-9, stock: 2.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₅NO₄.

(6Z)-6-Octadecenoic Acid, CAS: 593-39-5, stock: 3.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₄O₂.

(all-cis)-8,11,14,17-Eicosatetraenoic Acid (10 mg/mL ethanol), CAS: 24880-40-8, stock: 7.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₂.

(all-cis)-8,11,14,17-Eicosatetraenoic Acid N-Hydroxysuccinimidyl Ester, CAS: 1798416-88-2, stock: 5.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₅NO₄.

1-(2,6-Dichlorophenyl)-1,3-dihydro-6-hydroxy-2H-indol-2-one, CAS: 1173794-86-9, stock: 1.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉Cl₂NO₂.

1-(Benzo[b]thien-2-yl)ethanol, CAS: 51868-95-2, stock: 3.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀OS.

1-Bromo-2,5,8,11,14,17,20-tricosaheptayne, CAS: /, stock: 5.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₉Br.

1-Bromo-2,5,8,11,14,17-icosahexayne, CAS: /, stock: 3.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₇Br.

1-Bromo-2,5,8,11,14-heptadecapentayne, CAS: 93322-84-0, stock: 7.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅Br.

12(S),20-DiHETE, CAS: 89614-44-8, stock: 3.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₄.

12(S)-HHTrE, CAS: 54397-84-1, stock: 7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₈O₃.

12(S)-Hydroxy (5Z,8Z,10E,14Z)-Eicosatetraenoic Acid, CAS: 54397-83-0, stock: 6.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₃.

12(S)-Hydroxy (5Z,8Z,10E,14Z)-Eicosatetraenoic Acid-d4, CAS: /, stock: 1.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈D₄O₃.

14,15-Epoxyeicosatrienoic Acid, CAS: 197508-62-6, stock: 8.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₃.

15(S)-HETE, CAS: 54845-95-3, stock: 9.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₃.

15(S)-HPETE, CAS: 70981-96-3, stock: 9.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₄.

15-KETE (15-oxo-ETE), CAS: 81416-72-0, stock: 6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀O₃.

15-Keto Prostaglandin E2, CAS: 26441-05-4, stock: 8.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀O₅.

16(S)-HETE, CAS: 183509-23-1, stock: 1.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₃.

17(S)-HETE, CAS: 183509-25-3, stock: 3.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₃.

2,5,8,11,14,17,20-Tricosaheptayn-1-ol, CAS: /, stock: 2.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₀O.

2,5,8,11,14,17-Icosahexayn-1-ol, CAS: /, stock: 2.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈O.

2,5,8,11,14-Heptadecapentayn-1-ol, CAS: 93318-79-7, stock: 9.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆O.

2,6-Dichloro-N-(3-methoxyphenyl)benzenamine, CAS: 320777-21-7, stock: 5.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁Cl₂NO.

2-Chloro-N-(2,6-dichlorophenyl)-N-(3-methoxyphenyl)-acetamide, CAS: 1173794-83-6, stock: 3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂Cl₃NO₂.

2-[(2,6-Dichlorophenyl)amino]-4-(phenylmethoxy)-benzeneacetic Acid, CAS: 1173794-94-9, stock: 3.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₇Cl₂NO₃.

20-Carboxy Arachidonic Acid, CAS: 79551-84-1, stock: 7.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀O₄.

20-Carboxy Arachidonic Acid-d8, CAS: /, stock: 7.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂D₈O₄.

20-HETE, CAS: 79551-86-3, stock: 9.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₃.

3’-Hydroxy-4’-methoxydiclofenac, CAS: 106610-60-0, stock: 6.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃Cl₂NO₄.

2-Chloro-N6-cyclopentyl-d4 Adenosine, CAS: /, stock: 6.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆D₄ClN₅O₄.

4-Hydroxy Diclofenac Acyl Glucuronide, CAS: /, stock: 7.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉Cl₂NO₉.

6-(Benzyloxy)-1-(2,6-dichlorophenyl)indolin-2-one, CAS: /, stock: 6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₅Cl₂NO₂.

Apadenoson-d5, CAS: /, stock: 1.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅D₅N₆O₆.

trans-1,4-Cyclohexanedimethanol, CAS: 3236-48-4, stock: 5.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆O₂.

8(S),15(S)-DiHETE (Z, E, Z, E), CAS: 80234-65-7, stock: 1.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₄.

Arachidonic Acid 1,2,3,4-13C4, CAS: /, stock: 1.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆¹³C₄H₃₂O₂.

trans-4-(2-Propynyl)-cyclohexanemethanol, CAS: 250682-79-2, stock: 2.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆O.

Arachidonic Acid Alkyne, CAS: 1219038-32-0, stock: 1.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₂.

Arachidonic Acid Glycidyl Ester, CAS: 439146-24-4, stock: 3.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₆O₃.

trans-4-(2-Propynyl)cyclohexanecarboxylic Acid Methyl Ester, CAS: 250682-81-6, stock: 6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆O₂.

Arachidonic Acid Glycidyl Ester-d5, CAS: /, stock: 3.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₁D₅O₃.

Arachidonic Acid Methyl Ester, CAS: 2566-89-4, stock: 3.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₄O₂.

Arachidonic Acid Methyl Ester-d3, CAS: /, stock: 7.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₁D₃O₂.

Arachidonic Acid N-Hydroxysuccinimidyl Ester, CAS: 187224-28-8, stock: 1.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₅NO₄.

Arachidonic Acid,  >90% Technical Grade Discontinued, see A765000, CAS: 506-32-1, stock: 8.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₂.

Arachidonic Acid, >97%, CAS: 506-32-1, stock: 8.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₂.

Arachidonic Acid-d11, CAS: 1287387-84-1, stock: 1.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁D₁₁O₂.

Arachidonic Acid-d8 (Major, 10mg/ml in Methyl Acetate), CAS: 69254-37-1, stock: 9.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄D₈O₂.

Arachidonoyl Chloride, CAS: 57303-04-5, stock: 7.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₁ClO.

Arachidonoyl-1-thio-Glycerol, CAS: 1309664-54-7, stock: 6.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₈O₃S.

Caffeic Acid Phenethyl Ester, CAS: 104594-70-9, stock: 5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆O₄.

Cholesteryl Arachidonate, CAS: 604-34-2, stock: 6.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₇₆O₂.

delta17-Prostaglandin E1, CAS: 7046-45-9, stock: 9.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₅.

Eicosapentaenoic Acid, CAS: 10417-94-4, stock: 7.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀O₂.

Eicosapentaenoic Acid Ethyl Ester, CAS: 86227-47-6, stock: 3.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₄O₂.

Eicosapentaenoic Acid-d5, CAS: 1197205-73-4, stock: 1.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅D₅O₂.

Eicosapentaenoic Acid-d5 Ethyl Ester, CAS: 1185247-85-1, stock: 3.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₉D₅O₂.

Eoxin D4, CAS: 75290-64-1, stock: 7.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₀N₂O₆S.

Ethyl Arachidonate, CAS: 1808-26-0, stock: 4.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₆O₂.

Ethyl Arachidonate-d5, CAS: 1331642-74-0, stock: 3.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₁D₅O₂.

Human AA(Arachidonic Acid) ELISA Kit (96T), CAS: /, stock: 9.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Leukotriene B5, CAS: 80445-66-5, stock: 3.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀O₄.

Leukotriene Bx, CAS: 79056-01-2, stock: 1.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₄.

Leukotriene E4, CAS: 75715-89-8, stock: 9.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₇NO₅S.

Leukotriene E4-d11, CAS: 1356578-40-9, stock: 5.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆D₁₁NO₅S.

N-(1-Benzo[b]thien-2-yl-ethyl)-N-hydroxy O-phenyl Carbamate, CAS: 1026256-93-8, stock: 7.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅NO₃S.

N-(p-amylcinnamoyl) Anthranilic Acid, CAS: 110683-10-8, stock: 2.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃NO₃.

n-Propyltriphenylphosphonium-d5 Bromide, CAS: 1703757-22-5, stock: 3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

NQ 301, CAS: 130089-98-4, stock: 6.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₂ClNO₃.

O-Arachidonoyl Ethanolamine Hydrochloride, CAS: 443129-35-9, stock: 5.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₆NO₂•HCl.

p-Anisyl Ethyl Ether, CAS: 55249-73-5, stock: 5.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄O₂.

Prostaglandin B1, CAS: 13345-51-2, stock: 6.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₄.

rac-12-bis(Heptanoylthio)glycerophosphocholine, CAS: 210584-04-6, stock: 5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₄NO₆PS₂.

RHC-80267, CAS: 83654-05-1, stock: 4.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₄N₄O₄.

Tenidap, CAS: 120210-48-2, stock: 2.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉ClN₂O₃S.

Tenidap-d3, CAS: /, stock: 9.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₆D₃ClN₂O₃S.

Tetranor-PGDM, CAS: 70803-91-7, stock: 10g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄O₇.

Tetranor-PGDM-d6, CAS: 1314905-92-4, stock: 7.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈D₆O₇.

Triarachidonin-d5, CAS: /, stock: 7.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₃H₉₃D₅O₆.

Universal AA(Arachidonic Acid) ELISA Kit (96T), CAS: /, stock: 9.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

(1S)-1-(3-Ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethylamine, CAS: 608141-42-0, stock: 4.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉NO₄S.

Zileuton, CAS: 111406-87-2, stock: 4.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂O₂S.

Zileuton-d4 (major), CAS: 1189878-76-9, stock: 3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈D₄N₂O₂S.

(2S,3S,4S,5R,6S)-6-(5-((R)-1-(4-Acetamido-1,3-dioxoisoindolin-2-yl)-2-(methylsulfonyl)ethyl)-2-ethoxyphenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic Acid, CAS: /, stock: 9.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₀N₂O₁₃S.

(αR)​-3-​Ethoxy-​4-​methoxy-​α-​[(methylsulfonyl)​methyl]​-benzenemethanamine, CAS: 608142-27-4, stock: 6.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉NO₄S.

(αR)​-3-​Ethoxy-​4-​methoxy-​α-​[(methylsulfonyl)​methyl]​-benzenemethanamine-d5, CAS: /, stock: 5.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄D₅NO₄S.

(αS)-3-Ethoxy-4-methoxy-α-[(methylsulfonyl)methyl]-N-[(1S)-1-phenylethyl]-benzenemethanamine, CAS: /, stock: 7.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆N₂O₈S.

(R)-Apremilast, CAS: 608141-44-2, stock: 7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄N₂O₇S.

(R)-Apremilast-d5, CAS: /, stock: 8.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉D₅N₂O₇S.

1-(3-Ethoxy-4-methoxy-phenyl)-2-methanesulfonylethylamine, CAS: 253168-94-4, stock: 8.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉NO₄S.

2-(Acetylamino)-6-[[[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]amino]carbonyl]-benzoic Acid, CAS: 1809170-71-5, stock: 5.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆N₂O₈S.

3-(Acetylamino)-1,2-benzenedicarboxylic Acid Methyl Ester, CAS: 144841-10-1, stock: 5.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO₅.

3-Acetamidophthalic Acid, CAS: 15371-06-9, stock: 1.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉NO₅.

3-Acetylaminophthalic Anhydride, CAS: 6296-53-3, stock: 3.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇NO₄.

3-Aminophthalic Acid, CAS: 5434-20-8, stock: 8.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇NO₄.

Apremilast, CAS: 608141-41-9, stock: 1.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄N₂O₇S.

Apremilast-d5, CAS: 1258597-47-5, stock: 5.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉D₅N₂O₇S.

Des-acetyl Apremilast, CAS: 635705-72-5, stock: 9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂N₂O₆S.

Desoxo Apremilast, CAS: /, stock: 9.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₄₈N₄O₁₄S₂.

Methyl 3-Nitrophthalate, CAS: 21606-04-2, stock: 4.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇NO₆.

N-(2-(1-(3-Ethoxy-4-methoxyphenyl)-2-((2-hydroxyethyl)sulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide, CAS: /, stock: 2.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆N₂O₈S.

N-Desacetyl O4-Desmethyl Apremilast, CAS: 1384440-16-7, stock: 6.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀N₂O₆S.

N-Desacetyl O4-Desmethyl O3-Desethyl Apremilast, CAS: 1384439-80-8, stock: 7.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆N₂O₆S.

N-Desacetyl-N-formyl Apremilast, CAS: 2077897-94-8, stock: 2.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂N₂O₇S.

N-[2-[(1S)-1-(3-Ethoxy-4-hydroxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]acetamide, CAS: 1384441-38-6, stock: 4.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂N₂O₇S.

O3-Desethyl Apremilast, CAS: 1384967-20-7, stock: 1.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀N₂O₇S.

O4-Desmethyl O3-Desethyl Apremilast, CAS: 1384439-79-5, stock: 6.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈N₂O₇S.

rac-3’-O-Desethyl-3’-O-methyl Apremilast, CAS: /, stock: 4.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂N₂O₇S.

rac-3’-O-Desethyl-3’-O-methyl Apremilast-d3, CAS: /, stock: 2.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₉D₃N₂O₇S.

rac-4-Desacetamido-4-acetyl 3’-O-Desethyl-3’-O-methyl Apremilast, CAS: /, stock: 6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁NO₇S.

rac-4’-O-Desmethyl-4’-O-ethyl Apremilast, CAS: /, stock: 4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆N₂O₇S.

rac-4’-O-Desmethyl-4’-O-ethyl Apremilast-d5, CAS: /, stock: 8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₁D₅N₂O₇S.

rac-4’-O-Ethyl-3’-O-methyl Apremilast, CAS: /, stock: 1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄N₂O₇S.

rac-4’-O-Ethyl-3’-O-methyl Apremilast-d5, CAS: /, stock: 7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉D₅N₂O₇S.

rac-N-Deacetyl-2-carboxy-(seco-phthalimido) Apremilast, CAS: /, stock: 3.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O₇S.

Aegeline, CAS: 456-12-2, stock: 9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉NO₃.

Aegeline-d3, CAS: /, stock: 4.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆D₃NO₃.

α-(Aminomethyl)-p-anisyl Alcohol, CAS: 55275-61-1, stock: 8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃NO₂.

(1S)-1-Cyclopropylethan-1-amine Hydrochloride, CAS: 178033-78-8, stock: 2.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁N • HCl.

(±)-Apomorphine, CAS: 61503-74-0, stock: 7.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇NO₂.

(±)-Apomorphine-d3 hydrochloride, CAS: /, stock: 6.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆F₃NO.

(R)-(-)-Apomorphine Hydrochloride, CAS: 314-19-2, stock: 5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇NO₂ •HCl.

(R)-Apomorphine 2-Picolinate, CAS: /, stock: 7.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇NO₂•C₆H₅NO₂.

(R)-Apomorphine 5-Hydroxy-2-picolinate, CAS: /, stock: 4.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇NO₂•C₆H₅NO₃.

(R)-Apomorphine Foscarnet, CAS: /, stock: 1.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇NO₂•CH₃O₅P.

(R)-Apomorphine Hydrobromide, CAS: 57072-41-0, stock: 9.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇NO₂ • HBr.

(R)-Apomorphine Hydrochloride Hemihydrate, CAS: 41372-20-7, stock: 7.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈ClNO₂ • 1/2 H ₂O.

(R)-Apomorphine Methanesulfinic Acid Salt, CAS: /, stock: 3.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇NO₂•MeSO₃H.

(R)-Apomorphine Succinyl-α-cyclodextin, CAS: /, stock: 1.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇NO₂•C₄₀H₆₄O₃₃.

(R)-Apomorphine Trifluoroacetic Acid Salt, CAS: /, stock: 7.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇NO₂•CF₃CO₂H.

(R)-Apomorphine-d2-d4 Hydrochloride, CAS: /, stock: 7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅D₂NO₂ . (HCl).

(R)-Apomorphine-d3 Hydrochloride, CAS: 1286600-66-5, stock: 2.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅D₃ClNO₂.

(R)-Apomorphine-d5 Hydrochloride (Major), CAS: 76787-63-8, stock: 1.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₃D₅ClNO₂.

(1’R,2R,3R)-Defluoro Fosaprepitant Dimeglumine, CAS: /, stock: 2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₇F₆N₆O₁₆P.

(R)​-​(-​)​-​Apomorphine, CAS: 58-00-4, stock: 9.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇NO₂.

(1’R,2R,3R)-Fosaprepitant Dimeglumine, CAS: /, stock: 5.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₆F₇N₆O₁₆P.

(1’R,2R,3S)-Defluoro Fosaprepitant Dimeglumine, CAS: /, stock: 7.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₇F₆N₆O₁₆P.

(S)-Apomorphine Hydrochloride, CAS: 41035-30-7, stock: 6.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈ClNO₂.

(1’R,2S,3R)-Defluoro Fosaprepitant Dimeglumine, CAS: /, stock: 6.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₇F₆N₆O₁₆P.

(1’R,2S,3R)-Fosaprepitant Dimeglumine, CAS: /, stock: 8.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₆F₇N₆O₁₆P.

(1’R,2S,3S)-Defluoro Fosaprepitant Dimeglumine, CAS: /, stock: 8.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₇F₆N₆O₁₆P.

(1’R,2S,3S)-Fosaprepitant Dimeglumine, CAS: /, stock: 3.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₆F₇N₆O₁₆P.

5,7-Dihydroxy-2-(2-oxobenzo[d][1,3]dioxol-5-yl)chroman-4-one, CAS: /, stock: 3.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₀O₇.

(1’S,2R,3R)-Defluoro Fosaprepitant Dimeglumine, CAS: /, stock: 5.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₇F₆N₆O₁₆P.

(1’S,2R,3R)-Fosaprepitant Dimeglumine, CAS: /, stock: 4.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₆F₇N₆O₁₆P.

(1’S,2R,3S)-Defluoro Fosaprepitant Dimeglumine, CAS: /, stock: 1.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₇F₆N₆O₁₆P.

(1’S,2R,3S)-Fosaprepitant Dimeglumine, CAS: /, stock: 4.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₆F₇N₆O₁₆P.

(1’S,2S,3R)-Defluoro Fosaprepitant Dimeglumine, CAS: /, stock: 8.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₇F₆N₆O₁₆P.

L-Prolyl-L-leucylglycinamide, CAS: 2002-44-0, stock: 7.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₄N₄O₃.

(1’S,2S,3R)-Fosaprepitant Dimeglumine, CAS: /, stock: 4.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₆F₇N₆O₁₆P.

(1’S,2S,3S)-Defluoro Fosaprepitant Dimeglumine, CAS: /, stock: 7.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₇F₆N₆O₁₆P.

(1’S,2S,3S)-Fosaprepitant Dimeglumine, CAS: /, stock: 8.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₆F₇N₆O₁₆P.

(2R)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-5,6-dihydro-2H-1,4-oxazine, CAS: 380499-07-0, stock: 7.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆F₇NO₂.

(2R)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-4-(phenylmethyl)-3-morpholinone, CAS: 287930-75-0, stock: 5.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₉F₆NO₃.

(2R,3R,1’S)-Aprepitant, CAS: 1242175-34-3, stock: 9.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₁F₇N₄O₃.

Norapomorphine Glucuronidate, CAS: /, stock: 10g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃NO₈.

(2S,3R,1’R)-Aprepitant, CAS: 1185502-97-9, stock: 7.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₁F₇N₄O₃.

(2S,3S,1’R)-Aprepitant, CAS: 172822-28-5, stock: 5.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₁F₇N₄O₃.

(5R,6R)-6-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-5-(4-fluorophenyl)-3-morpholinone, CAS: 419574-33-7, stock: 2.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆F₇NO₃.

(5R,6S)-6-[(1S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-5-(4-fluorophenyl)-3-morpholinone, CAS: /, stock: 6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆F₇NO₃.

(5S,6R)-6-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-5-(4-fluorophenyl)-3-morpholinone[Aprepitant-M3], CAS: 419574-04-2, stock: 6.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆F₇NO₃.

(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol, CAS: 127852-28-2, stock: 9.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈F₆O.

(R,R,R)-Aprepitant, CAS: 1148113-53-4, stock: 3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₁F₇N₄O₃.

(S)-3’,5’-Bis(trifluoromethyl)-1-phenethanol, CAS: 225920-05-8, stock: 9.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈F₆O.

(S,S,S)-Aprepitant, CAS: 1242175-40-1, stock: 3.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₁F₇N₄O₃.

1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(p-tolyl)morpholino)methyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic Acid, CAS: /, stock: 6.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₁F₆N₄O₆P.

2,2-Bis[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-1-(4-fluorophenyl)ethanone, CAS: 419574-40-6, stock: 6.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₁₉F₁₃O₃.

2-(R)-[1-(R)-(3,5-Bis(trifluoromethyl)phenyl)ethoxy]-3-(S)-fluorophenyl-4-[(2-N-methoxycarbonyl)acetamidrazono]morpholine-13C2,d2, CAS: /, stock: 7.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂¹³C₂H₂₃D₂F₇N₄O₄.

2-(R)-[1-(R)-(3,5-Bis(trifluoromethyl)phenyl)ethoxy]-3-(S)-fluorophenylmorpholine[Aprepitant-M2], CAS: 171338-27-5, stock: 1.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈F₇NO₂.

S(+)-Propylnorapomorphine Hydrochloride, CAS: 84454-80-8, stock: 2.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁NO₂ • (HCl).

2-(R)-[1-(R)-(3,5-Bis(trifluoromethyl)phenyl)ethoxy]-3-(S)-fluorophenylmorpholine-d2[Aprepitant-M2-d2], CAS: 1217645-68-5, stock: 2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆D₂F₇NO₂.

2-(R)-[1-(S)-(3,5-Bis(trifluoromethyl)phenyl)ethoxy]-3-(S)-fluorophenylmorpholine, CAS: 170729-79-0, stock: 3.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈F₇NO₂.

2-(R)-[1-(S)-(3,5-Bis(trifluoromethyl)phenyl)ethoxy]-3-(S)-fluorophenylmorpholine-d2, CAS: 1217725-13-7, stock: 8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆D₂F₇NO₂.

2-Hydroxy-4-(phenylmethyl)-3-morpholinone, CAS: 287930-73-8, stock: 5.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₃.

2-[(1S)-1-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-2-(4-fluorophenyl)-2-oxoethoxy]acetic Acid Methyl Ester, CAS: 419574-29-1, stock: 4.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₇F₇O₅.

3-Des-(4-fluorophenyl) 3-(4-Fluorobiphen-3-yl) Aprepitant, CAS: /, stock: 3.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₅F₇N₄O₃.

3-Des-(4-fluorophenyl) 3-(R)-(4’-Fluorobiphen-4-yl) Aprepitant, CAS: /, stock: 6.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₅F₇N₄O₃.

4-Benzyl-2,3-morpholinedione, CAS: 110843-90-8, stock: 4.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO₃.

4-Defluoro-3-(p-fluorophenyl) Aprepitant, CAS: /, stock: 9.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₅F₇N₄O₃.

4-Defluoro-4-(p-fluorophenyl)aprepitant, CAS: /, stock: 9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₅F₇N₄O₃.

4-Defluoro-4-(p-fluorophenyl)aprepitant-13C, 15N2, CAS: /, stock: 6.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈¹³CH₂₅F₇N₂¹⁵N₂O₃.

5-Chloromethyl-2H-1,2,4-triazolin-3-one, CAS: 252742-72-6, stock: 3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₄ClN₃O.

6-(4-Fluorophenyl)-3-morpholinone, CAS: 951626-54-3, stock: 4.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀FNO₂.

Aprepitant, CAS: 170729-80-3, stock: 8.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₁F₇N₄O₃.

Aprepitant 2,3,4-Tri-O-acetyl-β-Glucuronide Methyl Ester, CAS: /, stock: 3.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₇F₇N₄O₁₂.

Aprepitant Di-(2,3,4-tri-O-acetyl-β-Glucuronide Methyl Ester), CAS: /, stock: 2.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₉H₅₃F₇N₄O₂₁.

Aprepitant β-Glucuronide Sodium Salt, CAS: /, stock: 1.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₈F₇N₄NaO₉.

Aprepitant N-Oxide, CAS: 172673-23-3, stock: 7.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₁F₇N₄O₄.

Aprepitant-13C2,d2 (Major), CAS: 1217676-37-3, stock: 8.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁¹³C₂H₁₉D₂F₇N₄O₃.

Aprepitant-d4, CAS: 1133387-60-6, stock: 7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₇D₄F₇N₄O₃.

Aprepitant-d4 N-Oxide, CAS: /, stock: 4.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₇D₄F₇N₄O₄.

Defluoro Aprepitant, CAS: 170729-76-7, stock: 2.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₂F₆N₄O₃.

Des-1,2,4-triazol-3-one-5-methyl (2S,3R,1’R)-Aprepitant, CAS: 1185503-48-3, stock: 2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈F₇NO₂.

Des-1,2,4-triazol-3-one-5-methyl (2S,3R,1’S)-Aprepitant, CAS: 327623-37-0, stock: 5.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈F₇NO₂.

ent-Aprepitant, CAS: 172822-29-6, stock: 4.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₁F₇N₄O₃.

ent-Aprepitant-13C15N2, CAS: /, stock: 9.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂¹³CH₂₁F₇N₂¹⁵N₂O₃.

Fosaprepitant Dibenzyl Ester, CAS: 265121-01-5, stock: 8.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₃₄F₇N₄O₆P.

Fosaprepitant Dimeglumine, CAS: 265121-04-8, stock: 6.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₆F₇N₆O₁₆P.

Fosaprepitant N-oxide, CAS: /, stock: 7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₂F₇N₄O₇P.

Fosaprepitant-13C,15N3 Dimeglumine, CAS: /, stock: 6.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆¹³CH₅₆F₇N₃¹⁵N₃O₁₆P.

Fosaprepitant-d4 Dimeglumine, CAS: /, stock: 9.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₂D₄F₇N₆O₁₆P.

Monobenzyl Fosaprepitant, CAS: 889852-02-2, stock: 7.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₈F₇N₄O₆P.

Monobenzyl Fosaprepitant-d4, CAS: /, stock: 2.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₄D₄F₇N₄O₆P.

N-(Destriazolonomethyl) N-(Methylcarboxyacetamidohydrazono) Aprepitant, CAS: 219821-37-1, stock: 1.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅F₇N₄O₄.

[1(S)-Phenylethoxy]-Aprepitant, CAS: 170902-81-5, stock: 5.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₁F₇N₄O₃.

(2S)-2-Amino-hexanedioic Acid, CAS: 1118-90-7, stock: 2.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₄.

1,4,7-Trioxacyclotridecane-8,13-dione, CAS: 6607-34-7, stock: 4.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆O₅.

1,6-Dioxacyclododecane-7,12-dione, CAS: 777-95-7, stock: 6.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆O₄.

2,5-Dimethyl-3-thiaadipic Acid, CAS: 106014-16-8, stock: 3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂O₄S.

2-Bromo-1,6-dimethyl Ester Hexanedioic Acid, CAS: 3196-19-8, stock: 9.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃BrO₄.

2-Hydroxyhexanedioic Acid Disodium Salt, CAS: /, stock: 6.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈Na₂O₅.

3-Aminoadipic Acid, CAS: 5427-96-3, stock: 9.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₄.

3-Hydroxyhexanedioic Acid, CAS: 14292-29-6, stock: 4.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₅.

3-Methyl-1-(2-(1-piperidinyl)phenyl)butylamine Adipate (1:3), CAS: 1262393-01-0, stock: 9.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₆N₂•3 x   C₆H₁₀O₄.

3-Oxohexanedioic Acid, CAS: 689-31-6, stock: 7.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈O₅.

3-Oxohexanedioic Acid Diethyl Ester, CAS: 7149-59-9, stock: 5.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆O₅.

4-(Dimethyl-t-butylsilyloxy)butan-1-ol-d8, CAS: 1224439-44-4, stock: 8.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆D₈O₂Si.

6-Oxo DL-Norleucine, Formate Salt, CAS: 1962-83-0, stock: 8.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃NO₅.

6-Oxo-L-pipecolic Acid, CAS: 34622-39-4, stock: 7.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉NO₃.

Adipic Acid, CAS: 124-04-9, stock: 4.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₄.

Adipic Acid Dihydrazide, CAS: 1071-93-8, stock: 3.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄N₄O₂.

Adipic Acid Dihydrazide Bis-methylene Hydrazone, CAS: /, stock: 2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄N₄O₂.

Adipic Acid Dihydrazide Monomethylene Hydrazone, CAS: /, stock: 8.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄N₄O₂.

Adipic Acid Monoethyl Ester, CAS: 626-86-8, stock: 6.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄O₄.

Adipic Acid Monomethyl Monohydrazide, CAS: 1207956-09-9, stock: 3.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄N₂O₃.

Adipic Acid Propyl 2-Propyl Ester, CAS: /, stock: 7.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₄.

Adipic Acid-13C6, CAS: 942037-55-0, stock: 8.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₁₀O₄.